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Abstract
 The work presented in this thesis is focused on the molecular recognition of DNA by minor 
groove binding polyamides. Methods and strategies for the solution-phase synthesis of hairpin and 
cyclic pyrrole-imidazole polyamides are presented with optimized protocols requiring little to no 
chromatography. These synthetic strategies have led to the design of cyclic polyamides targeted to 
the androgen response element and are shown to be biologically active and cell permeable in cell 
culture experiments in addition their binding affi nities rival that of most polyamide architectures. 
The structural elucidation of an α-amino-turn-linked cyclic polyamide is presented at 1.17 Å 
resolution providing insight into the detailed molecular recognition process and allosteric modulation 
responsible for the inhibition of transcription factor-DNA binding. Additionally, structural 
elucidation of a β-amino-turn-linked cyclic polyamide, highlighting the conformational differences 
compared to the α-amino-turn linked structure is presented. A structural basis for the inability of 
polyamides to bind dsRNA is also proposed based on biophysical, structural, and modeling data. 
In addition to these studies a new class of programmable oligomers targeting the DNA sequence 
5’-WGGGGW-3’ were shown to inhibit DNA binding of the Nf-kB transcription factor by EMSA 
gel shift. Compounds synthesized in this study were found to possess unique fl uorescent properties 
with the ability to modulate their fl uorescence by binding their targeted dsDNA, leading to sequence 
specifi c fl uorescent detection reagents. Efforts toward the templated-assembly of polyamides using 
higher-order DNA structure (NCP) are also reported and the development of a new profl uorescent 
class of heterocycle, which has the potential to be used as a chemical reporter of ligation events is 
described. 
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1Chapter 1: Introduction to Molecular Recognition of DNA
21.1 Background and Signifi cance
 The fi eld of molecular recognition has come a long way since the organic solvent based 
host-guest chemistry of Lehn and Cram (crown ether cation complexes).1-3 Understanding in a 
predictive and mechanistic sense the molecular recognition between synthetic ligands and biological 
macromolecules in water is fundamental to understanding biochemical processes and cellular 
composition.4 The overall free energy of these complexes often includes a superposition of non-
covalent forces such as hydrogen bonding interactions, dipole-dipole, induced dipole, cation-π, 
lone pair-π, and van der Waals interactions in addition to hydrophobic effects. Understanding 
the intimate interplay of these forces and their contributions to the overall free energy of a host-
guest system has remained one of the ultimate challenges in chemistry and biology. The molecular 
recognition processes involved in nucleic acid-drug and nucleic acid-protein interations are similar 
with both being driven by the hydrophobic effect, a phenomenon which is still not well understood. 
As ligand-receptor recognition proceeds, the optimization of multiple forces ensues including 
minimization of water exposed hydrophobic surfaces and simultaneous maximization of van der 
Waals interactions. Additionally, optimization of all buried hydrogren-bond donor and acceptor 
pairings including solvent-assisted and counterion charge neutralization contribute to the complex 
recognition event. Intimate structural and biophysical knowledge of these processes is fundamental 
to the understanding of nature at the molecular level.
 The DNA double helix, in addition to being the molecular storage unit of genetic information, 
represents one of the ultimate challenges in aqueous based molecular recognition. Over billions of 
years, nature has used selection to evolve protein surfaces that recognize DNA in a cooperative and 
combinatorial fashion allowing for the stringent regulation of the molecular processes crucial to all 
living organisms on earth. Prior to the 1960s, histologists and cell biologists realized that certain 
small molecules could interact specifi cally with cell nuclei.5 Dye molecules such as aminoacridines 
were regularly used for staining tissues and cells and it was recognized that specifi city for different 
nucleic acid structures could be obtained using different dyes. However it was not until the 1960s 
that a formal DNA drug binding hypothesis would be formulated. The “intercalation hypothesis” 
formulated by Leonard Lerman (a graduate student of Linus Pauling at Caltech) in 1961, working 
at the Cambridge MRC laboratory, provided the pivotal turning point in the fi eld of drug-nucleic 
acid recognition.6 Since the intercalation hypothesis, a plethora of biophysical, biochemical, and 
biostructural investigations have unveiled the detailed chemistry and biology of many DNA binding 
drugs, some of which have had a profound impact on human disease (i.e. actinomycin D).5,7,8 The 
3intercalating natural product actinomycin D remained one of the most potent chemotherapeutics 
throughout the 1950s and 1960s along with other nucleic acid binding drugs including cross-
linking agents and powerful alkylators, however the fi rst minor groove binding agents would not 
be discovered until the mid 1960s.5 Even though Lerman himself relied upon X-ray fi ber diffraction 
data for his intercalation hypothesis in the 1960s, it took another 15-20 years before the fi rst single 
crystal X-ray structures of drug-nucleic acid complexes (intercalators) would emerge with the 
seminal work of Sobell, Rich, and Neidle.9-11 The fi rst X-ray structure of a minor groove binder 
would not appear until Dickerson’s report on the 1:1 structure of netropsin complexed with DNA 
in 1985.12 This was soon followed by the 1:1 structure of the distamycin-DNA complex by Rich in 
1987.13 In a seminal study, structural evidence using NMR for the 2:1 binding motif of distamycin 
was provided by Wemmer in 1989,14 however the fi rst single crystal X-ray structure of a 2:1 minor 
groove binding ligand-DNA complex was not realized until the work of Ramakrishnan in 1994 on 
distamycin A.15 Since this work many advances have been made in the fi eld of DNA molecular 
recognition, with minor groove binders representing one of the most promising classes of DNA-
binding molecules for targeted transcriptional therapy.
 The modulation of gene expression using small molecules has been one of the ultimate 
goals of nucleic acid molecular recognition. Complex natural products such as actinomycin D, 
netropsin, and distamycin A have served as inspiration to chemists for the construction of molecular 
architectures capable of nucleic acid recognition with specifi city and affi nities equivalent to and 
rivaling that of endogenous proteins. Initially inspired by the 2:1 binding natural product distamycin, 
pyrrole-imidazole polyamides have evolved into a modular programmable molecular recognition 
system capable of specifi cities and affi nities rivaling that of endogenous transcription factors.16,17 
Modulation of transcription factor-DNA interfaces with small molecules such as pyrrole-imidazole 
polyamides provides a powerful strategy for controlling regulation of the genetic material and 
could eventually impact human medicine. The future of molecular recognition is poised to benefi t 
greatly from advances in biochemical, biophysical, computational, and structural (X-ray, NMR, 
EM, Cryo-EM, etc.) methods along with the new tools of physical biology leading to ever increasing 
resolution and a quantitative understanding of molecular level processes.4,18
1.2 Nucleic Acid Structure
 Deoxyribose nucleic acid (DNA) is the fundamental storage material of genetic information 
and can be characterized chemically as a hetero-polymer consisting of nucleotide monomers linked 
4through their sugar-phosphate backbones.19,20 The 5’ and 3’ hydroxyl groups of the deoxyribose 
sugar defi ne the directionality of the DNA strand while a set of four nucleobases [adenine (A), 
guanine (G), cytosine (C), and thymine (T)] distinguish the nucleotide monomers, providing the 
fundamental building blocks of the genetic code. Figure 1.1 shows the chemical structure of a 
short DNA strand containing all four bases and Figure 1.2 shows the atom numbering conventions. 
Early studies by Chargaff demonstrated that A and T occurred in similar molar ratios as did G 
and C, which in combination with fi ber diffraction data from Rosalind Franklin and Maurice 
Wilkins would eventually lead to Watson and Crick’s base-paired helical model of B-DNA.21 The 
Watson-Crick base paired model of DNA contains a set of rules for which A prefers to bind T 
through two hydrogen bonds and G prefers to bind C through three hydrogen bonds on opposite 
strands as shown in Figure 1.2 (U replaces T in RNA).22 The strands are oriented in an antiparallel 
fashion as they base pair and wind around a central axis. These opposite strands form a double 
helical structure where the Watson-Crick base pairs are stacked and stabilized by a combination of 
favorable hydrophobic effects and hydrogen bonding between paired bases. Due to the length of 
the sugar-phosphate backbone, a helical twist is required to minimize the distance between adjacent 
base pairs and maximize their hydrophobic stacking.19,20
 The sugar-phosphate backbone of DNA is highly dynamic allowing for a diverse range 
of higher order structures depending on 
environmental conditions. The torsion 
angles for the sugar-phosphate backbone 
are defi ned in Figure 1.3 and typically vary 
with ionic strength, pH, sequence, and 
many other factors.19,20 In constrast to RNA, 
where the 2’-hydroxyl of the sugar locks the 
A-form helix into a fairly rigid structure, the 
sugar-phosphate backbone of DNA is highly 
mobile.19,20 DNA conformation can often 
be defi ned by the sugar puckering modes, 
which by convention are named after the 
ring atom and either endo or exo referring 
to the 5’ side of the furanose ring or the 3’ 
side, respectively. Figure 1.3 shows typical 
Figure 1.1 Chemical structure of DNA.
5sugar pucker conformations along with their preference in 
nucleic acid structures. In addition to the sugars displaying 
conformational preferences, the phosphodiester bond exhibits 
conformational rigidity analogous to a peptide bond. This 
conformation rigidity, known as the gauche effect, is a result 
of stereoelectronic effects from lone pair hyperconjugation/
donation of the O3' and O5' oxygen atoms into the σ* orbital 
of the P-O5' and P-O3' bonds, respectively.23 Double helical 
DNA is a dynamic structure which is capable of forming 
three primary double strand conformations known as A, B, 
and Z forms. In contrast to this, double helical RNA is far less 
fl exible with the 2'-OH locking its sugar ring conformation 
into a C3'-endo pucker resulting in a preference for an A form 
helix similar to that of A-form DNA. A structural comparison 
of these ideal DNA polymorphs along with A-form RNA is 
shown in Figure 1.4 and Table 1.1.19,20,23,24,
 In biological systems, especially eukaryotic cells, DNA is assembled around octameric 
proteins called histones and compacted into macrohelical fi bers forming the high-order structure of 
chromatin. This DNA-histone complex is called the nucleosome core particle (NCP) and represents 
the fundamental repeating unit of chromatin consisting of 147 base pairs of DNA forming two 
super helical turns around the histone octomer with 20-80 base pairs of linker DNA separating 
one NCP from the next. The Richmond group25-27 at ETH Zurich has made seminal contributions 
to elucidate biologically relevant higher-order DNA structures such as the NCP25,26 and the tetra-
NCP27 presented Figure 1.5. In addition, a theoretical model of four tetra-NCPs assembled into a 
super-helical chromatin fi ber is presented in Figure 1.5. Chromatin architecture and accessibility in 
biological systems represents a higher-order level of regulation and a profoundly important problem 
for the fi eld of DNA recognition.
1.3 Molecular Recognition of DNA
 One of the largest projects in modern science, the human genome project,28-30 is poised to 
deliver detailed information and make major impacts in biotechnology and medicine through the 
physical and functional characterization of the approximately 20,000 to 25,000 genes in the human 
Figure 1.2 DNA base pairs show-
ing numbering convention for het-
eroatoms and Watson-Crick base 
pairing.
6Figure 1.3 DNA sugar phosphate backbone torsion angle map and sugar puckering conventions. 
a) Chemical structure of DNA sugar phosphate backbone with torsion angles next to the 3-dimen-
sional structure of a nucleoside taken from the native high resolution B-DNA structure solved in 
Chapter 4 of this thesis. b) Pseudorotation phase angle (P) diagram defi ning 5-membered ring sugar 
puckering modes. Equation describing the pseudorotation phase angle and maximum torsion angle 
for 5-membered rings. c) Chemical structure of the most common sugar puckering modes for B-
DNA (C2'-endo) and A-DNA/A-RNA (C3'-endo).
7genome. These genes are tightly regulated in higher organisms by transcription factor assemblies 
that function in a concerted cooperative and combinatorial fashion to modulate eukaryotic gene 
expression. The molecular recognition processes involved in nucleic acid-protein interations 
are completely analogous to those of nucleic acid-drug interactions where initial complexation 
is often driven by the hydrophobic effect. Optimization of the same forces is also required, 
involving minimization of water exposed hydrophobic surfaces and maximization of van der 
Waals interactions in conjuction with the optimization of all buried hydrogren bond donor and 
acceptor pairings (solvent-assisted or counterion charge neutralization).31 The recognition of the 
B-DNA interface by proteins and small molecules can occur at the major groove, minor groove, 
and phosphate backbone, or any combination, with interactions mediated through electrostatics, 
hydrogen bonding, and van der Waals interactions along with base pair stacking for the case of 
intercalators. The DNA base pair edges in the major groove and minor groove provide an array 
Figure 1.4 A comparison of double helical DNA polymorphs and A-form RNA.
8of functionality for hydrogen bonding, hydrophobic interaction, and steric complementarity with 
proteins and small molecule binders.5,8,16,17,31 The molecule electrostatic potential surfaces for the 
minor and major groove base pair edges are shown in Figure 1.6.32 In addition, primary driving 
forces such as the hydrophobic effect and shape complementarity are common to both proteins and 
small molecules. 
 The regulation of gene transcription is controlled by the sequence specifi c cooperative 
assembly of transcription factors, which form regulatory switches and networks in the cell 
providing strigent control over biochemical processes.33 The minor groove and major groove of 
Table 1.1 Typical nucleic acid structural parameters.
9DNA provide distinct surfaces for the interaction of transcription factors through specifi c and 
nonspecifi c interactions such as (hydrogen bonding, electrostatics, van der Waals, etc.). Several 
DNA-binding transcription factors are presented in Figure 1.7 to highlight the diverse architectures 
used for recognizing DNA, ranging from homodimeric coiled coils interacting with the major 
groove to monomeric beta-sheet containing proteins interacting with the minor groove. In addition 
to homodimeric motifs, heterodimeric motifs are utilized along with metal ion coordinated 
assemblies (i.e. Nf-κB p65-p50 and androgen receptor).33 Transcriptional co-activating proteins 
serve to integrate information from transcription factor assemblies and modulate gene expression 
through communication with RNA polymerase II leading to the transcription of protein-coding 
regions in the eukaryotic genome.33,34
 Transcription factors (TF) can communicate indirectly through allosteric modulation of DNA 
resulting in cooperative assembly with very little direct protein-protein interaction. Transcription 
factor binding can cause DNA-sequence dependent structural perturbations which modulate the 
binding of the next TF. TF's can also interact directly through protein-protein interactions to increase 
Figure 1.5 Nucleosome core particle structures. a) Crystal structure of the nucleosome core par-
ticle at 2.80Å determined by Richmond and coworkers. b) X-ray structure of the tetra-NCP deter-
mined at 9Å resolution. c) Theoretical model of a chromatin fi ber constructed from four tetra-NCPs 
by rotation and translation about the central axis.
10
cooperativity. The β-enhancesome (Figure 1.8) is one such example of a cooperative assembly with 
cooperativity most likely arising at the DNA and coactivator levels. A conserved stretch of 55 bp's 
Figure 1.6 Anatomy of the DNA base pair edges and their molecular recognition properties. a) 
Electrostatic potential maps of the base pair edges presented to the major (top) and minor (bottom) 
grooves of DNA. Hydrogen bond donors are designated with red arrows and the letter D. Hydrogen 
bond acceptors are designated with purple arrows and the letter A and functionality for the potenital 
for van der Waals interactions is designated with the appropriate colored line and vdW. b) Top view 
of the Watson-Crick base pair molecular selectrostatic potential surfaces. Electrostatic potential 
maps from native DNA crystal structure sovled in Chapter 4 of this Thesis. 
11
(160 Å long) in a nucleosome free region of the IFN-β promoter serves as a regulatory element 
for the cooperative assembly of 8 proteins into a continuous surface, burying 72% of the DNA 
solvent accessible area with very little protein-protein interaction.35 Transcriptional co-activating 
proteins serve to integrate information from the assembly to modulate gene expression through 
communication with RNA polymerase II leading to transcription.33,34
Figure 1.7 X-ray structures of DNA binding transcription factors [GCN4 (Harrison, 1993), Nf-
κB p65-p50 (Ghosh, 1998), TBP-TATA box (Dickerson, 1996), Zif268 (Pabo, 1996), Androgen 
receptor (Gewirth, 2004)].
12
 A diverse range of natural products and secondary metabolites have been shown to bind 
DNA with interaction modes consisting primarily of either intercalation or groove binding.5,7,8 
In addition, some ligands rely on a combination of intercalation and groove binding that can 
also be augment by covalent modifying chemical domains, as in the case of anthramycin and 
neocarzinostatin. A collection of diverse DNA binding natural products are shown in Figure 1.9 
with echinomycin and daunomycin representing intercalators and anthramycin and dystamicin A 
representing minor groove binders. The natural product distamycin (Figure 1.9) binds to A,T tracks 
in the minor groove of DNA, four to fi ve base pairs in size, in both a 2:1 and a 1:1 ligand:DNA 
stoichiometry.12-14 The affi nity and specifi city of dystamycin is controlled by a superposition of 
shape complementarity, hydrophobic effects, and specifi c hydrogen bonding to the minor groove 
of B-form DNA. Due to it's modular design of repeating pyrrole amino acids and ammenability 
to rational modifi cation, distamycin has served as the inspiration for the design of several classes 
sequence specifi c DNA minor-groove binders, with the ultimate goal of designing highly specifi c 
targeted gene regulation agents.
Figure 1.8 Atomic model of the cooperative assembly of interferon-β enhancesome showing 4-6 
base pair transcription factor binding sites along the highly conserved composite DNA interface of 
55 base pairs spanning approximately 160 Å in length.35
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1.4 DNA Recognition by Minor-Groove Binders
 Prior to the fi rst structure of a molecule bound to DNA, specifi c recognition of B-form 
DNA was predicted to occur in major groove rather than minor groove.5 An observation that was 
based on the fact that the hydrogen bond acceptors at N3 of adenine and O2 of thyamine A/T base 
pairs are similarly placed and lack any prominent distinguishing features.36 With the combination of 
biophysical and structural data from NMR and X-ray studies, it was verifi ed that the minor groove of 
B-form DNA was a legitimate target for specifi c recognition.12-15 (For crystal structures of netropsin 
and distamycin A, see Figure 1.10.) Building upon inspiration from the natural products, netropsin 
Figure 1.9 DNA-binding natural products. 
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and dystamycin, minor groove binders have progressed to a modular molecular recognition platform 
with high affi nity and specifi city for many different sequences of DNA.5,7,8,16,17
 Over the past two decades, the development of minor groove DNA binders has evolved from 
the initial discovery of the natural product dystamycin to a new class of programmable heterocyclic 
oligomers demonstrating high affi nity and sequence specifi city.16,17 In addition to the incorporation 
of alternative heterocycles such as imidazole that have enabled specifi city for guanine recognition 
using the Im-Py pair, much research has gone into linking the two heterocyclic strands in a dimeric 
motif.37-39 Covalent linkage of the two anti-parallel heterocyclic strands by a gamma amino butyric 
acid (GABA) linkage results in increases in affi nity of 100–3600 fold relative to the unlinked 
homodimeric motif.40,41 The incorporation of the turn linkage in the form of a GABA or substituted 
GABA turn represented a major technological advance allowing for the fi rst time the incorporation 
of unsymmetrical ring pairs for the targeting of non-palindromic DNA sequences.37 In addition, 
covalent linkage of the two strands has led to sub-nanomolar increases in affi nity competing with 
and often rivaling that of andogenous DNA binding proteins.16,17,37-39 This high affi nity modular 
dimeric motif has allowed for the regulation of gene expression by direct interaction with the DNA-
Figure 1.10 X-ray crystal structures illustrating DNA recognition by the natural products netropsin 
(left) and distamycin (middle, right). The dicationic natural product netropsin binds preferentially 
to narrow AT tracts in the DNA minor groove as a monomer (PDB: 6BNA). The monocationic 
natural product distamycin also binds AT tracts of the DNA minor groove in a 1:1 (PDB: 2DND)
and 2:1 (PDB: 378D) ligand:DNA stoichiometry.
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protein interface.16,17 
 The four Watson-Crick base pairs can be differentiated by their molecular shape, electrostatic 
potential, and positions of hydrogen bond donors and acceptors in the DNA minor groove fl oor. 
The minor groove edge of a G•C base pair contains a steric hydrogen bond donating “bump” in the 
form of the exocyclic amine of guanine. The steric properties of the exocyclic amine of guanine 
form the basis for the A•T selectivity observed for netropsin and dystamycin binding due to steric 
interaction with the edge of the pyrrole ring. It was discovered in a key study in the early 1990s that 
imidazole in place of pyrrole in a three ring polyamide analogous to dystamycin could bind the 5 
base pair sequence 5’-WGWCW-3’ (where W=A or T) resulting in a 2:1 polyamide-DNA complex 
where the imidazole ring is stacked against a pyrrole ring allowing differentiation of G•C base pairs 
from C•G, A•T, or T•A.42 The Im/Py pair has been used extensively in unlinked polyamides and in 
turn linked polyamides culminating in the recent publication of a polyamide library, that represents 
Figure 1.11 Crystal structure (PDB: 365D) of the 2:1 binding single strand Py/Im polyamide tar-
geted to the sequence 5'-CCAGGCCTGG-3' (2.00 Å resolution). Overall complex is shown on the 
right and the space fi lling model showing the basis for GC recognition is at the bottom left where 
the imidazole lone pair forms a hydrogen bond with the exocyclic N-H of guanine.
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the solutions for targeting various 6 base pair sequences with high affi nity and specifi city.16,17,43 
Thermodynamic studies have revealed that the Im/Py pair sequence selectivity is primarily driven 
by favorable enthalpic factors44,45 and X-ray crystallographic studies in collaboration with the Rees 
group provided structural insight based on a specifi c hydrogen bond between the imidazole lone 
pair and the exocyclic amine of guanine in unlinked 2:1 homodimeric polyamides (Figure 1.11).46
 Discrimination of T•A from A•T base pairs represents a much greater challenge due to the 
ability of thyamine and adenine to both accept a hydrogen bond and the lack of unsymmetrical 
steric features as in the G•C case.16,17 Despite this challenge, a small asymmetric cleft between the 
C2 of adenine and the O2 of thyamine has been exploited for specific targeting by the N-methyl-
3-hydroxypyrrole/N-methylpyrrole (Hp/Py) pair, however affinities of these molecules are slightly 
lower than their Py/Py containing counterparts.16,17 In another seminal structural study with the 
Rees group on Hp containing 2:1 binders, it was revealed that a combination of shape selective 
recognition of the asymmetric cleft along with a specific hydrogen bond between the Hp hydroxyl 
and the thymine O2 was responsible for the A•T specificity (Figure 1.12).47,48 The combination of 
Figure 1.12 Crystal structure (PDB: 407D) of the 2:1 binding single strand ImHpPyPy-β-Dp 
polyamide targeted to the sequence 5'-CCAGTACTGG-3' (2.20 Å resolution). Overall complex is 
shown on the right and the space fi lling model of the basis for AT recognition is shown at the bot-
tom left where the hydroxypyrrole-OH is within hydrogen bonding distance of the carbonyl lone 
pair on T.
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Py, Im, and Hp combined as unsymmetrical pairs in opposite strands of a unlinked homodimeric 
or turn linked polyamide can be used to specifically recognize the four Watson-Crick base pairs 
Figure 1.13 Molecular recognition of the DNA minor groove and polyamide pairing rules. a) Mo-
lecular recognition of the DNA minor groove edges with molecular electrostatic potential surfaces 
showing the array of hydrogen bond donors (D), hydrogen bond acceptors (A), and hydrophobic 
functionality (vdW). b) Polyamide pairing rules.
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(Figure 1.13).16,17 These interactions can be described as a set of guidelines or pairing rules for the 
design of sequence specific B-form DNA targeted polyamides where Im/Py specifies G•C and 
Hp/Py specifies A•T. Some limitations do exist for certain sequences such as homopurine tracts, 
certain G-rich sequences, and sequences beyond 6 base pairs due to the sequence-dependent DNA 
microstructure and overcurvature of longer polyamides, however unique solutions to some of these 
problems have been developed (i.e. incorporation of a flexible β-Ala residue in 1:1 and hairpin 
polyamide motifs).16,17
 In addition to the 2:1 and hairpin polyamide architectures many other strand linkage strategies 
have been explored such as linking through the N-methyl groups on the central heterocycles (H-pin 
motif)49-50 or in the terminal heterocycles (U-pin motif).51 However, one of the highest affi nity and 
in some cases most specifi c polyamide architectures has been the covalent linking of the C- to 
N-termini at both ends of the polyamide into a macrocycle, eliminating all possibility of extended 
binding modes.41,52-55 Macrocyclic γ-turn linked polyamides were fi rst explored as 6 ring systems 
targeting a 5 base pair sequence of DNA in 1995 and were shown to have signifi cantly higher 
affi nity, however their specifi city versus mismatch DNA was only 3-fold compared to 40-fold 
for their hairpin counterparts.52 Mainly due to limitations in synthetic methodology and initial 
discouraging thermodynamic results the cyclic polyamide motif was not investigated further 
until 1999.41 After improvements in solid-phase synthetic methodology, nanomole to micromole 
quantities of polyamides could be readily synthesized although cyclic polyamides still remained 
Figure 1.14 Consequence of covalent attachment of two polyamide strands by incorporation of 
GABA-based turns. (For a structural key to the ball-and-stick nomenclature see the Nomenclature 
and Symbology section at the beginning of this thesis or Figure 1.13).
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challenging.53-55 Using solid-phase methods cyclic polyamides were reinvestigated with two major 
architectural changes.41,53-55 The fi rst being the use of an 8 rings system as oppose to 6 in the original 
studies and the second major change was moving the charge from the pyrrole N-methyl group to the 
alpha position of the γ-turn in the form of (R)-2,4-diaminobutyric acid, that had been discovered to 
increase the affi nity, sequence specifi city, and orientational preference of hairpin polyamides. This 
second generation cyclic 8 ring polyamide motif was found to have greatly improved specifi city 
and affi nity over its hairpin and unlinked counterparts targeting the sequence 5'-AGTACT-3'.41 
The results of covalent attachment of the two polyamide strands can be seen in Figure 1.14. In 
a second study, multiple Hp/Py pairs were introduced into the 8-ring cyclic polyamide motif, 
which resulted in increased affi nity and specifi city relative to hairpin polyamides targeted to the 
sequences 5'-TGAACT-3' and 5'-TGATCT-3'.53 Despite these advances the cyclic polyamide motif 
has received little attention relative to its hairpin counterpart mainly due to synthetic limitations. 
 The chiral (R)-2,4-diaminobutyric acid turn (α-turn) was a major advance in polyamide 
design not only for the cyclic polyamides but primarily for the hairpin motif.38 The addition of 
an amino substituent to the alpha position of the γ-turn helps to disfavor extended 1:1 binding 
modes and reverse binding due to a steric clash with the minor groove fl oor. In addition, the chiral 
amino turn helps to increase the overall affi nity of polyamides while maintaining specifi city and 
improving water solubility.38 The chiral α-turn was proposed to increase affi nity through electrostatic 
interactions between the protonated cationic amine group and the anionic DNA backbone however 
this interaction has not been born out in structural studies (see Chapter 5 and 6 of this thesis).17 In 
Figure 1.15 Consequence of covalent attachment of two polyamide strands by incorporation of 
GABA-based turns.  
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addition to substitution of the γ-turn at the alpha position, many other variations have been studied 
with shorter turns, longer turns, and conformationally constrained variations.16,17,56 The most recent 
and one of the most successful advances in polyamide turn technology is the β-amino γ-linked 
turn.39 Recent studies have demonstrated that this turn can provide substantial increases in affi nity 
for certain polyamide sequences, however the effect is less pronounced as the imidazole content of 
the polyamide is increased (Figure 1.15).39
 NMR structural studies using NOESY-restrained molecular dynamics models have also 
provided insight into 1:1 and 6-ring cyclic polyamides complexed with DNA.55,57 Figure 1.16 shows 
an NMR model of a 1:1 polyamide with 11 out of 40 of the best calculated models overlayed.57 
This shows very small coordinate deviation towards the center of the DNA helix and bound 
polyamide with increasing conformational mobility at the ends. The 6-ring cyclic polyamide model 
represented in Figure 1.16 shows an overlay of 21 of the best calculated models.55 This structure 
shows signifi cant conformational mobility in the 6-ring cyclic complex with a highly fl exible DNA 
sugar-phosphate backbone.
Figure 1.16 NMR NOESY-restrained molecular dynamics models of 1:1 and 6-ring cyclic poly-
amide DNA complexes.
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Figure 1.17 Polyamide 2:1 DNA crystal structures colored by B-factor with red representing the 
largest B-factors and blue representing the smallest.
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 X-ray crystallographic studies resulting from collaborations between the Rees and Dervan 
groups have provided valuable insight into the polyamide-DNA molecular recognition process by 
elucidating the structure of fi ve 2:1 polyamide-DNA complexes at a resolution ranging from 2.00 
to 2.27 Å and a summary comparing specifi c structural parameters is shown in Figure 1.17.46-48 
These crystallographic studies revealed that the DNA rise per base pair matches the polyamide rise 
Figure 1.18 X-ray crystal structures of polyamide-NCP complexes. a) Five polyamides in com-
plex with the NCP at 2.30 Å resolution. b) Two polyamides in complex with the NCP at 2.45 Å 
resolution. c) One polyamides in complex with the NCP at 2.65 Å resolution.
Figure 1.19 Turn-linked polyamide clamp bound to the NCP with the linker traversing the nu-
cleosome super-groove.
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per residue, however the polyamide structure is over-curved with respect to the DNA minor groove 
and shape complementarity is lost beyond a sequence of 5 contiguous base pairs.46 In addition, 
these crystallographic studies elucidated the basis for GC recognition by the Im/Py pair46 and TA 
recognition by the Hp/Py pair47,48 providing fundamental insight into polyamide binding. A variety 
of space groups were observed including monoclinic, orthorhombic, and trigonal with resolutions 
ranging from 2.00 to 2.27 Å. Average R-factors were in the mid-20s and polyamide B-factors 
averaged 47 to 86 Å2 whereas DNA B-factors averaged 43 to 67 Å2 for all structures presented in 
Figure 1.17. The 2:1 binding polyamide crystal structures also frequently exhibited disorder in the 
polyamide tail region and was usually modeled in alterate conformations refl ecting the dynamic 
nature of the β-alanine linked dimethylamino propylamine terminus.
 DNA binding polyamides are also able to bind sequence specifi cally to DNA on the 
nucleosome core particle.58 Hairpin polyamide-NCP crystal structures have been solved at 
resolutions ranging from 2.05 to 2.65 Å providing structural proof that polyamides can bind 
biologically relevant higher-order DNA structure however a combination of resolution limits and 
high B-factors for the polyamide prevented a detailed picture beyond confi rmation of the polyamide 
binding location (Figures 1.18 and 1.19).58,59 The current state of macromolecular crystallography, 
with regard to minor groove binding DNA-drug structures, was assessed prior to beginning the 
structural work presented in Chapter 5 and 6 of this thesis and is presented in Figure 1.20. This 
survey demonstrates the lack of high resolution structures of DNA minor groove binders and the 
notable absence of linked dimeric minor groove binder structures. This survey underscores the 
pressing need for atomic resolution X-ray crystal structures of DNA minor groove binders to truly 
understand the molecular basis of recognition.
1.5 Scope of this work
 The work presented in this thesis is focused on the molecular recognition of DNA by 
minor groove binding polyamides. In Chapter 2 of this thesis, a solution-phase synthesis of pyrrole-
imidazole polyamides is presented with optimized protocols utilizing little to no chromatography. 
Chapter 3 builds on synthetic methodology in Chapter 2 allowing the effi cient synthesis of cyclic 
polyamides targeted to the androgen response element. This chapter demonstrates that cyclic 
polyamides can be synthesized in an effi cient manner, are biologically active and cell permeable 
in cell culture experiments, and rival the binding affi nity of most other polyamide architectures. 
Chapter 4 details an oligomerization route to macrocyclic polyamides and reports on the DNA 
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Figure 1.20 Current state of macromolecular crystallography: A DNA-drug perspective. Data 
compiled from the PDB on 11/04/2007.60 (The number of structures solved is designated in paren-
thesis.)
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binding ability of higher order macrocycles. The structural elucidation of an α-amino-turn-linked 
cyclic polyamide is presented in Chapter 5 at 1.18 Å resolution providing insight into the detailed 
molecular recognition processes. Chaper 6 details the structural elucidation of a β-amino-turn-
linked cyclic polyamide highlighting the conformational differences compared to the α-amino-
turns and providing a structural basis for the inability of polyamides to bind dsRNA. In Chapter 7, a 
new class of programmable oligomers targeting the DNA sequence 5'-WGGGGW-3' were shown to 
inhibit DNA binding of the Nf-κB transcription factor by EMSA gel shift. Compounds discovered 
in Chapter 7 were found to possess unique fl uorescent properties with the ability to modulate their 
fl uorescence by binding their targeted dsDNA site and this work is presented in Chapter 8. Chapter 
9 describes an ongoing effort in the templated-assembly of polyamides using higher-order DNA 
structure (NCP). Additionally, this chapter describes the development of a new profl uorescent class 
of heterocycle, that has the potential to be used as a chemical reporter for templated ligation events. 
Appendix A through F detail results from efforts not covered in the main thesis and a continuation 
of studies from Chapters 3 and 8.
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Chapter 2: Solution-Phase Synthesis of Pyrrole–Imidazole Polyamides
The text of this chapter was taken in part from a manuscript coauthored with Daniel A. Harki, and 
Peter B. Dervan* (Caltech)
(Chenoweth, D.M., Harki, D.A., Dervan, P. B. J. Am. Chem. Soc. 2009 In Press.)
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Abstract
 Pyrrole–imidazole polyamides are DNA-binding molecules that are programmable for a 
large repertoire of DNA sequences. Typical syntheses of this class of heterocyclic oligomers rely 
on solid-phase methods. Solid-phase methodologies offer rapid assembly on a micromole scale 
suffi cient for biophysical characterizations and cell culture studies. In order to produce gram-scale 
quantities necessary for effi cacy studies in animals, polyamides must be readily synthesized in 
solution. An 8-ring hairpin polyamide 1, which targets the DNA sequence 5’-WGWWCW-3’, was 
chosen for our synthesis studies as this oligomer exhibits androgen receptor antagonism in cell 
culture models of prostate cancer. A convergent solution-phase synthesis of 1 from a small set of 
commercially available building blocks is presented which highlights principles for preparing gram 
quantities of pyrrole–imidazole oligomers with minimal chromatography. 
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2.1 Introduction
 Pyrrole–imidazole polyamides are a class of small molecules that bind the minor groove 
of DNA sequence-specifi cally.1,2 Encoded by side-by-side arrangements of N-methylpyrrole (Py) 
and N-methylimidazole (Im) carboxamide monomers, Im/Py pairs distinguish G•C from C•G base 
pairs, whereas Py/Py pairs are degenerate for T•A and A•T.3  Hairpin Py-Im polyamides have been 
shown to bind a broad repertoire of DNA sequences,4 permeate cell membranes and traffi c to the 
nucleus,5 access chromatin,6 and disrupt protein–DNA interfaces.2  Hairpin polyamide inhibition 
of transcription factor–DNA binding of HIF-1α,7 androgen receptor (AR),8 and AP-19 has been 
exploited for controlling expression of medically relevant genes such as VEGF, PSA, TGF-β1, and 
LOX-1 in cell culture experiments. 
 An underpinning to transition polyamide studies from cell culture to small animal disease 
models is the ability to synthesize Py-Im polyamides on gram-scale.  Over the years advances in 
polyamide solid-phase synthesis have been reported, including Boc- and Fmoc-based approaches 
from our laboratories and others.10 Solid-phase methodologies offer many advantages for 
milligram-scale polyamide syntheses, including rapid and reliable amino acid couplings and facile 
purifi cations owing to immobilization of the polyamide oligomer on a solid support.  However, these 
techniques intrinsically limit the scale of synthesis.  Conversely, effi cient gram-scale solution-phase 
methods for polyamide synthesis that avoid arduous chromatographic purifi cations and employ 
commercially available Py-Im amino acid building blocks as reagents are less well developed. 
Remarkably, solution-phase synthesis of hairpin polyamides was the standard in our laboratory 
prior to the development of solid-phase methodologies,11a and many variations on this theme 
have been published.11  However, laborious chromatographic purifi cations and modest reaction 
yields are commonplace.  Therefore, we sought to develop a general solution-phase polyamide 
synthesis method that would allow access to gram quantities of material in high yield with minimal 
chromatography. 
 We report a proof-of-principle study demonstrating that hairpin Py-Im polyamides can 
be synthesized in solution from a small set of building blocks on large scale with minimal use of 
chromatography.  This method involves Boc-protected dimers, trimers, and tetramers of heterocycles 
suitable for convergent syntheses.  By exploiting differences in the physical solubility properties of 
starting materials versus products, a solution-phase synthesis of an 8-ring hairpin Py-Im polyamide 
1 (Figure 2.1) has been achieved.  Notably, our synthesis permits core polyamide 2 (Figure 2.2) 
to be prepared without a single chromatographic purifi cation, thereby providing large quantities 
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of 2 for subsequent modifi cation at the 
C-terminus such as 1.  Py-Im polyamide 
1, which targets the DNA sequence 
5’-WGWWCW-3’, was selected for 
our studies because it antagonizes AR 
binding to androgen response elements 
(ARE) in gene promoters and regulates 
a subset of AR-driven genes, such as 
PSA.5g The regulation of aberrant AR-
activated gene expression in prostate 
cancer is a promising strategy for 
developing novel therapeutics.8 This 
biological activity, coupled with our desire to conduct small animal effi cacy experiments with 1, 
renders this polyamide an ideal candidate for scale-up and optimization studies.  In addition, we 
discuss unifying principles for planning solution-phase polyamide syntheses of different Py-Im 
arrangements.
2.2 Results and Discussion
 Our retrosynthetic approach for the preparation of an 8-ring hairpin polyamide, ImPyPyPy-
(R)β-H2Nγ-ImPyPyPy-(+)-IPA (1), is shown in Figure 2.2.  Sequential couplings of ImPyPyPy 
tetramer 3 to turn moiety 5, followed by ester saponifi cation and coupling to PyPyPy trimer 4, afford 
polyamide 2 in a convergent manner.  Advanced intermediates 3–5 were prepared from building 
blocks 6–10,12 which have been previously synthesized by our laboratory and others.10a,10c,13 The 
cornerstone of our synthesis strategy capitalizes on the disparate physical properties of starting 
materials versus products, which permit purifi cation of each intermediate to be achieved by 
combinations of precipitation, trituration, and crystallization.  Such details are described below. 
 The synthesis of pyrrole trimer 4 begins with pyrrole amine salt 10 (Scheme 2.1). Amide 
coupling of 10 with activated pyrrole monomer 7 affords dimer 11 in 93% yield.  The utilization 
of a small excess of 10 relative to 7 drives the reaction to completion, and residual 10 is readily 
separated from 11 following precipitation in water and aqueous washing of the residual solid 11. 
Reaction of dimer 11 with anhydrous HCl in diethyl ether removes the carbamate protecting group 
and facilitates precipitation of 12 as the HCl salt during the course of the reaction.  Isolation of solid 
12 by fi ltration, followed by washing of the residual solid with excess Et
2
O, provides the amine 
Figure 2.1 Structure of Py-Im hairpin polyamide 1 
targeting the DNA sequence 5’-WGWWCW-3’ and its 
ball-and-stick representation.
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HCl salt in 99% yield. By exploiting the 
aqueous solubility of 10 versus insolubility 
of 11, PyPy dimer 11 is easily purifi ed 
from a small excess of 10 by precipitation, 
whereas deprotected 12 is separable 
from Boc-protected 11 by virtue of the 
Et
2
O solubility of 11 versus insolubility 
of 12.  This reaction sequence highlights 
our synthesis strategy: exploiting the 
different solubility profi les of reactants 
versus products for chromatography-free 
purifi cations. Accordingly, pyrrole trimer 4 
was obtained from dimer 12 by coupling with 
7, followed by acidic deprotection to yield 
4 in 95% yield (two steps) from dimer 12. 
The ImPyPyPy tetramer 3 was synthesized 
in two steps from trimer 4.  1-Methyl-2-
trichloroacetylimidazole (6), prepared in 
one step from N-methylimidazole,10c,13 was 
allowed to react with a small excess of 4 to 
deliver tetramer 14 in 83% yield following 
precipitation in H
2
O, trituration with Et
2
O, 
and drying in vacuo.  Saponifi cation of 
14 with aqueous NaOH in 1,4-dioxane, 
followed by neutralization with aqueous 
HCl, precipitation, and Et
2
O trituration, 
afforded tetramer 3 in 77% overall yield 
from trimer 4.
 The Im-turn fragment 5 was synthesized in two steps from the Im•HCl salt monomer10a 
9 by coupling to PyBOP-activated (R)-3,4-Cbz-Dbu(Boc)-OH (8) yielding protected dimer 15 in 
95% yield (Scheme 2.2).  The utilization of a small excess of 9 drives the coupling reaction to 
completion and is easily separated in the aqueous wash step.  Removal of the carbamate protecting 
Figure 2.2 Retrosynthetic strategy for the conver-
gent solution-phase synthesis of polyamide 1.  7–10 
are commercially available building blocks.  Boc = 
tert-butyl carbamate, Bt = benzotriazole, Cbz = ben-
zyl carbamate. 
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group with anhydrous HCl in 1,4-dioxane yielded 
the fi nal synthon for our studies, imidazole-turn 
dimer 5, in quantitative yield following fi ltration 
and washing of the residual salt.  With compound 
5 in hand, the assembly of core polyamide 2 was 
initiated.  PyBOP-mediated coupling of tetramer 
3 to a small excess of water-soluble Im-turn dimer 
5 yielded the advanced intermediate 16 in 97% 
yield. Saponifi cation of 16 to acid 17, followed by 
amide coupling with an excess of water-soluble 
trimer 4, delivered core Py-Im hairpin polyamide 
2 in 88% yield for the two steps.  Consistent with 
the previously discussed strategy for synthesizing 
intermediates 3–5, the differences in solubility 
of reactants versus products were exploited to 
isolate pure material by precipitation, washing, 
and trituration.  In most cases a low-boiling-point 
solvent was employed in the fi nal trituration step 
to facilitate effi cient solvent removal in vacuo. 
Core polyamide 2 was synthesized without a 
single chromatographic purifi cation in high 
overall purity, as depicted by the analytical HPLC analysis of 2 shown in Figure 2.3.  Multigram 
quantities of 2 have been readily synthesized by this method, providing a stockpile of material for 
elaboration at the C-terminus into discrete polyamide conjugates, such as 1.  
 Py-Im polyamide 1 was synthesized in solution from advanced core 2 by coupling the 
preassembled C-terminal tail moiety 21 with saponifi ed core 22.  This convergent approach begins 
by preparing Boc-protected C-terminus moiety 20 (Scheme 2.3).  PyBOP-mediated coupling of 
mono-Boc-protected triamine linker 1814 with monobenzyl-protected isophthalic acid 1915 afforded 
Boc-protected 20 in 98% yield.  Deprotection of 20 with anhydrous CF
3
CO
2
H in dichloromethane 
(1:1) yielded amine 21, which was used immediately following concentration under high vacuum. 
Saponifi cation of core polyamide 2 with aqueous NaOH in 1,4-dioxane at 23 °C yielded 8-ring 
acid 22 in 89% yield (Scheme 2.4).  The transformation of 2 to 22 proved somewhat diffi cult 
Scheme 2.1 Preparation of 3 and 4. Reagents 
and Conditions: (i) DMF, DIEA, 7, 23 ºC, 8 h, 
93%; (ii) 2.0 M HCl in Et
2
O, 23 ºC, 18 h, 99%; 
(iii) DMF, DIEA, 7, 23 ºC, 8 h, 96%; (iv) 4.0 
M HCl in 1,4-dioxane, 23 ºC, 18 h, 99%; (v) 
DMF, DIEA, 6, 23 ºC, 2 h, 83%; (vi) NaOH 
(aq), 1,4-dioxane, 42 ºC, 2 h, 93%.
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in early studies due to formation of an 
unidentifi ed side product. Avoiding reaction 
temperatures above 23 °C suppresses most 
of the byproduct formation, whereas a 
screen of aqueous bases commonly used 
for ester saponifi cation (KOH and LiOH) 
failed to identify a better reagent.  Coupling 
of residual acid 22 with freshly prepared 21 
delivered the penultimate oligomer 23 in 
87% yield.  Unfortunately, crude oligomer 
23 could not be satisfactorily purifi ed 
by our standard method and required 
chromatography on silica gel to achieve 
pure material.  Hundreds of milligrams 
of 23 have been prepared by this method 
in a single reaction sequence. Global 
deprotection of 23 by hydrogenation (Pd/C, 
~1 atm H
2
) at 23 °C for 48 h yields Py-Im 
polyamide 1 in 81% yield. Final product 1 
can be separated from residual catalyst by 
solid-phase extraction and then purifi ed by 
preparative reverse-phase HPLC.
 With multi-milligram quantities of 1 on 
hand, we investigated in detail the UV 
properties of Py-Im polyamide 1 in a variety 
of laboratory and biologically relevant solvents.  As shown in Figure 2.4, a strong solvent infl uence 
on the molar extinction coeffi cient of 1 is observed as the amount of organic cosolvent is increased. 
For example, an extinction coeffi cient (ε, M-1cm-1) of 26500 was measured for 1 in distilled and 
deionized H
2
O, whereas this value doubled to 54800 in 50% acetonitrile in aqueous CF
3
CO
2
H (0.1% 
v/v CF
3
CO
2
H), a widely utilized laboratory solvent for purifying and quantifying peptides.  A stock 
solution frequently encountered for preparing biological samples, 10% DMSO in DEPC-treated H
2
O 
yielded an intermediary value of 40900 M-1cm-1. Hence, care must be taken to consider the solvent 
Scheme 2.2 Preparation of 5 and assembly of core 
polyamide 2. Reagents and Conditions: (i) DMF, 
DIEA, PyBOP, (R)-3,4-Cbz-Dbu(Boc)-OH (8), 23 
ºC, 8 h, 95%; (ii) HCl in 1,4-dioxane, 23 ºC, 16 h, 
99%; (iii) DMF, DIEA, PyBOP, 3, 23 ºC, 2 h, 97%; 
(iv) KOH (aq), MeOH, 1,4-dioxane, 42 ºC, 2 h, 92%; 
(i) DMF, DIEA, PyBOP, 4, 23 ºC, 10 h, 96%.
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system utilized when performing 
UV spectroscopy to determine 
polyamide concentrations.
2.3 Conclusion
 A solution-phase synthesis 
of Py-Im hairpin polyamide 1 is 
presented, highlighting unifying 
principles for the preparation of 
related polyamides. A convergent 
synthesis was developed, requiring 
no chromatographic purifi cations to 
arrive at core 8-ring polyamide 2 on 
multi-gram scale. Final elaboration 
of the C-terminus affords AR 
polyamide antagonist 1 in high yield. 
The synthetic methodology permits 
gram-scale synthesis of Py-Im 
polyamides, a minimum next step as 
we transition these small molecules 
to animal models for biological 
effi cacy.
2.4 Experimental Section
2.4.1 General
Chemicals were purchased from 
Sigma-Aldrich and were used without 
further purifi cation. (R)-3,4-Cbz-
Dbu(Boc)-OH was purchased from 
Senn Chemicals AG (code number 
44159).  Bulk grade solvents were 
from Fisher Scientifi c. Centrifugation 
Scheme 2.3 Preparation of 21. Reagents and Conditions: 
(i) DMF, DIEA, PyBOP, 23 ºC, 3 h, 98%; (ii) CF
3
CO
2
H, 
CH
2
Cl
2
, 23 ºC, 20 min, concentration in vacuo and used 
crude. 
Scheme 2.4 Final steps for the synthesis of Py-Im poly-
amide 1. Reagents and Conditions: (i) NaOH (aq), 1,4-diox-
ane, 23 ºC, 11 h, 89%; (ii) DIEA, DMF, PyBOP, 21, 23 ºC, 
12 h, 87%; (iii) DMF, Pd/C, H
2
 (1 atm), 23 ºC, 48 h, 81%.
Figure 2.3 Analysis of polyamide 2 purity by analytical 
HPLC.  Wavelength shown is 310 nm.
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was performed in a Beckman Coulter 
benchtop centrifuge (Allegra 21R) 
equipped with a Beckman swing-
out rotor (model S4180). Analytical 
HPLC analysis was conducted on a 
Beckman Gold instrument equipped 
with a Phenomenex Gemini analytical 
column (250 × 4.6 mm, 5 μm) and a 
diode array detector, and the mobile 
phase consisted of a gradient of 
acetonitrile (MeCN) in 0.1% (v/v) 
aqueous CF
3
CO
2
H. Preparative 
HPLC was performed on an Agilent 
1200 system equipped with a solvent 
degasser, a diode array detector, 
and a Phenomenex Gemini column 
(250 × 21.2 mm, 5 μm).  A gradient 
of MeCN in 0.1% (v/v) aqueous 
CF
3
CO
2
H was utilized as the mobile 
phase.  UV–Vis measurements were 
made on a Hewlett-Packard diode 
array spectrophotometer (model 
8452 A).  NMR spectroscopy was 
performed on a Varian instrument 
operating at 499.8 MHz (for 1H) 
or 125.7 MHz (for 13C) at ambient 
temperature.  All NMR analyses were 
performed in DMSO-d
6
, and chemical shifts are reported in parts per million relative to the internal 
solvent peak referenced to 2.49 (for 1H) or 39.5 (for 13C).  High-resolution mass spectrometry 
(HRMS) was recorded in positive-ion mode by fast-atom bombardment (FAB+) on a JEOL JMS-
600H instrument or by electrospray ionization (ESI+) on a Waters Acquity UPLC-LCT Premiere 
XE TOF-MS system.
Figure 2.4 UV properties of polyamide 1 in solvent sys-
tems I–VIII. (A) UV traces of I–VIII from 250–600 nm and 
(B) tabular form of data.  Molar extinction coeffi cients were 
calculated from the λ
max
 for each individual system, which 
ranged from 313 to 317 nm.  DEPC = diethylpyrocarbonate 
treated H
2
O.
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2.4.2 HCl•H
2
N-Py-CO
2
Me (10)
Prepared as previously described.10a 1H NMR: δ 10.09 (br s, 3H), 7.25 (d, J = 2.0 Hz, 1H), 6.80 (d, J 
= 2.2 Hz, 1H), 3.85 (s, 3H), 3.74 (s, 3H); 13C NMR: δ 160.2, 123.7, 120.8, 113.9, 111.4, 51.3, 36.6; 
HRMS (FAB+) calc’d for C
7
H
11
N
2
O
2
 [M+H]+ 155.0821, found 155.0847.   
2.4.3 BocHN-PyPy-CO
2
Me (11)
A solution of BocHN-Py-OBt 7 (6.16 g, 17.2 mmol) and HCl•H
2
N-Py-CO
2
Me 10 (3.61 g, 19.0 
mmol) in DMF (39 mL) and DIEA (6 mL, 34.4 mmol) was stirred at 23 ºC for 8 h.  The solution 
was then added to distilled H
2
O (500 mL) preacidifi ed with aqueous HCl (1 N, 300 mL, 300 mmol), 
yielding a precipitate that was isolated by centrifugation (~ 4500 rpm).  The residual solid was 
again suspended in distilled H
2
O (80 mL) and collected by centrifugation (repeated 2X).  The 
resultant solid, which contained a small amount of residual H
2
O, was frozen and lyophilized to 
dryness.  Drying of the light-brown solid in vacuo yielded dimer 11 (6.03 g, 93%).  1H NMR: δ 
9.84 (s, 1H), 9.10 (s, 1H), 7.44 (d, J = 1.7 Hz, 1H), 6.88 (m, 2H), 6.82 (s, 1H), 3.82 (s, 3H), 3.79 (s, 
3H), 3.72 (s, 3H), 1.44 (s, 9H); 13C NMR: δ 160.8, 158.4, 152.8, 123.0, 122.6, 122.4, 120.7, 118.4, 
117.1, 108.3, 103.8, 78.3, 50.9, 36.1, 36.0, 28.2; HRMS (FAB+) calc’d for C
18
H
25
N
4
O
5
 [M+H]+ 
377.1825, found 377.1835.   
2.4.4 HCl•H
2
N-PyPy-CO
2
Me (12)
Dimer 11 (4.0 g, 10.6 mmol) in a solution of anhydrous HCl in Et
2
O (2.0 M, 400 mL) was stirred 
at 23 ºC for 18 h. The mixture was then diluted with 400 mL of anhydrous Et
2
O and fi ltered over 
a sintered glass funnel. The resultant solid was washed with copious amounts of anhydrous Et
2
O 
and dried in vacuo to yield dimer 12 as a tan solid (3.3 g, 99%).  1H NMR: δ 10.12 (s, 1H), 10.07 
(br s, 3H), 7.46 (d, J = 2.0 Hz, 1H), 7.10 (d, J = 2.0 Hz, 1H), 7.00 (d, J = 2.0 Hz, 1H), 6.91 (d, J = 
2.0 Hz, 1H), 3.87 (s, 3H), 3.83 (s, 3H), 3.72 (s, 3H); 13C NMR: δ 160.8, 157.7, 124.6, 122.6, 121.7, 
120.8, 118.6, 113.1, 108.4, 107.2, 51.0, 36.6, 36.2; HRMS (FAB+) calc’d for C
13
H
17
N
4
O
3
 [M+H]+ 
277.1301, found 277.1292.   
2.4.5 BocHN-PyPyPy-CO
2
Me (13)
A solution of BocHN-Py-OBt 7 (3.1 g, 8.7 mmol) and dimer 12 (3.0 g, 9.59 mmol) in DMF (20 mL) 
and DIEA (3 mL, 17.4 mmol) was stirred at 23 ºC for 8 h.  The solution was then added to distilled 
H
2
O (250 mL) preacidifi ed with aqueous HCl (1 N, 150 mL, 150 mmol), yielding a precipitate that 
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was isolated by centrifugation (~4500 rpm).  The residual solid was again suspended in distilled 
H
2
O (40 mL) and collected by centrifugation (repeated 2x).  The resultant solid, which contained 
a small amount of residual H
2
O, was frozen and lyophilized to dryness.  Drying of the light-brown 
solid in vacuo yielded trimer 13 (4.17 g, 96%).  1H NMR: δ 9.91 (s, 1H), 9.86 (s, 1H), 9.09 (s, 1H), 
7.46 (d, J = 2.0 Hz, 1H), 7.21 (d, J =1.7 Hz, 1H), 7.05 (d, J = 1.5 Hz, 1H), 6.89 (m, 2H), 6.83 (s, 
1H), 3.83 (s, 6H), 3.80 (s, 3H), 3.73 (s, 3H), 1.45 (s, 9H); 13C NMR: δ 160.8, 158.5, 158.4, 152.8, 
123.0, 122.8, 122.4, 122.30, 122.29, 120.7, 118.48, 118.47, 117.0, 108.3, 104.8, 103.8, 78.3, 50.9, 
36.2, 36.05, 36.04, 28.2; HRMS (FAB+) calc’d for C
24
H
30
N
6
O
6
 [M•]+ 498.2227, found 498.2233.   
2.4.6 HCl•H
2
N-PyPyPy-CO
2
Me (4)
Trimer 13 (4.0 g, 8.02 mmol) in a solution of anhydrous HCl in 1,4-dioxane (4.0 M, 300 mL) was 
stirred at 23 ºC for 18 h. The mixture was then diluted with 600 mL of anhydrous Et
2
O and fi ltered 
over a sintered glass funnel. The resultant solid was washed with copious amounts of anhydrous 
Et
2
O and dried in vacuo to yield trimer 4 as a brown-orange solid (3.45 g, 99%).  1H NMR: δ 10.16 
(s, 3H), 10.13 (s, 1H), 9.97 (s, 1H), 7.46 (d, J = 2.0 Hz, 1H), 7.25 (d, J = 1.7 Hz, 1H), 7.11 (d, J = 
2.0 Hz, 1H), 7.08 (d, J = 2.0 Hz, 1H), 7.02 (d, J = 2.0 Hz, 1H), 6.91 (d, J = 2.0 Hz, 1H), 3.88 (s, 
3H), 3.84 (s, 3H), 3.82 (s, 3H), 3.72 (s, 3H); 13C NMR: δ 160.8, 158.4, 157.7, 124.8, 123.0, 122.6, 
121.9, 121.6, 120.8, 118.7, 118.5, 113.0, 108.4, 107.2, 104.8, 51.0, 36.6, 36.2, 36.1; HRMS (FAB+) 
calc’d for C
19
H
22
N
6
O
4
 [M•]+ 398.1702, found 398.1685.   
2.4.7 ImPyPyPy-CO
2
Me (14)
A solution of trimer 4 (1.019 g, 2.34 mmol) and 1-methyl-2-trichloroacetylimidazole (6)10c,13 (478 
mg, 2.10 mmol) in DMF (4.5 mL) and DIEA (910 μL, 5.22 mmol) was stirred at 23 ºC for 2 h. 
The solution was then added to distilled H
2
O (40 mL) pre-acidifi ed with aqueous HCl (1N, 910 μL, 
0.91 mmol), yielding a precipitate that was isolated by centrifugation (~ 4500 rpm).  The residual 
solid was again suspended in distilled H
2
O (40 mL) and collected by centrifugation (repeated 1X). 
The resultant solid, which contained a small amount of residual H
2
O, was frozen and lyophilized to 
dryness. The solid was triturated with anhydrous Et
2
O and fi ltered over a sintered glass funnel. The 
resultant solid was washed with copious amounts of anhydrous Et
2
O and dried in vacuo to yield 
tetramer 14 as a light brown solid (886 mg, 83%).  1H NMR: δ 10.68 (s, 1H), 10.00 (s, 1H), 9.94 (s, 
1H), 7.48 (s, 1H), 7.47 (d, J = 2.0 Hz, 1H), 7.31 (d, J = 1.7 Hz, 1H), 7.24 (d, J = 1.7 Hz, 1H), 7.18 (s, 
1H), 7.17 (d, J = 2.0 Hz, 1H), 7.08 (d, J = 2.0 Hz, 1H), 6.91 (d, J = 1.7 Hz, 1H), 4.01 (s, 3H), 3.86 (s, 
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3H), 3.84 (s, 3H), 3.83 (s, 3H), 3.73 (s, 3H); 13C NMR: δ 160.8, 158.5, 158.4, 155.0, 138.2, 126.4, 
125.6, 123.1, 123.0, 122.5, 122.2, 121.2, 120.7, 118.8, 118.6, 118.5, 108.3, 104.9, 104.8, 50.9, 
36.18, 36.17, 36.1, 35.4; HRMS (FAB+) calc’d for C
24
H
27
N
8
O
5
 [M+H]+ 507.2104, found 507.2116.
2.4.8 ImPyPyPy-CO
2
H (3)
A solution of tetramer 14 (804 mg, 1.59 mmol) in 1,4-dioxane (8 mL) and aqueous NaOH (1N, 8.0 
mL, 8.00 mmol) was stirred at 42 ºC for 2 h.  The solution was then added to distilled H
2
O (40 mL) 
pre-acidifi ed with aqueous HCl (1N, 8 mL, 8.00 mmol), yielding a precipitate that was isolated by 
centrifugation (~ 4500 rpm).  The residual solid was again suspended in distilled H
2
O (40 mL) and 
collected by centrifugation (repeated 1X).  The resultant solid, which contained a small amount of 
residual H
2
O, was frozen and lyophilized to dryness. The solid was triturated with anhydrous Et
2
O 
and fi ltered over a sintered glass funnel. The resultant solid was washed with copious amounts of 
anhydrous Et
2
O and dried in vacuo to yield tetramer 3 as a brown solid (728 mg, 93%).   1H NMR: 
δ 10.45 (s, 1H), 9.97 (s, 1H), 9.91 (s, 1H), 7.43 (s, 1H), 7.38 (s, 1H), 7.29 (s, 1H), 7.24 (s, 1H), 
7.17 (s, 1H), 7.07 (s, 1H), 7.03 (s, 1H), 6.85 (s, 1H), 3.99 (s, 3H), 3.85 (s, 3H), 3.84 (s, 3H), 3.82 
(s, 3H); 13C NMR: δ 162.0, 158.48, 158.46, 156.1, 138.8, 127.0, 126.4, 123.0, 122.7, 122.6, 122.2, 
121.5, 120.3, 119.5, 118.7, 118.5, 108.4, 105.0, 104.8, 36.14, 36.07, 35.1; HRMS (FAB+) calc’d for 
C
23
H
25
N
8
O
5
 [M+H]+ 493.1948, found 493.1952.
2.4.9 BocHN-(R)β-CbzHNγ-Im-CO
2
Et (15)
A solution of (R)-3,4-Cbz-Dbu(Boc)-OH 8 (1.03 g, 2.93 mmol) and PyBOP (1.83 g, 3.51 mmol) 
in DMF (12 mL) and DIEA (1.5 mL, 8.8 mmol) was stirred at 23 ºC for 22 min.  The solution was 
then added to solid (powdered) HCl•H
2
N-Im-CO
2
Et 9 (850 mg, 3.15 mmol) and stirred at 23 ºC for 
8 h. The solution was then added to distilled H
2
O (30 mL) pre-acidifi ed with aqueous HCl (1N, 9 
mL, 9 mmol), yielding a precipitate that was isolated by centrifugation (~ 4500 rpm).  The residual 
solid was again suspended in distilled H
2
O (40 mL) and collected by centrifugation (repeated 2X). 
The resultant solid, which contained a small amount of residual H
2
O, was frozen and lyophilized to 
dryness.  Drying of the brown solid in vacuo yielded dimer 15 (1.4 g, 95%). 1H NMR: δ 10.57 (s, 
1H), 7.51 (s, 1H), 7.31-7.27 (m, 5H), 7.02 (d, J = 8.5 Hz, 1H), 6.79 (m, 1H), 4.97 (s, 2H), 4.25 (q, 
J = 7.2 Hz, 2H), 3.93 (m, 1H), 3.89 (s, 3H), 3.01 (m, 2H), 2.44-2.35 (m, 2H), 1.35 (s, 9H), 1.27 (t, 
J = 7.2 Hz, 3H); 13C NMR: δ 167.6, 158.4, 155.8, 155.4, 137.4, 137.1, 130.7, 128.2, 127.6, 127.5, 
114.8, 77.7, 65.1, 60.5, 48.6, 43.5, 38.1, 35.4, 28.2, 14.0; HRMS (FAB+) calc’d for C
24
H
34
N
5
O
7
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[M+H]+ 504.2458, found 504.2462.
2.4.10 HCl•H2N-(R)β-CbzHNγ-Im-CO
2
Et (5)
Dimer 15 (500 mg, 0.993 mmol) in a solution of anhydrous HCl in 1,4-dioxane (4.0 M, 10 mL) 
and anhydrous Et
2
O (4 mL) was stirred at 23 ºC for 16 h. The mixture was then diluted with 20 mL 
of anhydrous Et
2
O and fi ltered over a sintered glass funnel. The resultant solid was washed with 
copious amounts of anhydrous Et
2
O and dried in vacuo to yield dimer 5 as a white solid (432 mg, 
99%).  1H NMR: δ 10.75 (s, 1H), 8.05 (m, 3H), 7.52 (s, 1H), 7.38 (d, J = 8.5 Hz, 1H), 7.34-7.28 (m, 
5H), 5.01 (m, 2H), 4.25 (q, J = 7.1 Hz, 2H), 4.13 (m, 1H), 3.90 (s, 3H), 2.96-2.84 (m, 2H), 2.60-
2.51 (m, 2H), 1.27 (t, J = 7.1 Hz, 3H); 13C NMR: δ 166.8, 158.4, 155.7, 137.2, 136.8, 130.9, 128.3, 
127.8, 127.7, 114.9, 65.5, 60.6, 46.6, 42.1, 38.2, 35.4, 14.0; HRMS (FAB+) calc’d for C
19
H
26
N
5
O
5
 
[M+H]+ 404.1934, found 404.1928.
2.4.11 ImPyPyPy-(R)β-CbzHNγ-Im-CO
2
Et (16)
A solution of tetramer 3 (1.28 g, 2.59 mmol) and PyBOP (1.49 g, 2.86 mmol) in DMF (8 mL) and 
DIEA (1.8 mL, 10.4 mmol) was stirred at 23 ºC for 20 min.  The solution was then treated with 
solid (powdered) HCl•H
2
N-(R)β-CbzHNγ-Im-CO
2
Et 5 (1.2 g, 2.73 mmol) and stirred at 23 ºC for 2 
h. The solution was then added to distilled H
2
O (30 mL) pre-acidifi ed with aqueous HCl (1 N, 20 
mL, 20 mmol), yielding a precipitate that was isolated by centrifugation (~4500 rpm).  The residual 
solid was again suspended in distilled H
2
O (40 mL) and collected by centrifugation (repeated 2x). 
The resultant solid, which contained a small amount of residual H
2
O, was frozen and lyophilized to 
dryness. The solid was triturated with anhydrous Et
2
O and fi ltered over a sintered glass funnel. The 
resultant solid was washed with copious amounts of anhydrous Et
2
O and dried in vacuo to yield 
ImPyPyPy-(R)β-CbzHNγ-Im-CO
2
Et 16 as a tan solid (2.2 g, 97%).  1H NMR: δ 10.60 (s, 1H), 10.46 
(s, 1H), 9.96 (s, 1H), 9.91 (s, 1H), 7.97 (t, J = 5.6 Hz, 1H), 7.52 (s, 1H), 7.39 (s, 1H), 7.29-7.26 (m, 
6H), 7.24 (m, 1H), 7.18-7.14 (m, 3H), 7.04 (m, 2H), 6.90 (m, 1H), 4.98 (m, 2H), 4.24 (q, J = 7.1 
Hz, 2H), 4.10 (m, 1H), 3.99 (s, 3H), 3.89 (s, 3H), 3.845 (s, 3H), 3.839 (s, 3H), 3.77 (s, 3H), 3.29 (m, 
2H), 2.49 (m, 2H, obstructed by NMR solvent), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR: δ 167.7, 161.5, 
158.49, 158.48, 158.45, 156.0, 155.6, 138.7, 137.4, 137.1, 130.8, 128.2, 127.7, 127.6, 126.8, 126.4, 
123.0, 122.8, 122.7, 122.24, 122.17, 121.4, 118.7, 118.5, 118.0, 114.9, 105.0, 104.7, 104.4, 65.2, 
60.5, 48.6, 42.1, 38.2, 36.13, 36.11, 36.0, 35.4, 35.2, 14.0; HRMS (FAB+) calc’d for C
42
H
48
N
13
O
9
 
[M+H]+ 878.3698, found 878.3668.
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2.4.12 ImPyPyPy-(R)β-CbzHNγ-Im-CO
2
H (17)
A solution of ImPyPyPy-(R)β-CbzHNγ-Im-CO
2
Et 16 (2.0 g, 2.28 mmol) dissolved in 1,4-dioxane (2 
mL), MeOH (6 mL), and aqueous KOH (1 N, 9.1 mL, 9.1 mmol) was stirred at 42 ºC for 2 h.  The 
solution was then acidifi ed with aqueous HCl (1 N, ~9.1 mL, ~9.1 mmol) to a pH = 4.5, yielding a 
precipitate that was isolated by centrifugation (~4500 rpm).  The residual solid was again suspended 
in distilled H
2
O (10 mL) and collected by centrifugation (repeated 1x).  The resultant solid, which 
contained a small amount of residual H
2
O, was frozen and lyophilized to dryness.  The solid was 
triturated with anhydrous Et
2
O and fi ltered over a sintered glass funnel. The resultant solid was 
washed with copious amounts of anhydrous Et
2
O and dried in vacuo to yield ImPyPyPy-(R)β-CbzHNγ-
Im-CO
2
H 17 as a tan solid (1.78 g, 92%). 1H NMR: δ 10.50 (s, 1H), 10.47 (s, 1H), 9.96 (s, 1H), 
9.92 (s, 1H), 7.98 (m, 1H), 7.48 (s, 1H), 7.40 (s, 1H), 7.30-7.27 (m, 6H), 7.24 (m, 1H), 7.19-7.14 
(m, 3H), 7.05 (m, 2H), 6.90 (m, 1H), 4.99 (m, 2H), 4.10 (m, 1H), 3.99 (s, 3H), 3.88 (s, 3H), 3.845 
(s, 3H), 3.838 (s, 3H), 3.77 (s, 3H), 3.30 (m, 2H), 2.49 (m, 2H, obstructed by NMR solvent); 13C 
NMR: δ 167.7, 161.5, 160.0, 158.5, 155.8, 155.6, 138.6, 137.1, 131.6, 128.3, 127.7, 127.6, 126.7, 
126.4, 123.0, 122.8, 122.7, 122.23, 122.16, 121.4, 118.7, 118.5, 118.0, 114.6, 105.0, 104.7, 104.4, 
65.2, 48.6, 42.2, 38.2, 36.13, 36.10, 36.0, 35.4, 35.2; HRMS (FAB+) calc’d for C
40
H
44
N
13
O
9
 [M+H]+ 
850.3385, found 850.3383.
2.4.13 ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me (2)
A solution of ImPyPyPy-(R)β-CbzHNγ-Im-CO
2
H 17 (1.5 g, 1.77 mmol) and PyBOP (546 mg, 1.85 
mmol) in DMF (8.8 mL) and DIEA (922 μL, 5.3 mmol) was stirred at 23 ºC for 10 min.  The 
solution was then treated with solid (powdered) HCl•H
2
N-PyPyPy-CO
2
Me 4 (806 mg, 1.85 mmol) 
and stirred at 23 ºC for 10 h. The solution was then added to distilled H
2
O (35 mL) preacidifi ed 
with aqueous HCl (1 N, 5 mL, 5 mmol), yielding a precipitate that was isolated by centrifugation 
(~4500 rpm).  The residual solid was again suspended in distilled H
2
O (40 mL) and collected by 
centrifugation (repeated 3x).  The resultant solid, which contained a small amount of residual H
2
O, 
was frozen and lyophilized to dryness. The solid was triturated with anhydrous Et
2
O and fi ltered 
over a sintered glass funnel. The resultant solid was washed with copious amounts of anhydrous 
Et
2
O and dried in vacuo to yield ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me 2 as a tan solid (2.09 
g, 96%).  1H NMR: δ 10.66 (s, 1H), 10.21 (s, 1H), 10.00 (s, 1H), 9.98 (s, 1H), 9.96 (s, 1H), 9.93 
(s, 1H), 9.92 (s, 1H), 8.00 (m, 1H), 7.48 (s, 1H), 7.46 (d, J = 2.0 Hz, 1H), 7.45 (s, 1H), 7.31-7.27 
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(m, 7H), 7.23 (m, 2H), 7.20-7.14 (m, 5H), 7.06 (m, 2H), 6.92 (m, 1H), 6.90 (d, J = 2.0 Hz, 1H), 
5.00 (m, 2H), 4.11 (m, 1H), 4.00 (s, 3H), 3.95 (s, 3H), 3.854 (s, 3H), 3.850 (s, 3H), 3.842 (s, 3H), 
3.837 (s, 3H), 3.828 (s, 3H), 3.78 (s, 3H), 3.73 (s, 3H), 3.32 (m, 2H), 2.53 (m, 2H); 13C NMR: δ 
167.9, 161.6, 160.8, 158.5, 158.42, 158.38, 155.8, 155.6, 137.6, 137.1, 136.0, 134.0, 128.3, 127.7, 
127.6, 126.4, 123.3, 123.1, 123.0, 122.80, 122.77, 122.5, 122.26, 122.24, 122.1, 121.2, 120.9, 
120.8, 118.9, 118.70, 118.64, 118.5, 118.0, 114.1, 108.4, 104.9, 104.79, 104.76, 104.5, 65.2, 51.0, 
48.8, 42.2, 38.4, 36.25, 36.21, 36.19, 36.13, 36.10, 36.0, 35.8, 35.0; HRMS (FAB+) calc’d for 
C
59
H
64
N
19
O
12
 [M+H]+ 1230.498, found 1230.504.
2.4.14 ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
H (22)
A solution of polyamide 2 (500 mg, 0.406 mmol) dissolved in 1,4-dioxane (8 mL) and aqueous 
NaOH (1 N, 8.0 mL, 8.0 mmol) was stirred at 23 ºC for 11 h.  The solution was then cooled to 
0 ºC in an ice bath and the pH adjusted to pH = 4.0 with aqueous HCl (1 N, ~8 mL, 8 mmol), 
yielding a precipitate that was isolated by centrifugation (~4500 rpm).  The residual solid was again 
suspended in distilled H
2
O (40 mL) and collected by centrifugation (repeated 2x).  The resultant 
solid, which contained a small amount of residual H
2
O, was frozen and lyophilized to dryness. The 
solid was triturated with anhydrous Et
2
O and fi ltered over a sintered glass funnel. The resultant 
solid was washed with copious amounts of anhydrous Et
2
O and dried in vacuo to yield ImPyPyPy-
(R)β-CbzHNγ-ImPyPyPy-CO
2
H 22 as a tan solid (442 mg, 89%).  1H NMR: δ 10.52 (s, 1H), 10.22 (s, 
1H), 10.00 (s, 1H), 9.97 (s, 1H), 9.95 (s, 1H), 9.93 (s, 1H), 9.90 (s, 1H), 8.00 (m, 1H), 7.45 (s, 1H), 
7.42 (m, 2H), 7.30-7.27 (m, 7H), 7.24 (m, 2H), 7.19-7.14 (m, 4H), 7.09 (s, 1H), 7.06 (m, 2H), 6.92 
(m, 1H), 6.84 (d, J = 2.0 Hz, 1H), 5.01 (m, 2H), 4.11 (m, 1H), 3.99 (s, 3H), 3.95 (s, 3H), 3.851 
(s, 3H), 3.848 (s, 3H), 3.843 (s, 3H), 3.838 (s, 3H), 3.81 (s, 3H), 3.79 (s, 3H), 3.32 (m, 2H), 2.53 
(m, 2H); 13C NMR: δ 167.9, 162.0, 161.6, 158.48, 158.47, 158.44, 158.40, 155.8, 155.6, 138.6, 
137.1, 136.0, 134.0, 128.3, 127.7, 127.6, 126.4, 123.06, 123.05, 122.8, 122.74, 122.70, 122.6, 
122.24, 122.19, 122.15, 121.4, 121.2, 120.3, 119.5, 118.7, 118.55, 118.47, 118.0, 114.1, 108.4, 
104.9, 104.86, 104.80, 104.75, 104.5, 65.2, 48.7, 42.2, 38.3, 36.2, 36.13, 36.10, 36.07, 35.97, 35.2, 
34.9; HRMS (FAB+) calc’d for C
58
H
62
N
19
O
12
 [M+H]+ 1216.483, found 1216.487.
2.4.15 BocHN-(+)-BnOIPA (20)
A solution of acid 1915 (211 mg, 0.824 mmol) and PyBOP (624 mg, 1.2 mmol) in DMF (3 mL) and 
DIEA (211 μL, 1.2 mmol) was stirred at 23 ºC for 10 min.  Protected triamine 1814 (373 mg, 1.52 
45
mmol) was then added to the solution and stirring was continued at 23 ºC for 3 h. The solution was 
then added to distilled H
2
O (15 mL) and a viscous oil was isolated following centrifugation (~4500 
rpm) and decanting of the aqueous layer.  The residual oil was again washed with distilled H
2
O 
(10 mL) and collected by centrifugation (repeated 3x).  Drying of the residual oil in vacuo yielded 
BocHN-(+)-BnOIPA 20 as a viscous amber oil (391 mg, 98%). 1H NMR: δ 8.77 (t, J = 5.5 Hz, 1H), 
8.43 (app t, J = 1.5 Hz, 1H), 8.14-8.09 (m, 2H), 7.63 (app t, J = 7.8 Hz, 1H), 7.48-7.34 (m, 5H), 6.85 
(t, J = 4.9 Hz, 1H), 5.38 (s, 2H), 3.30 (m, 2H), 3.00 (m, 1H), 2.94 (m, 2H), 2.72-2.51 (m, 4H), 2.38 
(br s, 3H), 1.75 (m, 2H), 1.59 (m, 2H), 1.34 (s, 9H); 13C NMR: δ 165.3, 165.2, 155.6, 136.0, 135.0, 
131.9, 131.7, 129.8, 129.0, 128.6, 128.2, 128.1, 127.9, 77.5, 66.4, 54.3, 54.0, 40.6, 37.7, 37.3, 28.2, 
25.9, 25.5; HRMS (FAB+) calc’d for C
27
H
38
N
3
O
5
 [M+H]+ 484.2811, found 484.2793.
2.4.16 ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-(+)-BnOIPA (23)
A solution of ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
H 22 (192 mg, 0.158 mmol) and PyBOP (99 
mg, 0.189 mmol) in DMF (2 mL) and DIEA (220 μL, 1.3 mmol) was stirred at 23 ºC for 30 min. 
In a separate vial, BocHN-(+)-BnOIPA 20 (122 mg, 0.252 mmol) was deprotected by treating with 
a solution of CH
2
Cl
2
:CF
3
CO
2
H (1:1, 2 mL) for 20 minutes at 23 ºC followed by concentration 
to dryness in vacuo.  This residual material was then treated with the preactivated solution of 
ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
H 22 and allowed to stir at 23 ºC for 12 h.  The solution 
was then added to distilled H
2
O (30 mL) preacidifi ed with aqueous HCl (1 N, 2 mL, 2 mmol), 
yielding a precipitate that was isolated by centrifugation (~4500 rpm).  The residual solid was again 
suspended in distilled H
2
O (40 mL) and collected by centrifugation (repeated 3x).  The resultant 
solid, which contained a small amount of residual H
2
O, was frozen and lyophilized to dryness. 
The residual brown solid was purifi ed by SiO
2
 chromatography with the mobile phase consisting 
of a step gradient of 49:1 CH
2
Cl
2
:MeOH to 44:5:1 CH
2
Cl
2
:MeOH:NH
3
 to provide ImPyPyPy-(R)
β-CbzHNγ-ImPyPyPy-(+)-BnOIPA 23 as a tan solid (217 mg, 87%) after drying under high vacuum.  1H 
NMR: δ 10.43 (s, 1H), 10.20 (s, 1H), 9.98 (s, 1H), 9.95 (s, 1H), 9.93 (s, 1H), 9.92 (s, 1H), 9.87 (s, 
1H), 8.73 (t, J = 5.5 Hz, 1H), 8.41 (app t, J = 1.6 Hz, 1H), 8.11-8.07 (m, 2H), 8.03-7.98 (m, 2H), 
7.60 (app t, J = 7.7 Hz, 1H), 7.48-7.32 (m, 7H), 7.30-7.23 (m, 9H), 7.19-7.14 (m, 5H), 7.06 (d, J = 
1.7 Hz, 1H), 7.05 (d, J = 1.7 Hz, 1H), 7.03 (d, J = 1.0 Hz, 1H), 6.92 (d, J = 1.2 Hz, 1H), 6.84 (d, J = 
1.7 Hz, 1H), 5.37 (s, 2H), 5.00 (m, 2H), 4.11 (m, 1H), 3.99 (s, 3H), 3.95 (s, 3H), 3.85 (s, 3H), 3.84 
(m, 6H), 3.83 (s, 3H), 3.79 (s, 3H), 3.77 (s, 3H), 3.30 (m, 4H), 3.18 (m, 2H), 2.53 (m, 2H), 2.35 (m, 
4H), 2.16 (br s, 3H), 1.71-1.60 (m, 4H); 13C NMR: δ 167.9, 165.20, 165.16, 161.6, 161.2, 158.50, 
46
158.46, 158.42, 156.1, 155.8, 155.6, 138.8, 137.1, 136.0, 135.2, 134.0, 131.9, 131.6, 129.7, 129.0, 
128.5, 128.3, 128.2, 128.1, 128.0, 127.8, 127.7, 127.6, 127.00, 126.99, 126.3, 123.1, 123.0, 122.80, 
122.77, 122.75, 122.26, 122.18, 122.14, 122.11, 121.4, 121.2, 118.7, 118.5, 118.0, 117.7, 114.1, 
105.0, 104.9, 104.8, 104.5, 104.1, 66.4, 65.2, 55.1, 55.0, 48.8, 42.2, 41.6, 38.3, 37.9, 37.0, 36.2, 
36.10, 36.09, 36.07, 35.96, 35.89, 35.1, 34.9, 26.9, 26.6; HRMS (ESI+) calc’d for C
80
H
89
N
22
O
14
 
[M+H]+ 1581.6929, found 1581.6992.
2.4.17 ImPyPyPy-(R)β-H2Nγ-ImPyPyPy-(+)-IPA (1)
A solution of ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-(+)-BnOIPA 23 (25 mg, 0.016 mmol) and Pd/C (10 
wt % dry, 10 mg) in DMF (2 mL) was stirred at 23 ºC for 48 h under H
2
 (~1 atm, balloon). [Note: 
The protecting groups are cleaved at different rates, and early reaction aliquots reveal a mono-
protected compound.]  The reaction was then fi ltered through a Sep-Pak cartridge (5 g of C-18 
sorbent), and the Sep-Pak was washed with DMF (4 mL), aqueous MeCN (50%, 20 mL), MeCN 
(250 mL), and MeOH (250 mL).  The fi ltrate was then concentrated in vacuo, purifi ed by reverse-
phase HPLC, and lyophilized to dryness.  The solid was triturated with anhydrous Et
2
O and fi ltered 
over a sintered glass funnel. The resultant solid was washed with copious amounts of anhydrous 
Et
2
O and dried in vacuo to yield ImPyPyPy-(R)β-H2Nγ-ImPyPyPy-(+)-IPA 1 as a light tan solid (18.9 
mg, 81%). 1H NMR: δ 10.61 (s, 1H), 10.46 (s, 1H), 9.95 (s, 2H), 9.94 (s, 1H), 9.92 (s, 1H), 9.89 (s, 
1H), 9.46 (br s, 1H), 8.82 (t, J = 5.8 Hz, 1H), 8.42 (app t, J = 1.4 Hz, 1H), 8.20 (m, 1H), 8.15 (m, 
1H), 8.08 (d, J = 1.7 Hz, 1H), 8.07 (d, J = 1.7 Hz, 1H), 7.97 (m, 3H), 7.60 (app t, J = 7.6 Hz, 1H), 
7.45 (s, 1H), 7.40 (d, J = 0.7 Hz, 1H), 7.28 (d, J = 2.0 Hz, 1H), 7.26 (d, J = 1.7 Hz, 1H), 7.22 (d, 
J = 2.0 Hz, 1H), 7.21 (d, J = 1.7 Hz, 1H), 7.18 (d, J = 1.7 Hz, 1H), 7.16 (m, 2H), 7.15 (d, J = 1.7 
Hz, 1H), 7.08 (m, 2H), 7.05 (d, J = 1.0 Hz, 1H), 7.03 (d, J = 1.7 Hz, 1H), 6.94 (d, J = 1.8 Hz, 1H), 
3.99 (s, 3H), 3.96 (s, 3H), 3.85 (s, 3H), 3.844 (s, 3H), 3.842 (s, 3H), 3.83 (s, 3H), 3.82 (s, 3H), 3.79 
(s, 3H), 3.69 (m, 1H), 3.44 (m, 2H), 3.35 (m, 2H), 3.24 (m, 2H), 3.18-3.12 (m, 2H), 3.11-3.04 (m, 
2H), 2.76 (m, 3H), 2.50 (m, 2H, obstructed by NMR solvent), 1.95-1.91 (m, 2H), 1.90-1.83 (m, 
2H); 13C NMR: δ 166.84, 166.82, 165.7, 162.1, 161.6, 158.52, 158.49, 158.40, 158.1, 157.8, 156.0, 
155.7, 138.7, 135.6, 134.6, 134.2, 131.9, 131.5, 131.0, 128.7, 128.0, 126.9, 126.3, 123.1, 123.0, 
122.8, 122.7, 122.5, 122.4, 122.24, 122.16, 122.10, 121.4, 121.1, 118.7, 118.5, 118.3, 118.0, 115.7, 
105.0, 104.9, 104.8, 104.54, 104.52, 59.2, 53.3, 48.2, 36.5, 36.2, 36.08, 36.07, 35.99, 35.6, 35.38, 
35.35, 35.1, 35.0, 24.3, 24.0; HRMS (ESI+) calc’d for C
65
H
77
N
22
O
12
 [M+H]+ 1357.6086, found 
1357.6091.
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2.4.18 Calculation of Molar Extinction Coeffi cients
Solid 1 (0.51 mg, 0.35 μmoles) was weighed into a tared vial on a microbalance (Sartorius Micro 
M4).  A molecular weight of 1471.46 was utilized for 1, which assumes 1 exists as the CF
3
CO
2
H 
salt.  The material was dissolved in distilled and deionized H
2
O (1000 μL), yielding a 0.35 μM 
stock solution.  Fifty-fold dilutions of this stock solution were made into the appropriate solvent 
systems (Figure 2.4).  Data were collected at 23 ºC in a 1 cm quartz cuvette, and molar extinction 
coeffi cients are based on the λ
max
 for each solvent system (range: 313–317 nm).  The instrument 
was blanked on each discrete solvent system prior to data collection.  Duplicate analysis of each 
sample yielded similar results (data not shown).  A second polyamide stock solution was generated 
by dissolving solid 1 in 50% MeCN in aqueous CF
3
CO
2
H (0.1% v/v), followed by 50-fold dilution 
into the individual solvent systems, and data collection yielded similar results to those shown in 
Figure 2.4 (data not shown).  DEPC-treated H
2
O (RNase- and DNase-free) was purchased from USB 
Corp.  EtOH was absolute grade from Pharmaco-AAPER, and DMSO was molecular biology grade 
from Sigma-Aldrich.  DMF was anhydrous synthesis grade from Sigma-Aldrich, and acetonitrile 
was HPLC grade from Fisher.
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2.6 Spectra and Supplemental Information
 1H and 13C NMR spectra for synthesized compounds.  
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Chapter 3: Cyclic Pyrrole–Imidazole Polyamides Targeted to the 
Androgen Response Element
The text of this chapter was taken in part from a manuscript coauthored with Daniel A. Harki, John 
W. Phillips, Christian Dose, and Peter B. Dervan* (Caltech)
(Chenoweth, D.M., Harki, D.A., Phillips, J.W., Dose, C., Dervan, P. B. J. Am. Chem. Soc. 2009 In 
Press) 
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Abstract
 Hairpin pyrrole–imidazole (Py-Im) polyamides are a class of cell-permeable DNA-binding 
small molecules that can disrupt transcription factor–DNA binding and regulate endogenous 
gene expression. The covalent linkage of antiparallel Py-Im ring pairs with an γ-amino acid turn 
unit affords the classical hairpin Py-Im polyamide structure. Closing the hairpin with a second 
turn unit yields a cyclic polyamide, a lesser-studied architecture mainly attributable to synthetic 
inaccessibility.  We have applied our methodology for solution-phase polyamide synthesis to cyclic 
polyamides with an improved high-yield cyclization step. Cyclic 8-ring Py-Im polyamides 1–3 
targets the DNA sequence 5’-WGWWCW-3’ which corresponds to the androgen response element 
(ARE) bound by the androgen receptor transcription factor to modulate gene expression. We fi nd 
that cyclic Py-Im polyamides 1–3 bind DNA with exceptionally high affi nities and regulate the 
expression of AR target genes in cell culture studies, from which we infer that the cycle is cell 
permeable. 
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3.1 Introduction
 Modulating the expression of eukaryotic gene networks by small molecules is a challenge 
at the frontier of chemical biology. Pyrrole–imidazole polyamides are a class of cell-permeable 
small molecules that bind to the minor groove of DNA in a sequence-specifi c manner.1,2 Side-
by-side stacked N-methylpyrrole (Py) and N-methylimidazole (Im) carboxamides (Im/Py pairs) 
distinguish G•C from C•G base pairs, whereas Py/Py pairs specify for both T•A and A•T.3  Py-
Im hairpin polyamides have been programmed for a broad repertoire of DNA sequences with 
affi nities similar to endogenous transcription factors.4 They are cell permeable and infl uence gene 
transcription by disrupting protein–DNA interfaces.2,5,6 Hairpin polyamide interference of DNA 
binding by transcription factors such as HIF-1α,7 androgen receptor (AR),8 and AP-19 has been 
described in recent years, yielding a new approach toward gene control by small molecules.
 In parallel with our gene 
regulation studies, a signifi cant effort 
has been devoted to maximizing the 
biological potency of hairpin Py-
Im polyamides through structural 
modifi cations.  In particular, we have 
recently demonstrated that hairpin 
polyamides bearing the (R)-β-amino-
γ-turn, such as polyamide 4, possess 
favorable binding affi nities to DNA and 
are useful in gene regulation studies 
(Figure 3.1).5g A signifi cant effort 
exists in our laboratory to regulate 
aberrant AR-activated gene expression 
in prostate cancer.8 To further optimize 
lead oligomer 4, it would seem 
reasonable that closing the hairpin with 
an identical linker, yielding a cyclic 
structure 1, would further enhance 
DNA affi nity (Figure 3.1).  Previous 
syntheses of cyclic polyamides using 
Figure 3.1 Structures of cyclic and hairpin polyamides 
1–5 targeted to the DNA sequence 5’-WGWWCW-3’ and 
their ball-and-stick models. Ball-and-stick representation 
legend: black and white circles represent N-methylimida-
zole and N-methylpyrrole units, respectively, half-circle 
with - sign represents the terminal isophthalic acid sub-
stituent, and white half-diamond with + sign represents 
the triamine linker unit.
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solid-phase protocols are characterized by low reaction yields due to ineffi cient macrocyclization.10 
We report here the solution-phase synthesis of cyclic polyamides 1–3 with an improved high–yield 
cyclization step.  In addition, we examined the DNA binding properties of these compounds by 
thermal duplex DNA melting and performed preliminary studies of their in vitro ADMET properties. 
Cyclic Py-Im polyamides 1–3 were shown to regulate endogenous gene expression in cell culture 
experiments.  
3.2 Results and Discussion
3.2.1 Solution-Phase Synthesis of Cyclic Polyamides
 Due to the symmetrical nature of cyclic polyamides 1–3 and their sequence similarity to 
previously described hairpin polyamide 4,11 PyPyPy trimer 6 and Im-turn dimer 7 provide all the 
necessary atoms to synthesize 1–3.  The preparation of advanced intermediates 6 and 7 has been 
detailed in the Chapter 2 (this thesis)11 from readily available building blocks.12 The cornerstone of 
our synthesis strategy capitalizes on the disparate physical properties of starting materials versus 
products, which permit purifi cation of most intermediates to be achieved by combinations of 
precipitation, trituration, and crystallization. 
In addition, in situ deprotection of advanced 
pentafl uorophenyl ester polyamide 14 at 
high dilution leads to macrocyclization in 
high yield, affording cyclic polyamide 15.
 The synthesis of tetramer-turn 9 
begins with Im-turn dimer 7 (Scheme 3.1). 
Saponifi cation of 7 with aqueous KOH in 
methanol at 37 ºC, followed by neutralization, 
precipitation, and Et
2
O trituration, yields Im-
turn acid 8 in 95% yield. Amide coupling of 
8 with pyrrole trimer 6 provides pentamer 
9 in 96% yield.  The utilization of a small 
excess of 6 relative to 8 drives the reaction 
to completion, and residual 6 is readily 
separated from 9 following precipitation in 
water and aqueous washing of residual solid 
Scheme 3.1 Preparation of 10 and 11. Reagents and 
Conditions: (i) KOH (aq), MeOH, 37 ºC, 2 h, 95%; 
(ii) 8, PyBOP, DMF, DIEA, 6, 23 ºC, 4 h, 96%; (iii) 
HCl in 1,4-dioxane, 23 ºC, 2 h, 99% (iv) NaOH (aq), 
1,4-dioxane, 42 ºC, 3 h, 95%.
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9.  With all atoms in place for the target cyclic 
polyamide 1, compound 9 was elaborated to 
amine salt 10 (99% yield) by reaction with 
HCl in 1,4-dioxane. Carboxylic acid 11 was 
generated by saponifi cation of 9 with NaOH 
in 1,4-dioxane in 95% yield.
 Assembly of the acyclic advanced 
intermediate 12 was achieved by PyBOP-
mediated coupling of intermediates 10 and 
11 in 94% yield (Scheme 3.2).  A small 
excess of amine salt 10 was utilized to drive 
the reaction to completion. Saponifi cation 
of ester 12 proceeded smoothly with 
aqueous NaOH in 1,4-dioxane, yielding 
13 in 93% yield.  Activation of acid 13 as 
the pentafl uorophenol ester 14 provided 
the necessary functionality to afford 
macrocyclization following removal of 
the terminal tert-butyl carbamate (Boc) 
protecting group. In our hands, we found 
that the pentafl uorophenol ester suffi ciently 
activated the terminal acid for amide coupling 
while avoiding undesired oligomerization 
and/or decomposition processes that 
are conceivable with more reactive 
functionalities, such as acid chlorides. 
Premature initiation of the macrocyclization 
reaction was tempered by keeping the 
terminal amine protonated until it was 
transferred into a dilute solution of acetonitrile. Addition of an amine base (DIEA) then generated 
the free terminal amine, which could then undergo macrocyclization in dilute solvent conditions to 
deliver 15, which was directly deprotected following purifi cation. The benzyl carbamate protecting 
Scheme 3.2 Preparation of 1, 2, and 3. Reagents 
and Conditions: (i) PyBOP, DMF, DIEA, 23 ºC, 2 
h, 94%; (ii) NaOH (aq), 1,4-dioxane, 40 ºC, 4 h, 
93%; (iii) CH
2
Cl
2
, DCC, pentafl uorophenol, DMAP, 
23 ºC, 12 h, 80%; (iv) a) CF
3
CO
2
H, CH
2
Cl
2
, 23 ºC, 
concentrate; b) DMF, acetonitrile, DIEA, 0–23 ºC, 
3 days; (v) CF
3
SO
3
H, CF
3
CO
2
H, 23 ºC, 5 min, 68% 
over 3 steps; (vi) NMP, DIEA, Ac
2
O, 23 ºC, 18% of 
1 (recovered), 22% of 2, 40% of 3.
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groups were cleaved by treatment with 
superacid conditions (trifl uoromethylsulfonic 
acid–trifl uoroacetic acid) to provide 1 in 68% 
yield over three steps. Controlled acetylation of 
1 by reaction with substoichiometric quantities 
of Ac
2
O in NMP/DIEA provided a statistical 
population of 1 (18%), 2 (22%), and 3 (40%) 
that were easily separable by preparative HPLC. 
Acetylated hairpin 5 was prepared using excess 
Ac
2
O/pyridine in 95% yield from previously 
reported amine hairpin 4.11
3.2.2 Thermal Stabilization of DNA duplexes 
by Polyamides
 Quantitative DNase I footprint titrations 
have historically been utilized to measure polyamide–DNA binding affi nities and specifi cities.13 
However, this method is limited to measuring K
a
 values ≤2 × 1010 M-1, which invalidates this 
technique for quantifying the exceptionally high DNA-binding affi nities of cycles 1–3.14 The 
magnitude of DNA thermal stabilization (ΔT
m
) of DNA–polyamide complexes has been utilized to 
rank order polyamides with high DNA binding affi nities.5g,15  Accordingly, we have employed melting 
temperature analysis (ΔT
m
) for dissecting differences in DNA-binding affi nities of hairpin versus 
cyclic polyamides. Spectroscopic analyses were performed on a 14-mer duplex DNA mimicking 
the androgen response element (ARE) DNA sequence, 5ʹ-TTGCTGTTCTGCAA-3ʹ DNA duplex, 
which contains one polyamide binding site. As shown in Table 3.1 polyamides 1–5 provided an 
increase in the duplex DNA melting temperature relative to the individual DNA duplex, thereby 
confi rming polyamide-DNA binding.  Chiral hairpin 4 led to an increased melting temperature ΔT
m
 
= 18.4 °C whereas cyclic polyamide 1 yielded a higher ΔT
m
-value of 23.6 °C.  Cyclic polyamides 
1–3 reveal stronger stabilizations than parent hairpin analogs 4 and 5.  Acylation of the β-amino 
turns was shown to decrease the thermal stabilization values in both hairpin and cyclic motifs, 
presumably due to the loss of benefi cial electrostatics from the protonated-cationic amine on the 
turn unit.
Table 3.1 T
m
 values for polyamides for 1–5.a 
aAll values reported are derived from at least three 
melting temperature experiments with standard 
deviations indicated in parentheses. ΔTm values are 
given as Tm(DNA/polyamide) – Tm(DNA). The propagated 
error in ΔTm measurements is the square root of the 
sum of the square of the standard deviations for the 
Tm values.
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Figure 3.2 Targeting the ARE with DNA-binding polyamides. (a) X-ray crystal structure of an-
drogen receptor homodimer DNA-binding domain bound to the sequence 5’-CTGTTCTTGATGT-
TCTGG-3’ (PDB 1r4i).16 (b) Map of the PSA-ARE site (top) and schematic representation of a cy-
clic polyamide targeting the PSA-ARE site 5’-AGAACA-3’. (c) Inhibition of induced PSA mRNA 
expression in LNCaP cells by cyclic PI polyamides 1–3 and hairpin polyamides 4 and 5 (dosed at 
0.3, 3, and 30 μM) by real-time quantitative PCR.  The results were normalized to a DHT-induced, 
untreated control (control=1), and the error bars represent the standard error of the mean of a single 
experiment performed in biological triplicate. The entire experiment was reproduced four times, 
with similar results. NI = noninduced, I = induced, DHT = dihydrotestosterone.
89
3.2.3 Biological Assay for Cell Permeability
 Hairpin polyamides have been shown to modulate endogenous gene expression in living cells 
by disrupting transcription factor–DNA binding in gene promoters.2,7-9 Recently, hairpin polyamide 
4 was shown to inhibit androgen receptor-mediated expression of prostate-specifi c antigen (PSA) 
in LNCaP cells by targeting the DNA sequence 5´-AGAACA-3´ found in the ARE.5g  We utilized 
this cell culture transcription assay to investigate the biological activity of cyclic polyamides 1–3 
in comparison to hairpin polyamides 4 and 5. Since small structural changes to polyamides have 
been shown to correlate with differences in cellular uptake properties,5 it was not obvious whether 
cyclic polyamides 1–3 would permeate cell membranes and exhibit biological activity comparable 
to that of hairpin polyamides 4 and 5. Quantitative real-time RT-PCR analysis of DHT-induced 
PSA expression revealed that cyclic polyamides 1–3 all decreased PSA mRNA levels in LNCaP 
cells, with cycle 1 exhibiting activity comparable to that of acetylated hairpin polyamide 5 (Figure 
3.2). On the basis of these results, we can infer that this class of cyclic Py-Im polyamides are cell 
permeable and can regulate endogenous gene expression in cell culture.
3.2.4 ADMET Studies of Polyamides 1 and 5
 Due to the promising cell culture results obtained with cyclic polyamide 1 and hairpin 
polyamide 5 against PSA gene expression, we contracted preclinical in vitro absorption, distribution, 
metabolism, excretion, and toxicity (ADMET)17 studies for both compounds.18  Results from 
this study are summarized below and additional detail can be found in section 3.6 (Spectra and 
Supporting Information) and Appendix B of this thesis. Polyamides 1 and 5 were both found 
to exhibit low Caco-2 permeability, suggesting that neither compound may be orally available. 
Both 1 and 5 were found to be almost exclusively protein bound in plasma, with half-lives greater 
than 2 h.  A recent positron emission tomography (PET)-based biodistribution study of a related 
hairpin polyamide in mice revealed high levels of liver occupancy following tail vein dosage.19 
On the basis of this result, we investigated the liver stability of candidate polyamides 1 and 5. 
Microsomal intrinsic clearance studies found half-lives greater than 3 h for 1 and 5 in both human 
and rat liver microsomes, and no signifi cant inhibition was measured against any cytochrome P450 
isoform examined (Cyp1A2/CEC, Cyp2C8/DBF, Cyp2C9/DBF, Cyp2C19/DBF, Cyp2D6/AMMC, 
Cyp3A4/BFC, Cyp3A4/DBF).  Furthermore, no obvious toxicity (IC
50
 > 100 μM) was observed in 
the human hepatocellular carcinoma cell line HepG2. In addition, standard hERG FastPatch assays 
of cardiac toxicity found that both polyamides (1 and 5) were devoid of unwanted inhibition (IC
50
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> 100 μM).
3.3 Conclusion
 We describe a solution-phase synthesis methodology for preparing cyclic Py-Im 
polyamides, highlighted by an effi cient macrocyclization between the alkyl linker amine and a 
pentafl uorophenol ester-activated amino acid. The three cyclic Py-Im polyamides possessed high 
DNA-binding affi nities and were capable of accessing the nucleus in cell culture, as judged by their 
ability to downregulate AR-activated PSA expression in cell culture. Preclinical ADMET analysis 
of cyclic polyamide 1 and hairpin polyamide 5 revealed favorable drug-like properties such as high 
liver stability and low toxicity. Ongoing work is focused on characterizing the precise molecular 
interactions between cyclic polyamides and their cognate DNA sequences by high-resolution 
crystallographic studies.
3.4 Experimental Section
3.4.1 General
Chemicals and solvents were purchased from Sigma-Aldrich and were used without further 
purifi cation. (R)-3,4-Cbz-Dbu(Boc)-OH was purchased from Senn Chemicals AG (code number 
44159). All DNA oligomers were purchased HPLC purifi ed from Integrated DNA Technologies. 
Water (18 MΩ) was purifi ed using a Millipore Milli-Q purifi cation system.  Centrifugation was 
performed in a Beckman Coulter benchtop centrifuge (Allegra 21R) equipped with a Beckman 
swing-out rotor (model S4180).  Analytical HPLC analysis was conducted on a Beckman Gold 
instrument equipped with a Phenomenex Gemini analytical column (250 × 4.6 mm, 5 μm) and a 
diode array detector, and the mobile phase consisted of a gradient of acetonitrile (MeCN) in 0.1% 
(v/v) aqueous CF
3
CO
2
H.  Preparative HPLC was performed on an Agilent 1200 system equipped 
with a solvent degasser, a diode array detector, and a Phenomenex Gemini column (250 × 21.2 mm, 
5 μm).  A gradient of MeCN in 0.1% (v/v) aqueous CF
3
CO
2
H was utilized as the mobile phase. 
UV–Vis measurements were made on a Hewlett-Packard diode array spectrophotometer (model 
8452 A), and polyamide concentrations were measured in 0.1% (v/v) aqueous CF
3
CO
2
H using an 
extinction coeffi cient of 69200 M-1·cm-1 at λ
max
 near 310 nm.  NMR spectroscopy was performed on 
a Varian instrument operating at 499.8 (for 1H) or 125.7 MHz (for 13C) at ambient temperature.  All 
NMR analyses were performed in DMSO-d
6
, and chemical shifts are reported in parts per million 
relative to the internal solvent peak referenced to 2.49 (for 1H) or 39.5 (for 13C).  High-resolution 
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mass spectrometry (HRMS) was recorded in positive-ion mode by fast-atom bombardment (FAB+) 
on a JEOL JMS-600H instrument or by electrospray ionization (ESI+) on a Waters Acquity UPLC-
LCT Premiere XE TOF-MS system. 
3.4.2 UV Absorption Spectrophotometry
Melting temperature analysis was performed on a Varian Cary 100 spectrophotometer equipped 
with a thermo-controlled cell holder possessing a cell path length of 1 cm.  A degassed aqueous 
solution of 10 mM sodium cacodylate, 10 mM KCl, 10 mM MgCl
2
, and 5 mM CaCl
2
 at pH 7.0 
was used as analysis buffer. DNA duplexes and polyamides were mixed in 1:1 stoichiometry to 
a fi nal concentration of 2 μM for each experiment. Prior to analysis, samples were heated to 90 
°C and cooled to a starting temperature of 23 °C with a heating rate of 5 °C/min for each ramp. 
Denaturation profi les were recorded at λ = 260 nm from 23 to 90 °C with a heating rate of 0.5 °C/
min. The reported melting temperatures were defi ned as the maximum of the fi rst derivative of the 
denaturation profi le.
3.4.3 Measurement of Androgen-Induced PSA mRNA
Experiments were performed as described previously8 with the following modifi cations: (1) all 
compounds and controls were prepared in neat DMSO and then diluted with media to a fi nal 
concentration of 0.1% DMSO, and (2) mRNA was isolated with the RNEasy 96 kit (Qiagen, 
Valencia, CA).
3.4.4 BocHN-(R)β-CbzHNγ-Im-CO
2
H (8)
A solution of BocHN-(R)β-CbzHNγ-Im-CO
2
Et 7 (450 mg, 0.894 mmol) dissolved in MeOH (1.0 mL) 
and aqueous KOH (1 N, 2.0 mL, 2.0 mmol) was stirred at 37 ºC for 2 h. The reaction mixture was 
added to a cooled (ice bath) solution of distilled H
2
O (10 mL) preacidifi ed with aqueous HCl (1 
N, 2.0 mL, 2.0 mmol), yielding a precipitate that was isolated by centrifugation (~4500 rpm). The 
residual solid was again suspended in distilled H
2
O (10 mL) and collected by centrifugation.  The 
resultant solid, which contained a small amount of residual H
2
O, was frozen and lyophilized to 
dryness and then suspended in excess anhydrous Et
2
O and fi ltered, and the fi lter cake washed with 
copious amounts of anhydrous Et
2
O. Drying of the brown solid in vacuo yielded saponifi ed dimer 
8 (404 mg, 95%). 1H NMR: δ 10.46 (s, 1H), 7.47 (s, 1H), 7.31-7.26 (m, 5H), 7.02 (d, J = 8.3 Hz, 
1H), 6.79 (t, J = 5.4 Hz, 1H), 4.97 (s, 2H), 3.92 (m, 1H), 3.88 (s, 3H), 3.60 (s, 1H), 3.01 (m, 2H), 
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2.41 (m, 2H), 1.35 (s, 9H); 13C NMR: δ 167.6, 160.0, 155.8, 155.4, 137.11, 137.09, 131.6, 128.2, 
127.66, 127.55, 114.6, 77.7, 65.1, 48.7, 43.5, 38.0, 35.4, 28.2; HRMS (FAB+) calc’d for C
22
H
30
N
5
O
7
 
[M+H]+ 476.2145, found 476.2130.
3.4.5 BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me (9)
A solution of BocHN-(R)β-CbzHNγ-Im-CO
2
H 8 (300 mg, 0.631 mmol) and PyBOP (345 mg, 0.663 
mmol) in DMF (3.2 mL) and DIEA (330 μL, 1.9 mmol) was stirred at 23 ºC for 10 min. The 
solution was then treated with solid (powdered) HCl•H
2
N-PyPyPy-CO
2
Me 6 (288 mg, 0.663 mmol) 
and stirred at 23 ºC for 4 h. The solution was then added to distilled H
2
O (10 mL) preacidifi ed 
with aqueous HCl (1 N, 2 mL, 2 mmol), yielding a precipitate that was isolated by centrifugation 
(~4500 rpm). The residual solid was again suspended in distilled H
2
O (10 mL) and collected by 
centrifugation (repeated 3x). The resultant solid, which contained a small amount of residual H
2
O, 
was frozen and lyophilized to dryness. The solid was triturated with anhydrous Et
2
O and fi ltered 
over a sintered glass funnel. The resultant solid was washed with copious amounts of anhydrous 
Et
2
O and dried in vacuo to yield BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me 9 as a tan solid (518 mg, 
96%).  1H NMR: δ 10.17 (s, 1H), 10.00 (s, 1H), 9.95 (s, 1H), 9.93 (s, 1H), 7.46 (d, J = 1.7 Hz, 1H), 
7.44 (s, 1H), 7.31-7.29 (m, 5H), 7.27 (d, J = 1.7 Hz, 1H), 7.23 (d, J = 1.7 Hz, 1H), 7.14 (d, J = 1.7 
Hz, 1H), 7.07 (d, J = 1.7 Hz, 1H), 7.04 (d, J = 8.3 Hz, 1H), 6.90 (d, J = 2.0 Hz, 1H), 6.81 (t, J = 
5.9 Hz, 1H), 4.98 (s, 2H), 3.96 (m, 1H), 3.95 (s, 3H), 3.85 (s, 3H), 3.84 (s, 3H), 3.83 (s, 3H), 3.73 
(s, 3H), 3.03 (m, 2H), 2.46 (m, 2H), 1.36 (s, 9H); 13C NMR: δ 167.8, 160.8, 158.5, 158.4, 155.84, 
155.81, 155.5, 137.1, 136.0, 134.0, 128.3, 127.7, 127.6, 123.06, 123.00, 122.5, 122.2, 121.2, 120.7, 
118.7, 118.6, 118.5, 114.0, 108.4, 104.9, 77.8, 65.2, 50.9, 48.8, 43.6, 38.2, 36.20, 36.18, 36.09, 
34.9, 28.2; HRMS (FAB+) calc’d for C
41
H
49
N
11
O
10
 [M•]+ 855.3663, found 855.3688.
3.4.6 HCl•H2N-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me (10)
A solution of BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me 9 (125 g, 0.146 mmol) in anhydrous HCl in 
1,4-dioxane (4.0 M, 10 mL) was stirred at 23 ºC for 2 h. The mixture was then diluted with 100 mL 
of anhydrous Et
2
O and fi ltered over a sintered glass funnel. The resultant solid was washed with 
copious amounts of anhydrous Et
2
O and dried in vacuo to yield HCl•H
2
N-(R)β-CbzHNγ-ImPyPyPy-
CO
2
Me 10 as a brown solid (114 mg, 99%). 1H NMR: δ 10.38 (s, 1H), 9.98 (s, 1H), 9.96 (s, 1H), 
9.94 (s, 1H), 8.10 (m, 3H), 7.46 (d, J = 1.7 Hz, 1H), 7.45 (s, 1H), 7.42 (d, J = 8.3 Hz, 1H), 7.34-7.28 
(m, 5H), 7.28 (d, J = 1.7 Hz, 1H), 7.24 (d, J = 1.7 Hz, 1H), 7.16 (d, J = 1.7 Hz, 1H), 7.08 (d, J = 1.7 
93
Hz, 1H), 6.90 (d, J = 1.7 Hz, 1H), 5.02 (m, 2H), 4.14 (m, 1H), 3.95 (s, 3H), 3.85 (s, 3H), 3.84 (s, 
3H), 3.83 (s, 3H), 3.73 (s, 3H), 3.02 (m, 2H), 2.63 (m, 2H); 13C NMR: δ 167.0, 160.8, 158.5, 158.4, 
155.7, 136.8, 135.7, 134.0, 128.3, 127.8, 127.7, 123.05, 122.97, 122.5, 122.2, 121.1, 120.7, 118.64, 
118.60, 118.5, 108.4, 104.9, 65.6, 50.9, 46.7, 42.0, 38.2, 36.2, 36.1, 36.0, 34.9; HRMS (FAB+) 
calc’d for C
36
H
42
N
11
O
8
 [M+H]+ 756.3218, found 756.3211.
3.4.7 BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
H (11)
A solution of BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me 9 (200 mg, 0.234 mmol) dissolved in 
1,4-dioxane (2.3 mL) and aqueous NaOH (1 N, 2.3 mL, 2.3 mmol) was stirred at 42 ºC for 3 h.  The 
solution was then added to distilled H
2
O (5 mL) preacidifi ed with aqueous HCl (1 N, 2.3 mL, 2.3 
mmol), yielding a precipitate that was isolated by centrifugation (~4500 rpm).  The residual solid 
was again suspended in distilled H
2
O (10 mL) and collected by centrifugation (repeated 2x).  The 
resultant solid, which contained a small amount of residual H
2
O, was frozen and lyophilized to 
dryness and then suspended in excess anhydrous Et
2
O and fi ltered, and the fi lter cake washed with 
copious amounts of anhydrous Et
2
O. Drying of the tan solid in vacuo yielded BocHN-(R)β-CbzHNγ-
ImPyPyPy-CO
2
H 11 (187 mg, 95%).   1H NMR: δ 12.15 (s, 1H), 10.21 (s, 1H), 10.00 (s, 1H), 9.96 
(s, 1H), 9.92 (s, 1H), 7.44 (s, 1H), 7.42 (d, J = 1.7 Hz, 1H), 7.31-7.29 (m, 5H), 7.28 (d, J = 1.5 Hz, 
1H), 7.24 (d, J = 1.5 Hz, 1H), 7.16 (d, J = 1.5 Hz, 1H), 7.08 (m, 2H), 6.85 (d, J = 1.7 Hz, 1H), 6.82 
(t, J = 5.7 Hz, 1H), 4.98 (s, 2H), 3.95 (m, 4H), 3.85 (s, 3H), 3.84 (s, 3H), 3.81 (s, 3H), 3.03 (m, 2H), 
2.46 (m, 2H), 1.36 (s, 9H); 13C NMR: δ 167.8, 162.0, 158.44, 158.38, 155.80, 155.77, 155.4, 137.1, 
136.0, 133.9, 128.3, 127.7, 127.6, 123.0, 122.7, 122.6, 122.2, 121.2, 120.2, 119.5, 118.6, 118.5, 
114.0, 108.4, 104.87, 104.83, 77.7, 65.1, 48.8, 43.5, 38.2, 36.2, 36.13, 36.06, 34.9, 28.2; HRMS 
(FAB+) calc’d for C
40
H
47
N
11
O
10
 [M•]+ 841.3507, found 841.3498.
3.4.8 BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me (12)
A solution of BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
H 11 (25 mg, 0.029 mmol) and PyBOP (17 mg, 
0.031 mmol) in DMF (150 μL) and DIEA (16 μL, 0.089 mmol) was stirred at 23 ºC for 20 min. 
The solution was then treated with solid (powdered) HCl•H
2
N-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me 10 
(25 mg, 0.031 mmol) and stirred at 23 ºC for 2 h. The solution was then added to distilled H
2
O (10 
mL) preacidifi ed with aqueous HCl (1 N, 1 mL, 1 mmol), yielding a precipitate that was isolated by 
centrifugation (~4500 rpm).  The residual solid was again suspended in distilled H
2
O (10 mL) and 
collected by centrifugation (repeated 3x).  The resultant solid, which contained a small amount of 
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residual H
2
O, was frozen and lyophilized to dryness. The solid was triturated with anhydrous Et
2
O 
and fi ltered over a sintered glass funnel. The resultant solid was washed with copious amounts of 
anhydrous Et
2
O and dried in vacuo to yield BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-
CO
2
Me 12 as a tan solid (44 mg, 94%).  1H NMR: δ 10.20 (s, 1H), 10.16 (s, 1H), 9.98 (s, 2H), 
9.94-9.91 (m, 4H), 7.99 (m, 1H), 7.46 (d, J = 1.7 Hz, 1H), 7.45 (s, 1H), 7.44 (s, 1H), 7.32-7.14 (m, 
18H), 7.07 (m, 2H), 7.03 (d, J = 8.3 Hz, 1H), 6.92 (s, 1H), 6.90 (d, J = 2.0 Hz, 1H), 6.80 (t, J = 
5.6 Hz, 1H), 4.99 (m, 4H), 4.10 (m, 1H), 3.95 (m, 7H), 3.85-3.83 (m, 15H), 3.79 (s, 3H), 3.73 (s, 
3H), ~3.30 (m, 2H, obstructed by H
2
O peak), 3.04 (m, 2H), 2.53-2.44 (m, 4H, partially obstructed 
by NMR solvent), 1.36 (s, 9H); 13C NMR: δ 167.9, 167.8, 161.6, 160.8, 158.5, 158.44, 158.42, 
155.8, 155.6, 155.5, 137.1, 136.0, 134.00, 133.98, 128.3, 127.7, 127.63, 127.60, 123.11, 123.07, 
123.00, 122.80, 122.77, 122.5, 122.3, 122.2, 122.1, 121.3, 120.8, 118.69, 118.66, 118.62, 118.52, 
118.0, 114.1, 108.4, 104.9, 104.8, 104.5, 77.8, 65.21, 65.16, 50.9, 48.83, 48.78, 43.6, 42.2, 38.4, 
38.2, 36.2, 36.10, 36.07, 36.0, 34.9, 28.2; HRMS (TOF-ESI+) calc’d for C
76
H
87
N
22
O
17
 [M+H]+ 
1579.6620, found 1579.6580.
3.4.9 BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
H (13)
A solution of BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me 12 (25 mg, 0.0158 
mmol) dissolved in 1,4-dioxane (376 μL) and aqueous NaOH (1 N, 253 μL, 0.253 mmol) was 
stirred at 40 ºC for 4 h.  The solution was then added to distilled H
2
O (5 mL) preacidifi ed with 
aqueous HCl (1 N, 253 μL, 0.253 mmol), yielding a precipitate that was diluted with another 15 mL 
of H
2
O and was then isolated by centrifugation (~4500 rpm). The resultant solid, which contained 
a small amount of residual H
2
O, was frozen and lyophilized to dryness and then suspended in 
excess anhydrous Et
2
O, triturated, and fi ltered, and the fi lter cake washed with copious amounts 
of anhydrous Et
2
O. Drying of the tan solid in vacuo yielded BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)
β-CbzHNγ-ImPyPyPy-CO
2
H 13 (23 mg, 93%). 1H NMR: δ 12.13 (br s, 1H), 10.23 (s, 1H), 10.20 (s, 
1H), 9.98-9.90 (m, 6H), 8.01 (m, 1H), 7.443 (s, 1H), 7.439 (s, 1H), 7.42 (d, J = 1.7 Hz, 1H), 7.30-
7.15 (m, 18H), 7.07 (m, 3H), 6.92 (m, 1H), 6.84 (d, J = 2.0 Hz, 1H), 6.81 (t, J = 5.6 Hz, 1H), 5.00 
(m, 2H), 4.98 (s, 2H), 4.10 (m, 1H), 3.95 (m, 7H), 3.85-3.83 (m, 12H), 3.81 (s, 3H), 3.78 (s, 3H), 
~3.30 (m, 2H, obstructed by H
2
O peak), 3.03 (m, 2H), 2.53 (m, 2H), 2.46 (m, 2H), 1.36 (s, 9H); 13C 
NMR: δ 167.94, 167.87, 162.4, 162.0, 161.6, 158.54, 158.50, 158.43, 155.8, 155.75, 155.74, 155.6, 
155.5, 137.1, 136.0, 133.91, 133.90, 128.3, 127.7, 127.60, 127.57, 123.10, 123.07, 122.8, 122.7, 
122.6, 122.3, 122.24, 122.17, 121.16, 121.15, 120.3, 119.5, 118.64, 118.61, 118.5, 118.0, 114.10, 
95
114.06, 108.5, 105.0, 104.5, 77.8, 65.2, 65.1, 48.8, 43.6, 42.2, 38.4, 38.2, 36.2, 36.14, 36.10, 36.08, 
36.0, 35.8, 34.9, 28.2; HRMS (TOF-ESI+) calc’d for C
75
H
86
N
22
O
17
 [M+2H]2+/2 783.3271, found 
783.3237.
3.4.10 BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
Pfp (14)
A solution of BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
H 13 (250 mg, 0.160 mmol) 
and DCC (66 mg, 0.320 mmol) in CH
2
Cl
2
 (8.8 mL) was stirred at 23 ºC for 45 min.  The solution 
was then treated with DMAP (2 mg, 0.016 mmol) followed by pentafl uorophenol (175 mg, 0.950 
mmol) and stirred at 23 ºC for 12 h. The reaction mixture was then loaded onto a silica gel column 
with CH
2
Cl
2
 and eluted with step gradients of 100% CH
2
Cl
2
 to 100% acetone with incremental steps 
of 5% acetone. The product was concentrated in vacuo to yield BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)
β-CbzHNγ-ImPyPyPy-CO
2
Pfp 14 as a brown solid (221 mg, 80%).  1H NMR: δ 10.20 (s, 1H), 10.16 (s, 
1H), 10.08 (s, 1H), 9.99-9.91 (m, 5H), 7.99 (m, 1H), 7.73 (d, J = 1.7 Hz, 1H), 7.444 (s, 1H), 7.440 
(s, 1H), 7.30-7.12 (m, 20 H), 7.06 (d, J = 1.2 Hz, 1H), 7.03 (d, J = 8.5 Hz, 1H), 6.92 (s, 1H), 6.80 
(t, J = 5.4 Hz, 1H), 5.00 (m, 2H), 4.98 (m, 2H), 4.11 (m, 1H), 3.95 (m, 7H), 3.88 (s, 3H), 3.86-3.84 
(m, 12H), 3.78 (s, 3H), ~3.30 (m, 2H, obstructed by H
2
O peak), 3.04 (m, 2H), 2.52 (m, 2H), 2.46 
(m, 2H), 1.36 (s, 9H); HRMS (TOF-ESI+) calc’d for C
81
H
85
F
5
N
22
O
17
 [M+2H]2+/2 866.3192, found 
866.3236.
3.4.11 cyclo-(-ImPyPyPy-(R)β-H2Nγ-ImPyPyPy-(R)β-H2Nγ-) (1)
A solution of BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
Pfp 14 (84 mg, 0.049 
mmol) in anhydrous CF
3
CO
2
H:CH
2
Cl
2
 (1:1, 4 mL) was stirred at 23 ºC for 10 min prior to being 
concentrated to dryness in a 500 mL round-bottom fl ask. The residue was then dissolved in cold (0 
ºC) DMF (10 mL), followed by immediate dilution with MeCN (300 mL) and DIEA (1.6 mL). The 
reaction mixture was left at 23 ºC for 3 days without stirring. [Note: The solution turns cloudy as the 
macrocycliztion proceeds.] The reaction mixture was concentrated to a volume of 11 mL and added 
to a solution of H
2
O (30 mL) and aqueous HCl (1 N, 9.2 mL) at 0 ºC. The protected intermediate 
cyclo-(-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-) 15 was isolated by centrifugation (~4500 
rpm), lyophilized to dryness, and then suspended in excess anhydrous Et
2
O, triturated, and fi ltered, 
and the fi lter cake washed with copious amounts of anhydrous Et
2
O. Drying of the tan solid in 
vacuo yielded the protected intermediate cyclo-(-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-(R)β- CbzHNγ-) 15, 
HRMS (TOF-ESI+) calc’d for C
70
H
76
N
22
O
14
 [M+2H]2+/2 724.2956, found 724.2925. This material 
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was immediately deprotected by dissolving in CF
3
CO
2
H (2 mL) followed by addition of CF
3
SO
3
H 
(100 μL) at 23 ºC for 5 min. The solution was then frozen, and DMF (2 mL) was layered over the 
frozen solution. The thawed solution was diluted with H
2
O (6 mL) and purifi ed by reverse-phase 
HPLC to give a white solid after lyophilization. The solid was suspended in excess anhydrous Et
2
O, 
triturated, fi ltered, and the fi lter cake washed with copious amounts of anhydrous Et
2
O.  Drying 
of the white solid in vacuo yielded cyclo-(-ImPyPyPy-(R)β-H2Nγ-ImPyPyPy-(R)β-H2Nγ-) 1 (46 mg, 
68%). 1H NMR: δ 10.56 (s, 2H), 9.91 (s, 4H), 9.88 (s, 2H), 8.17 (t, J = 5.6 Hz, 2H), 7.96 (m, 6H), 
7.40 (s, 2H), 7.31 (d, J = 1.6 Hz, 2H), 7.27 (d, J = 1.6 Hz, 2H), 7.19 (d, J = 1.6 Hz, 2H), 7.00 (d, J = 
1.7 Hz, 2H), 6.96 (d, J = 1.6 Hz, 2H), 6.94 (d, J = 1.7 Hz, 2H), 3.94 (s, 6H), 3.83 (s, 12H), 3.80 (s, 
6H), 3.71 – 3.66 (m, 2H), 3.49 – 3.27 (m, 4H, partially obstructed by H
2
O peak), 2.79 (dd, J = 16.1 
Hz, 6.0 Hz, 2H), 2.60 (dd, J = 15.2 Hz, 5.2 Hz, 2H). HRMS (TOF-ESI+) calc’d for C
54
H
63
N
22
O
10
 
[M+H]+ 1179.5098, found 1179.5087.
3.4.12 cyclo-(-ImPyPyPy-(R)β-AcHNγ-ImPyPyPy-(R)β-H2Nγ-) (3) and cyclo-(-ImPyPyPy-(R)β-AcHNγ-
ImPyPyPy-(R)β-AcHNγ-) (2)
A solution of cyclo-(-ImPyPyPy-(R)β-H2Nγ-ImPyPyPy-(R)β-H2Nγ-) 1 (2.81 mg, 2.0 μmol) in anhydrous 
NMP (200 μL) and DIEA (20 μL) at 23 ºC was treated with a solution of Ac
2
O in NMP (0.122 
M, 6.8 μL). After 10 min, the reaction mixture was treated with another 6.8 μL of Ac
2
O in NMP 
(0.122 M) and allowed to stand for 5 h. The reaction mixture was then diluted to a volume of 10 
mL by addition of a 4:1 solution of aqueous CF
3
CO
2
H (0.1% v/v):MeCN (5 mL), followed by 
additional aqueous CF
3
CO
2
H (0.1% v/v, 5 mL), and then purifi ed by reverse-phase HPLC to yield 
cyclo-(-ImPyPyPy-(R)β-H2Nγ-ImPyPyPy-(R)β-H2Nγ-) 1 (363 nmol, 18%), cyclo-(-ImPyPyPy-(R)
β-AcHNγ-ImPyPyPy-(R)β-H2Nγ-) 3 (800 nmol, 40%), and cyclo-(-ImPyPyPy-(R)β-AcHNγ-ImPyPyPy-(R)
β-AcHNγ-) 2 (432 nmol, 22%). Cyclo-(-ImPyPyPy-(R)β-AcHNγ-ImPyPyPy-(R)β-H2Nγ-) 3 HRMS (TOF-
ESI+) calc’d for C
56
H
65
N
22
O
11
 [M+H]+ 1221.5203, found 1221.5204. Cyclo-(-ImPyPyPy-(R)β-AcHNγ-
ImPyPyPy-(R)β-AcHNγ-) 2 HRMS (TOF-ESI+) calc’d for C
58
H
68
N
22
O
12
 [M+2H]2+/2 633.2646, found 
633.2631.
3.4.13 ImPyPyPy-(R)β-H2Nγ-ImPyPyPy-(+)-IPA (4)
Prepared as described in Chapter 2 of this thesis.11
3.4.14 ImPyPyPy-(R)β-AcHNγ-ImPyPyPy-(+)-IPA (5)
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A solution of polyamide 411 (7.4 mg, 5.03 μmoles, assumes 4 as the mono-CF
3
CO
2
H salt) in DMF 
(1.76 mL) was treated with a solution of Ac
2
O in pyridine (10% v/v, 240 μL, 0.254 mmoles Ac
2
O). 
The solution was allowed to stand at 23 °C for 30 min, and then acidifi ed with aqueous CF
3
CO
2
H 
(15% v/v, 2 mL).  After 5 min the solution was further diluted with distilled H
2
O (5 mL), purifi ed 
by preparative RP-HPLC, and lyophilized to dryness. Suspension of the residual solid in anhydrous 
Et
2
O, following by fi ltration and drying under high vacuum yielded 5 (6.7 mg, 95%). HRMS (FAB+) 
calc’d for C
67
H
79
N
22
O
13
 [M+H]+ 1399.6191, found 1399.6181.
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Table 3.2 Caco-2 permeability summary from Apredica report (Appendix B). 
Table 3.3 Cytotoxicity summary from Apredica report (Appendix B). 
Figure 3.3 Polyamides 1 and 5 were subjected to preclinical ADMET testing by contract service 
at Apredica (Watertown, MA). Shown below (Table 3.2-3.7) are summaries of the ADMET results 
taken directly from the fi nal report provided by Apredica. The full ADMET report, which includes 
experimental conditions, can be found in Appendix B of this thesis.
3.6 Spectra and Supplemental Information
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Table 3.6 Plasma half-life summary from Apredica report (Appendix B). 
Table 3.7 Plasma protein binding summary from Apredica report (Appendix B). 
Table 3.5 hERG FastPatch summary from Apredica report (Appendix B). 
Table 3.4 Fluorescent Cyp IC50 summary from Apredica report (Appendix B). 
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Figure 3.5 13C NMR BocHN-(R)β-CbzHNγ-Im-CO
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Figure 3.6 1H NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
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Figure 3.7 13C NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
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Figure 3.8 1H NMR HCl•H
2
N-(R)β-CbzHNγ-ImPyPyPy-CO
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Figure 3.9 13C NMR HCl•H
2
N-(R)β-CbzHNγ-ImPyPyPy-CO
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Figure 3.10 1H NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
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Figure 3.11 13C NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
H (11)
109
N N
O
H N
N
O
H N
N
O
H N
N
H N
ON
H
O
NN
O
N H
N
O
N H
N
O
N H
N
N
HC
bz
N H
O
Bo
cH
N
O
C
bz
H
N
M
eO
Figure 3.12 1H NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me (12)
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Figure 3.13 13C NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
2
Me (12)
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Figure 3.14 1H NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
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Figure 3.15 13C NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
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Figure 3.16 1H NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-(R)β-CbzHNγ-ImPyPyPy-CO
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Figure 3.17 1H NMR cyclo-(-ImPyPyPy-(R)β-H2Nγ-ImPyPyPy-(R)β-H2Nγ-) (1)
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Analytical HPLC characterization of cyclic polyamide 15: 
 
 
 
 
 
Analytical HPLC characterization of cyclic polyamide 1: 
 
 
 
 
 
Analytical HPLC characterization of cyclic polyamide 2: 
 
 
Figure 3.18 Analytical HPLC characterization of cyclic polyamide 15.
Figure 3.19 Analytical HPLC characterization of cyclic polyamide 1.
Figure 3.20 Analytical HPLC characterization of cyclic polyamide 3.
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Analytical HPLC characterization of cyclic polyamide 3: 
 
 
 
 
 
Analytical HPLC characterization of hairpin polyamide 5: 
 
 
Figure 3.21 Analytical HPLC characterization of cyclic polyamide 2.
Figure 3.22 Analytical HPLC characterization of cyclic polyamide 5.
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Chapter 4: Oligomerization Route to Polyamide Macrocycles
The text of this chapter was taken in part from a manuscript coauthored with Daniel A. Harki and 
Peter B. Dervan* (Caltech)
(Chenoweth, D.M., Harki, D.A., Dervan, P. B. In Preparation.) 
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Abstract
 Cyclic pyrrole–imidazole polyamides are sequence-specifi c DNA-binding small molecules 
that are cell permeable and can regulate endogenous gene expression. Syntheses of cyclic polyamides 
have been achieved by solid-phase and more recently, solution-phase methods. We report a rapid 
solution-phase oligomerization approach to cyclic polyamides that yields 8, 12, and 16 membered 
macrocycles. A remarkable preference for DNA binding by the 8 and 16 membered oligomers 
was observed over the 12-ring macrocycle, which we attributed to a conformational constraint not 
present in the smaller and larger systems. 
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4.1 Introduction
 Pyrrole–imidazole polyamides are a class of cell-permeable small molecules that bind 
to the minor groove of DNA in a sequence specifi c manner.1,2 Antiparallel arrangements of 
N-methylpyrrole (Py) and N-methylimidazole (Im) carboxamides (Im/Py) recognize G•C from C•G 
base pairs, whereas Py/Py specifi es for both T•A and A•T.3 Hairpin Py-Im polyamides have been 
programmed for a broad repertoire of DNA sequences with high affi nities.4 These cell permeable5 
ligands can infl uence gene transcription by disrupting protein-DNA interfaces,2 and have been 
shown to control transcription of genes important in human disease.6 Py-Im polyamides have also 
been used for a variety of applications ranging from DNA detection7 and transcriptional activation8 
to the self-assembly of higher order structures.9 Conjugation of polyamides to functional domains 
have yielded artifi cial transcription factor mimics,8 fl uorescent sequence-specifi c DNA probes,7 and 
DNA nano-architectures.9
 We recently reported solution-phase methods for the synthesis of hairpin10 and cyclic 
polyamides.11 Key to the cyclic polyamide synthesis was a highly effi cient macrocyclization 
that yielded polyamide 1z (Figure 4.1) 
from an acyclic precursor. Activation of 
the C-terminal Py amino acid of 1z as a 
pentafl uorophenyl ester allowed effi cient 
macrocyclization by the γ-NH
2
 on the turn 
moiety under dilute reaction conditions. 
Our studies of polyamide 1, the deprotected 
analogue of 1z, revealed it possessed 
extremely high DNA binding affi nities, was 
cell permeable, and could disrupt androgen 
receptor-activated gene expression in cell 
culture. Additionally, preliminary studies 
of the in vitro ADMET properties of 1 
revealed excellent metabolic stability.11,12
 An orthogonal polymerization/
oligomerization strategy for the synthesis 
of 1 and related polyamides is reported 
here. This method delivers symmetrical Py-
Figure 4.1 Structures of macrocyclic polyamides 
1z–3z and 1–3, and their ball-and-stick models. 
Polyamide shorthand code: closed circles, Im; open 
circles, Py monomers. (Z = benzyl carbamate protect-
ing group)
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Im polyamide macrocycles from simple Py-Im building blocks in a rapid and convergent manner 
(Figure 4.2). Separable higher-order oligomers, such as the 12-membered (2) and 16-membered 
(3) cyclic polyamides are also produced by this method. In addition to describing the synthetic 
chemistry to prepare 1–3, we report for the fi rst time the DNA binding properties of such expanded 
polyamide macrocycles.
4.2 Results and Discussion
 Our strategy for this oligomerization route relied on the palindromic nature of polyamide 1. 
Disconnection of 1 at both γ-amino turns affords two identical halves of the molecule. Bimolecular 
coupling between two molecules, followed by intramolecular ring closure delivers cyclic Py-Im 
polyamides. Bifunctional monomer 4 contains every atom needed to construct cyclic polyamides 
1–3 by this process (Figure 4.2).
 The pentafl uorophenyl ester 4 was prepared in one step from the previously reported 
carboxylic acid of 4.11 Acidic deprotection of the γ-amino functionality of 4 followed by drying 
in vacuo yields intermediate 5 which is 
the substrate for the homodimerization/
oligomerization reaction. To initiate this 
sequence, the protected trifl uoroacetate 
salt 5 was diluted with DMSO, then treated 
with an organic base (DIEA) to unmask the 
highly nucleophilic primary γ-amine. The 
ensuing oligomerization/macrocyclization 
process provides benzylcarbamate 
protected cyclic polyamides 1z, 2z, 3z, and 
trace amounts of unisolated higher-order 
oligomers. A distribution of uncyclized 
intermediates corresponding to the dimer 
(8-ring cycle, 1z), trimer (12-ring cycle, 
2z), tetramer (16-ring cycle, 3z), and 
higher order adducts can be observed at 
early time points, as evidenced by HPLC 
analysis at 2 hr (Figure 4.3). Extended 
Figure 4.2 Synthesis of macrocyclic polyamides 
1–3 and higher order cycles by oligomerization of bi-
functional intermediate 5.
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reaction times (20 hours) reveals cyclized 
polyamides 1z, 2z, and 3z in a ratio of 
6.6:2.6:1 almost exclusively (Figure 4.3). 
Isolation of 1z (13.9%), 2z (5.5%), and 3z 
(2.1%) by preprative HPLC, followed by 
Cbz-deprotection under acidic conditions 
(CF
3
CO
2
H/CF
3
SO
3
H) provides polyamide 
macrocycles 1–3.
 With polyamide macrocycles 2 and 3 
in hand we evaluated their ability to bind 
duplex DNA relative to previously reported 
cycle 1.11 Polyamide 1 increases the 
dsDNA melting temperature by 23.6 ºC. To 
our surprise, trimeric macrocycle 2 failed 
to bind its target double stranded DNA 
sequence as evidenced by the complete lack 
of ligand-promoted thermal stabilization 
of duplex DNA melting (Table 4.1). 
This result is presumably due to inherent 
geometrical constraints of 2, preventing 
the side-by-side antiparallel alignment 
of the PyPyPyIm strands, a motif well 
accomodated by the DNA minor groove. 
In the case of tetrameric macrocycle 3, 
dsDNA binding and thermal stabilization 
was completely restored to a comparable 
value to dimer 1. We hypothesize that an even number of PyPyPyIm strands allows 3 to possess a 
collapsed or folded tetramer geometry, with two adjacent, antiparallel PyPyPyIm strands followed 
by an identical repeat of this motif linked through two intervening turn units.
4.3 Conclusion
 In summary, we have demonstrated that macrocyclic polyamides can by synthesized by 
Figure 4.3 (Top) Reverse phase HPLC analysis (2 
hr time point) of the oligomerization reaction show-
ing 1z, 2z, 3z, and acyclic intermediates. (Bottom) 
Analysis (20 h time point) of the oligomerization 
reaction revealing 1z, 2z, 3z, and consumption of 
uncyclized intermediates. Peaks were identifi ed by 
high-resolution mass spectrometry following separa-
tion and Cbz-deprotection.
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oligomerization of a bifunctional 
polyamide to yield a distribution 
of cyclic polyamide oligomers. 
Additionally, we show that certain 
cyclic polyamide geometries are 
completely devoid of the ability to 
bind dsDNA, a result which could 
be utilized in the design of highly 
specifi c molecules for targeting 
non-B-form DNA structures or 
other higher-order nucleic acid 
motifs.
4.4 Experimental Section
4.4.1 General
Chemicals were purchased from 
Sigma-Aldrich and were used 
without further purifi cation. 
(R)-3,4-Cbz-Dbu(Boc)-OH was 
purchased from Senn Chemicals AG (code number 44159).  Bulk grade solvents were from Fisher 
Scientifi c. Analytical HPLC analysis was conducted on a Beckman Gold instrument equipped with 
a Phenomenex Gemini analytical column (250 × 4.6 mm, 5 μm), a diode array detector, and the 
mobile phase consisted of a gradient of acetonitrile (MeCN) in 0.1% (v/v) aqueous CF
3
CO
2
H. 
Preparative HPLC was performed on an Agilent 1200 system equipped with a solvent degasser, 
diode array detector, and a Phenomenex Gemini column (250 × 21.2 mm, 5 μm).  A gradient of 
MeCN in 0.1% (v/v) aqueous CF
3
CO
2
H was utilized as the mobile phase.  NMR spectroscopy 
was performed on a Varian instrument operating at 499.8 MHz (for 1H) at ambient temperature. 
All NMR analyses were performed in DMSO-d
6
, and chemical shifts are reported in parts per 
million relative to the internal solvent peak referenced to 2.49 (for 1H). High-resolution mass 
spectrometry (HRMS) was recorded in positive-ion mode by fast-atom bombardment (FAB+) on 
a JEOL JMS-600H instrument or by matrix-assisted, LASER desorption/ionization time-of-fl ight 
mass spectrometry (MALDI-TOF MS) on an Applied Biosystems Voyager DE-Pro spectrometer 
Table 4.1 T
m
 values for cycles 1–3 in the presence of DNA.a 
aAll values reported are derived from at least three melting temperature 
experiments with standard deviations indicated in parentheses. ΔTm 
values are given as Tm(DNA/polyamide) – Tm(DNA). The propagated error in 
ΔTm measurements is the square root of the sum of the square of the 
standard deviations for the Tm values.
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using α-cyano-4-hydroxycinnamic acid as matrix.
4.4.2 BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
H
Synthesized as previously described in Chapter 3 of this thesis.
4.4.3 BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
Pfp (4)
A solution of BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
H (100 mg, 0.119 mmol) and DCC (49 mg, 0.238 
mmol) in CH
2
Cl
2
 (5.2 mL) was stirred at 23 ºC for 45 min. The solution was then treated with 
DMAP (1.4 mg, 0.012 mmol) followed by pentafl uorophenol (131.2 mg, 0.713 mmol) and stirred 
at 23 ºC for 12 h. The reaction mixture was then loaded onto a silica gel column with CH
2
Cl
2
 and 
eluted with step gradients of 100% CH
2
Cl
2
 to 100% acetone with incremental steps of 5% acetone. 
The product was concentrated in vacuo to yield BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
Pfp (4) as an 
off-white solid (84 mg, 71%). 1H NMR (500 MHz, DMSO-d
6
): δ 10.16 (s, 1H), 10.08 (s, 1H), 9.99 
(s, 1H), 9.97 (s, 1H), 7.74 (d, J = 1.8 Hz, 1H), 7.44 (s, 1H), 7.33 – 7.30 (m, 5H), 7.29 (d, J = 1.9 
Hz, 1H), 7.27 (d, J = 1.8 Hz, 1H), 7.25 (d, J = 1.8 Hz, 1H), 7.14 (d, J = 1.8 Hz, 1H), 7.13 (d, J = 1.8 
Hz, 1H), 7.03 (d, J = 8.4 Hz, 1H), 6.80 (t, J = 5.8 Hz, 1H), 4.98 (s, 2H), 3.95 (m, 4H), 3.89 (s, 3H), 
3.860 (s, 3H), 3.856 (s, 3H), 3.03 (m, 2H), 2.46 (m, 2H), 1.36 (s, 9H). HRMS (FAB+) calc’d for 
C
46
H
47
N
11
O
10
F
5
 [M+H]+ 1008.343, found 1008.342.
4.4.4 Oligomerization procedure
A glass vial (1 dram) was charged with 4 (5.0 mg, 4.96 μmole) and treated with a solution of 
CF
3
CO
2
H in CH
2
Cl
2
 (1:1 CF
3
CO
2
H:CH
2
Cl
2
, 1 mL) and stirred at 23 °C for 10 min. The solvent 
was removed in vacuo and the residual solid was dried under high vacuum for 20 min. The solid 
was diluted with DMSO (500 μL) followed by DIEA (80 μL) and the solution was stirred at 23 
°C for 20 h. After 20 h the reaction was complete by analytical HPLC analysis. The reaction was 
diluted to a fi nal volume of 10 mL by addition of a solution of DMF in aqueous CF
3
CO
2
H (2:3 
DMF:0.1% aqueous CF
3
CO
2
H). NOTE: A small amount of yellow insoluble material was observed 
and discarded.  Purifi cation by RP-HPLC yielded 1z (13.9% yield), 2z (5.5% yield), and 3z (2.1% 
yield). The yield of 1z is calculated from the mass of the purifi ed and isolated material (0.5 mg). 
Yields for 2z and 3z were calculated based on 1z using the relative product distribution as measured 
by integration of the preparative HPLC chromatogram at 310 nm (product distribution: 6.6:2.6:1.0 
ratio of 1z:2z:3z; UV integral values were normalized to the number of ImPyPyPy strands contained 
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in each cyclic oligomer).  The benzyl carbamate (Cbz) protecting groups of 1z-3z were removed as 
previously described.5g Characterization data for dimer 1 has been reported previously in Chapter 3 
of this thesis.11 Trimer 2 HRMS (MALDI-TOF) calc’d for C
81
H
94
N
33
O
15
 [M+H]+ 1768.7607, found 
1768.7566. Tetramer 3 HRMS (MALDI-TOF) calc’d for C
108
H
125
N
44
O
20
 [M+H]+ 2358.0112, found 
2358.0143.
4.4.5 UV Absorption Spectrophotometry
Melting temperature analysis was performed on a Varian Cary 100 spectrophotometer equipped 
with a thermo-controlled cell holder possessing a cell path length of 1 cm. A degassed aqueous 
solution of 10 mM sodium cacodylate, 10 mM KCl, 10 mM MgCl
2
, and 5 mM CaCl
2
 at pH 7.0 was 
used as analysis buffer. DNA duplexes and hairpin polyamides were mixed in 1:1 stoichiometry 
to a fi nal concentration of 2 μM for each experiment. Prior to analysis, samples were heated to 90 
°C and cooled to a starting temperature of 23 °C with a heating rate of 5 °C/min for each ramp. 
Denaturation profi les were recorded at λ = 260 nm from 23 °C to 90 °C with a heating rate of 0.5 
°C/min. The reported melting temperatures were defi ned as the maximum of the fi rst derivative of 
the denaturation profi le.
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Compound 12. 1 targets the DNA sequence 5’-WGWWCW-3’, where W =A/T or T/A.
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4.6 Spectra and Supplemental Information
Figure 4.4 1H NMR BocHN-(R)β-CbzHNγ-ImPyPyPy-CO
2
Pfp (4)
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Chapter 5: Allosteric Modulation of DNA by Small Molecules
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Abstract
 Many human diseases are caused by dysregulated gene expression. The oversupply of one 
or more transcription factors may be required for the growth and metastatic behavior of human 
cancers. Cell permeable small molecules which can be programmed to disrupt transcription factor-
DNA interfaces could silence aberrant gene expression pathways. Pyrrole-imidazole polyamides 
are DNA minor-groove binding molecules that are programmable for a large repertoire of DNA 
motifs. A high resolution X-ray crystal structure of an 8-ring cyclic Py/Im polyamide bound to 
the central six base pairs of the sequence d(5'-CCAGGC
I
CTGG-3')
2
 reveals a 4 Å widening of the 
minor groove and compression of the major groove along with a >18º bend in the helix axis toward 
the major groove. This allosteric perturbation of the DNA helix provides a molecular basis for 
disruption of transcription factor-DNA interfaces by small molecules, a minimum step in chemical 
control of gene networks. 
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5.1 Introduction
 Py/Im polyamides bind the minor groove of DNA sequence specifi cally,1,2 encoded by 
side-by-side arrangements of N-methylpyrrole (Py) and N-methylimidazole (Im) carboxamide 
monomers.  Im/Py pairs distinguish G•C from C•G base pairs, whereas Py/Py pairs are degenerate 
for T•A and A•T.3-6  Antiparallel Py/Im strands are connected by γ-aminobutyric acid linker (GABA) 
to create a hairpin-shaped oligomer. Hairpin Py/Im polyamides have been programmed to bind a 
broad library of different DNA sequences.7  They have been shown to permeate cell membranes,8-10 
access chromatin,11,12 and disrupt protein-DNA interactions.2 Disruption of transcription factor-
DNA interfaces six bp in size such as HIF-1α,13-15 androgen receptor (AR),16 and AP-117,18 have 
been exploited for controlling expression of medically relevant genes such as VEGF, PSA, TGF-β1 
and LOX-1 in cell culture experiments.13-18  X-ray crystallography of antiparallel 2:1 binding 
polyamides in complex with DNA reveal a 1 Å widening of the minor groove.5,6  This modest 
structural perturbation to the DNA helix by the side-by-side stacked arrangement of aromatic rings 
does not explain the large number of transcription factor-DNA interfaces disrupted by minor-
groove binding hairpin Py/Im polyamides.2,5,6,19  It must be that the turn unit in the hairpin oligomer 
connecting the two antiparallel strands plays a structural role.
 Here we report the atomic resolution 
structure (1.18 Å resolution) of an 8-ring 
cyclic polyamide in complex with double 
helical DNA. The cyclic polyamide 1 is 
comprised of two antiparallel ImImPyPy 
strands capped by (R)-α-amino-γ turn units. 
Polyamide 1, which codes for the sequence 
5’-WGGCCW-3’ was co-crystallized with the 
palindromic DNA oligonucleotide sequence 
5’-CCAGGC
I
CTGG-3’ 10 base pairs in 
length (Figure 5.1). We observe signifi cant 
structural allosteric perturbations of the 
DNA helix induced upon binding of GABA 
(γ-aminobutyric acid) turn-linked polyamides 
in the minor groove. A detailed view of the 
α-amino-γ-turn conformation and hydration 
Figure 5.1 Chemical structure of the cyclic poly-
amide and DNA sequence. Cyclic polyamide 1 tar-
geting the sequence 5’-WGGCCW-3’ shown with 
ball-and-stick model superimposed onto the DNA 
oligonucleotide used for crystallization. (Black 
circles represent imidazoles, open circles represent 
pyrroles, and ammonium substituted half circles at 
each end represent the (R)-α-amine-γ-turn.
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reveal a network of well-ordered water-
mediated interactions between the polyamide 
and the minor groove fl oor of DNA. 
5.2 Results and Discussion
 The structure was solved by direct 
methods to 1.18 Å resolution with synchrotron 
radiation. One cyclic polyamide bound to a 
single DNA duplex is present in the asymmetric 
unit of the crystal in the P1 space group. In 
the DNA complex the aromatic amino acids 
are bound with an N- to C- orientation of each 
ImImPyPy strand of the cycle adjacent to the 
5' to 3' direction of the DNA. To assess DNA 
structural perturbations imposed by polyamide 
binding we compared our polyamide-DNA 
complex to the free DNA. We solved the 
X-ray structure of d(CCAGGC
I
CTGG)
2
 
to a resolution of 0.98 Å for comparison.20 
Interestingly, this structure shows several 
discrete alternate conformations in 7 of the 10 
nucleotides in each strand of the DNA duplex, 
illustrating the dynamic and conformationally 
mobile nature of the B-DNA sugar-phosphate 
backbone. The comparison of polyamide-
DNA complex to free DNA is shown in Figure 
5.2. Polyamide binding locks out the alternate 
DNA conformations, rigidifying the sugar-
phosphate backbone, and strongly perturbing 
the overall helix structure. Binding of the 
polyamide widens the minor groove up to 4 Å 
while simultaneously compressing the major 
Figure 5.2 Comparison of native DNA to poly-
amide/DNA complex. a) Native DNA crystal 
structure at 0.98 Å resolution. b) Comparison to 
DNA/polyamide co-crystal structure at 1.18 Å res-
olution. (Both structure solved by direct methods.)
showing the bound cyclic polyamide with electron 
density contoured at the 1.0 σ level.
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groove by 4 Å. The polyamide bends the DNA strand >18º toward the major groove as shown in 
Figure 5.3, and shortening of the overall length of the helix by ~1 Å (Figure 5.2). 
 Py/Im Polyamides linked by a GABA or substituted GABA can adopt either of two possible 
conformations shown in Figure 5.4. In conformation A, the amino group is directed toward the minor-
groove wall of DNA with the potential for steric clash with the deoxyribose sugar. In conformation B 
the amine is directed up and out of the minor groove forcing the β-methylene to the fl oor of the minor 
groove with the potential for steric interaction with the nucleobases within van der Waals contact 
distance of the C2 hydrogen of adenine. We observe conformation B in our high resolution X-ray 
structure at both ends of the complex (Figure 5.4). It is possible that there is an intrinsic preference 
for conformation A, which relieves the β-methylene interaction with the fl oor of the minor groove. 
Figure 5.3 Analysis of native DNA (yellow) compared to polyamide complexed DNA (blue). 
Chart on the top left shows variation in the minor groove width for native DNA (yellow) and poly-
amide-complexed DNA (blue) over the central core sequence 5’-GGCC-3’. Chart on the bottom 
left shows variation in the major groove width for native DNA (yellow) and polyamide complexed 
DNA (blue) over the central core sequence 5’-GGCC-3’. Overlay of the Curves calculated geomet-
ric helix model from each structure showing a DNA bend of > 18º in the polyamide/DNA complex 
compared to native DNA.
132
However, for turn substitution at 
the α-position interaction with the 
minor-groove wall becomes the 
dominant steric interaction, leading 
to conformational inversion. Figure 
5.4 presents a view of the complex 
looking down the minor groove 
directly at the polyamide turn 
linkage. From this view, signifi cant 
van der Waals interactions can be 
observed between the outside face 
of the pyrrole-imidazole strands 
and the walls of the minor groove, 
which form a deep binding pocket 
for the cycle. Approximately 40% 
of the polyamide surface area is 
buried leaving only the top of the 
methyl groups on the heterocycles, 
the amide carbonyl oxygens, 
and the chiral α-ammonium turn 
solvent exposed. In addition the 
turn unit introduces conformational 
constraints preventing slipped or 
linear binding modes.
 The conformational 
constraints imposed by the turn 
linkage result in ring placement 
that is an intermediate of ring-over-
ring and ring-over-amide between adjacent PyPyImIm strands. This alignment allows the ring 
pairs to remain in phase with the nucleobases as the polyamide adopts an isohelical conformation 
complementary to the DNA helix. This is highlighted by comparison to the 2:1 structure in which 
the rings lie over the carboxamide linkages of the adjacent strand.5 The conformational constraints 
Figure 5.4 Conformation of the α-amino substituted GABA 
turn. (top), Two possible Conformations A and B are shown 
with conformation A directing the β-methylene up and away 
from the minor groove fl oor while orienting the α-ammonium 
toward the minor groove wall. Conformation B presents the 
β-methylene down toward the minor-groove fl oor while ori-
enting the α-ammonium up and out of the minor-groove, re-
lieving possibile steric interaction with the sugar-phosphate 
backbone (minor-groove wall). (bottom), View looking 
down the DNA minor-groove, showing the (R)-α-amine-γ-
turn conformation observed in the X-ray crystal structure, 
which matches that of conformation B. Electron density map 
is contoured at the 1.0 σ level.
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imposed by the turn and inability of the ligand to slip into a possibly more preferred orientation 
may impact the overall DNA structure by inducing bending and other allosteric distortions 
accommodated by the plasticity of DNA. In addition, the turn-constrained cycle may have a major 
entropic driving force leading to substantial pre-organization, increased affi nity, and increased 
specifi city by locking out unproductive conformations and alternate binding modes. The van der 
Waals interactions between rings may also lead to cooperativity in the binding process. In addition, 
we fi nd a shell of highly ordered water molecules around the α-ammonium substituent and a water-
mediated hydrogen bond from the ammonium to the N3 lone-pair of the adenine under the turn. 
The hydration pattern around the turn is highly conserved at both ends of the structure and the water 
mediated hydrogen bonds are within ~2.7–2.9 Å from the ammonium to water to the adenine lone-
pair (Figure 5.5a).
 The amide NH's and imidazole lone-pairs form a continuous series of direct hydrogen 
bonds to the fl oor of the DNA minor-groove, while the imidazoles impart specifi city for the 
exocyclic amine of guanine through relief of a steric interaction and a G(N2-hydrogen)-Im (lone 
pair) hydrogen bond. The amides linking the aromatic rings and the turns contribute hydrogen bonds 
to the purine N3 and pyrimidine O2 lone pairs. All amides are within hydrogen bonding distance of 
a single DNA base (~ 3.0 Å average, Figure 5.9). In all there are 10 direct amide hydrogen bonds 
(average distance = 2.97 Å), 4 direct imidazole hydrogen bonds (2 terminal average distance = 
3.27 Å and 2 internal average distance = 3.05 Å), and 2 (R)-α-ammonium turn water-mediated 
hydrogen bonds (average distance amine to water = 2.75 Å and average distance from the water 
to adenine N3 = 2.98 Å) to the fl oor of the DNA minor groove with at least one interaction for all 
12 DNA base-pairs in the 6 bp binding site for a total of 16 hydrogen bond interactions between 
the cyclic polyamide and the fl oor of the DNA minor-groove. These 16 hydrogen bonds utilize 
every heteroatom of the polyamide presented to the fl oor of the DNA minor-groove, which exactly 
matches the total number of Watson-Crick hydrogen bonds between all the DNA base pairs in the 
6 bp binding site. In addition to these 16 hydrogen bonds, we fi nd unique weak interactions in the 
form of lone pair-π interactions21,22 between the center of the leading imidazole ring and the lone 
pair of the adjacent deoxyribose O4’ oxygen (Figure 5.5d and 5.5e). Interestingly this interaction 
is only observed for the terminal imidazole aromatic ring and analysis of qualitative electrostatic 
potential surfaces substantiates the electropositive nature of the imidazole under these conditions 
(Figure 5.13).23
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5.3 Conclusion
 The crystal structure presented highlights the molecular recognition of turn-linked 
polyamides in the minor-groove of DNA and provides insight into the allosteric modulation of 
Figure 5.5 Direct and water-mediated non-covalent molecular recognition interactions. a) Ge-
ometry of the α-amino turn interacting with the AT base pair through water-mediated hydrogen 
bonding interactions. Structural basis for the turn preference for AT versus GC is demonstrated by 
the β-methylene conformational preference, which points down toward the DNA minor-groove 
fl oor within van der Waals contact distance of the adenine base. b) Isolated view of one half of the 
macrocyclic-polyamide showing hydrogen bond distances made to the DNA minor groove fl oor by 
the imidazoles and amides of compound 1. c) Im-Py pair showing the mechanism for GC specifi c-
ity. d) Interaction of the O4’ oxygen of a deoxyribose sugar with the terminal imidazole aromatic 
ring through a lone pair-π interaction. The sugar conformation is C2'-endo at the N-terminal imi-
dazole of the polyamide with the sugar oxygen lone-pair pointing directly to the centroid of the 
imidazole ring. The distance between the sugar oxygen and the ring centroid is 2.90 Å, which is 
less than the sum of the van der Waals radii to any atom in the imidazole ring. Electrostatic poten-
tial maps calculated at the HF/3-21g* level of theory show the slightly electropositive nature of the 
imidazole ring under these conditions (Figure 5.13). e) View of the O4’ deoxyribose oxygen atom 
looking through the imidazole ring showing the ring centroid superimposed on the oxygen atom. 
All distances are reported in angstroms (Å) and all electron density maps are contoured at the 1.0 
σ level (Im = imidazole and Py = pyrrole).
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B-form DNA by hairpin oligomers. The DNA structural distortion induced upon polyamide minor-
groove binding provides an allosteric model for disrupting DNA:transcription factor interfaces in 
the promoters of selected genes. The ability of DNA to undergo short and long-range allosteric 
effects coupled with DNA binding by proteins can have infl uence over important processes such as 
modulation of eukaryotic gene networks.24-27 Allosteric communication along and through the DNA 
helix forms the basis for cooperative interactions among transcription factor regulatory networks 
such as the interferon-β enhanceosome.25 The potential for allosteric control over the transcriptional 
machinery provides a powerful concept for the design of small molecules that can bind to distinct 
locations on DNA with the possibility of modulating transcription factor activity.1,2,19,27
5.4 Experimental Section
5.4.1 General
Chemicals and solvents were purchased from Sigma-Aldrich and Hampton Research and were 
used without further purifi cation. Water (18 MΩ) was purifi ed using a Millipore MilliQ purifi cation 
system. Analytical HPLC analysis was conducted on a Beckman Gold instrument equipped with 
a Phenomenex Gemini analytical column (250 x 4.6 mm, 5 μM), a diode array detector, and the 
mobile phase consisted of a gradient of acetonitrile (MeCN) in 0.1% (v/v) aqueous trifl uoroacetic 
acid (TFA).  Preparative HPLC was performed on an Agilent 1200 system equipped with a solvent 
degasser, diode array detector, and a Phenomenex Gemini column (5 μm particle size, C18 110A, 
250 x 21.2 mm, 5 micron).  A gradient of MeCN in 0.1% (v/v) aqueous trifl uoroacetic acid (TFA) 
was utilized as the mobile phase.  UV-Vis measurements were made on a Hewlett-Packard diode 
array spectrophotometer (model 8452 A) and polyamide concentrations were measured in 0.1% (v/v) 
aqueous TFA using an extinction coeffi cient of 69200 M-1cm-1 at λ
max
 near 310 nm. Matrix-assisted 
LASER desorption/ionization time-of-fl ight mass spectrometry (MALDI-TOF MS) was performed 
on an Applied Biosystems Voyager DR Pro spectrometer using α-cyano-4-hydroxycinnamic acid 
as matrix.
5.4.2 Synthesis
Polyamide 1 was synthesized by standard solid-phase synthesis methods28,29 on oxime resin (Figure 
5.6) and purifi ed by reverse-phase high-performance liquid chromatography (Figure 5.7). 
5.4.3 Cyclo-(-ImImPyPy-(R)α-BocHNγ-ImImPyPy-(R)α-H2Nγ-) (6)
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Oxime resin (R3) was generated by manual solid-phase synthesis from Kaiser oxime resin (1 g, 
0.48 mmol/g, Novabiochem) using previously described Boc-protected monomers.28,29 Boc-Py-
OBt (2) (716 mg, 2 mmol) was dissolved in 2 mL of DMF and added to 1 g of oxime resin followed 
by 1 mL of DIEA. The reaction was left in a 37 ºC shaker for 12 h. The resin was drained, washed 
with DMF 3x, DCM 3x, and the Boc group was removed upon treatment with 20% TFA/DCM 
for 30 min. After draining the resin and washing with DCM 3x followed by DMF 3x the second 
pyrrole residue was coupled in the same fashion as the fi rst, with complete coupling after 2 h at 23 
ºC. Boc-Im-OH (3)  (482 mg, 2 mmol) was dissolved in 2 mL of DMF and treated with 1.14 g (2 
mmol) of PyBOP and 2 mL of DIEA. This solution was stirred for 5 minutes prior to addition to the 
resin vessel. Coupling was allowed to proceed for 2 h at 23 ºC. The Boc-Im residue was deprotected 
using a 50% TFA/DCM solution for 30 min at room temperature followed by draining the resin 
and washing with DCM 3x and DMF 3x. A second imidazole residue was coupled following the 
exact same procedure as the fi rst. The turn unit, α-Fmoc-γ-Boc-(R)-diaminobutyric acid (Fmoc-
D-Dab-(Boc)-OH) (4) (660 mg, 1.5 mmol) was activated with PyBOP (855 mg, 1.5 mmol) in 2 
mL of DMF and 1 mL of DIEA at 23 ºC for 15 min prior to addition to the resin. Coupling was 
allowed to proceed for 2 h at 37 ºC. After deprotection with 20% TFA/DCM for 30 min, the next 
two pyrrole residues were attached in exactly the same manner as previously described using Boc-
Py-OBt. The last two imidazoles were added in the same fashion as the previous two. The fi nal turn 
unit, α-Boc-γ-Fmoc-(R)-diaminobutyric acid (Boc-D-Dab-(Fmoc)-OH) (5) (660 mg, 1.5 mmol) 
was activated with PyBOP (855 mg, 1.5 mmol) in 2 mL of DMF and 1 mL of DIEA at 23 ºC for 
15 min prior to addition to the resin. Coupling was allowed to proceed for 2 h at 37 ºC. After Fmoc 
deprotection with 25% piperidine/DMF for 3x5 min, the resin was washed with DMF 6x and 1:1 
DMF/DIEA 3x. Next, the resin was diluted with 10 mL of DMF and stored in a 37 ºC shaker on 
medium speed for 24 h. The resin was fi ltered off and the DMF concentrated to 1 mL volume, taken 
up in 9 mL of H
2
O (0.1% TFA), and purifi ed by preparative reverse-phase HPLC to give cyclo-(-
ImImPyPy-(R)α-BocHNγ-ImImPyPy-(R)α-H2Nγ-) (6) as a fl uffy white solid in 0.1% overall yield (0.480 
μmol). Cyclo-(-ImImPyPy-(R)α-BocHNγ-ImImPyPy-(R)α-H2Nγ-) (6) MALDI-TOF MS (m/z): calc’d 
for C
57
H
68
N
24
NaO
12
 [M+Na]+ 1303.53, found 1303.36.
5.4.4 Cyclo-(-ImImPyPy-(R)α-H2Nγ-ImImPyPy-(R)α-H2Nγ-) (1)
A solution of cyclo-(-ImImPyPy-(R)α-BocHNγ-ImImPyPy-(R)α-H2Nγ-) (6) (0.400 μmol) in anhydrous 
TFA/DCM (1:1, 500 μL) was stirred at 23 ºC for 5 min prior to being taken up in 9.5 mL of H
2
O 
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(0.1% TFA), and purifi ed by preparative reverse-phase HPLC to give cyclo-(-ImImPyPy-(R)α-H2Nγ-
ImImPyPy-(R)α-H2Nγ-) 1 as a fl uffy white solid in 90% yield (0.360 μmol). Cyclo-(-ImImPyPy-
(R)α-H2Nγ-ImImPyPy-(R)α-H2Nγ-) 1 MALDI-TOF MS (m/z): calc’d for C
52
H
61
N
24
O
10
 [M+H]+ 
1181.50, found 1181.55; calc’d for C
52
H
60
N
24
O
10
Na [M+Na]+ 1203.48, found 1203.37; calc’d for 
C
52
H
60
N
24
O
10
K [M+K]+ 1219.46, found 1219.33.
5.4.5 Oligonucleotide Purifi cation and Crystallization
Oligonucleotides were purchased HPLC purifi ed from Trilink Biotechnologies (San Diego, CA). 
Prior to use, oligonucleotides were de-salted using a Waters Sep-Pak cartridge (5g, C-18 sorbent). 
The Sep-Pak was pre-washed with acetonitrile (25 mL, 3x) followed by MilliQ water (25 mL, 3x). 
The oligonucleotide was dissolved in 5 mL of 2.0 M NaCl and loaded directly onto the sorbent 
followed by a wash with 5 mL of 2.0 M NaCl and 250 mL of MilliQ water. The oligonucleotide was 
eluted with acetonitrile:water (1:1) and lyophilized to dryness. Single strand DNA was quantitated 
by UV-Vis spectroscopy and incubated with a 2:1 ratio of DNA to polyamide prior to crystallization. 
Crystals were obtained after 2-8 weeks from a solution of 0.5 mM duplex DNA, 0.65 mM polyamide, 
21% 2-methyl-2,4-pentanediol (MPD), 35 mM calcium acetate, 10 mM Tris pH 7.5 equilibrated in 
sitting drops against a reservoir of 35% MPD at 4 ºC. Crystals were collected in Hampton nylon 
CryoLoops (10 micron, 0.1 mm) and fl ash cooled to 100 K prior to data collection (Figure 5.8).
5.4.6 UV-visible analysis
DNA/polyamide complex formation was verifi ed prior to structure solution by UV-Visible 
spectroscopy. Crystals were collected in Hampton nylon CryoLoops (10 micron, 0.1 mm) and 
washed with crystallization buffer 3 times prior to dissolution in 50 μL of MilliQ water. UV-Visible 
spectroscopy of the dissolved crystals confi rmed the presence of polyamide and DNA duplex in a 
1:1 stoichiometry (Figure 5.8). 
5.4.7 Data collection, Structure Determination, and Refi nement
Polyamide-DNA crystals grew in space group P1 with unit cell dimensions a = 22.50, b = 25.14, c = 
29.09, α = 66.53, β = 79.28, γ = 79.57, and one polyamide-duplex DNA complex in the asymmetric 
unit. This data set was collected at Stanford Synchrotron Radiation Laboratory (SSRL) beamline 
12-2 with a MAR Research imaging plate detector at wavelength 0.97 Å. DNA only crystals grew 
in space group C2 (C 1 2 1) with unit cell dimensions  a = 31.827, b = 25.636, c = 34.173, α = 90.00, 
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β = 116.72, γ = 90.00 and one DNA strand in the asymmetric unit. This data set was collected at 
Stanford Synchrotron Radiation Laboratory (SSRL) beamline 11-1 with a MAR Research imaging 
plate detector at wavelength 0.999 Å (Table 5.1).
 Data was processed with MOSFLM30 and SCALA31 from the CCP4 suite of programs.31 
Both crystals were solved by direct methods using the SHELX suite of programs (SHELXD).32,33 
Model building and structure refi nement was done with Coot34 and REFMAC5.35 The fi nal 
polyamide-DNA complex was refi ned to an R factor of 9.8 % and an R
free
 of 13.6 %. The fi nal DNA 
structure was refi ned to an R factor of 10.9 % and an R
free
 of 14.3 %. Anisotropic B factors were 
refi ned in the fi nal stages and riding hydrogens included (Table 5.1).
5.4.8 Structure Analysis and Figure Preparation
DNA helical parameters were calculated using the program Curves and 3DNA.36,37 Molecular 
electrostatic potential maps were calculated at the HF/3-21g* level using the Gamess program 
(Figure 5.13).38-40 Distance measurements and least squares fi tting procedures for ring-centroid 
measurements were performed using UCSF Chimera41 and Mercury.42 Structural fi gures were 
prepared using UCSF Chimera.41
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5.6 Spectra, Data Statistics, and Supplemental Information
Figure 5.6 Solid-phase synthesis of cyclic polyamide 1 using Kaiser oxime resin and the com-
mercially available building blocks presented above. Reagents and conditions: (i) Boc-Py-OBt 2, 
DIEA, DMF; (ii) 20% TFA/DCM; (iii) Boc-Py-OBt 2, DIEA, DMF; (iv) 20% TFA/DCM; (v) Boc-
Im-OH 3, PyBOP, DIEA, DMF; (vi) 50% TFA/DCM; (vii) Boc-Im-OH 3, PyBOP, DIEA, DMF; 
(viii) 50% TFA/DCM; (ix) Fmoc-D-Dab(Boc)-OH 4, PyBOP, DIEA, DMF; (x) 20% TFA/DCM; 
(xi) Boc-Py-OBt 2, DIEA, DMF; (xii) 20% TFA/DCM; (xiii) Boc-Py-OBt 2, DIEA, DMF;(xiv) 
20% TFA/DCM; (xv) Boc-Im-OH 3, PyBOP,DIEA, DMF; (xvi) 50% TFA/DCM; (xvii) Boc-Im-
OH 3, PyBOP, DIEA, DMF; (xviii) 50% TFA/DCM; (xix) Boc-D-Dab-(Fmoc)-OH 5, PyBOP, 
DIEA, DMF; (xx) piperidine, DMF; (xxi) DMF, 37ºC, 24 h; (xxii) 50% TFA/DCM. 
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Figure 5.7 Polyamide analytical data. Analysis of polyamides 6 and 1 by analytical RP-HPLC and 
MALDI-TOF MS. Wavelength shown is at 310 nm.
143
Table 5.1 Data collection and refi nement statistics. 
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Figure 5.8 Single crystal of the polyamide-DNA complex. a) Single crystal frozen in a cryoloop 
for data collection. b) UV-Vis of the single crystal polyamide-DNA complex dissolved in 50 μL 
of water.
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Figure 5.9 Hydrogen bond map of polyamide-DNA complex.
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Figure 5.10 Polyamide/DNA complex map. Schematic diagram of polyamide/DNA crystal struc-
ture showing the sugar conformation at each position and calcium ion coordination.
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Figure 5.11 DNA structure map. Schematic diagram of native DNA crystal structure showing 
the sugar conformation at each position and the electron density map of the DNA asymmetric unit 
contoured at the 1.0 σ level. The structure on the right is oriented 5’ to 3’ from top to bottom and 
corresponds to the right hand strand in the structure map.
148
Figure 5.12 Hydrogen bond map of DNA crystal structure and electron density of the AT base 
pair contoured at the 2.0 σ level.
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Figure 5.13 Molecular electrostatic potential maps of compounds 7-10 and complex 11. Complex 
11 coordinates were taken directly from the polyamide/DNA crystal structure and used without 
geometry optimization. All ab initio calculations reported here were performed using HF/3-231G* 
as implemented in the Gamess program.37-39 Full geometry optimization was performed on all struc-
tures except for complex 11 whose coordinates correspond to those of the crystal structure. Elec-
trostatic potential surfaces were generated by mapping the electrostatic potentials onto surfaces 
of molecular electron density (0.002 electron/Å3) and color-coding, using the Chimera program.40 
The molecular electrostatic potential energy values range from -25 kcal/mol for values of negative 
potential (red) to +25 kcal/mol for values of positive potential (blue). This range was chosen to 
emphasize the variations in the aromatic region and some regions of the electrostatic potential as-
sociated with heteroatoms may lie beyond the ±25 kcal/mol range.
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Figure 5.14 Comparison of Local base-pair step parameters for DNA with and without polyamide 
complexed. Parameters were calculated using 3DNA.
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Figure 5.15 Comparison of Local base-pair parameters and sugar conformations for DNA with 
and without polyamide complexed. Parameters were calculated using 3DNA.
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Figure 5.16 Comparison of Local base-pair helical parameters for DNA with and without poly-
amide complexed. Parameters were calculated using 3DNA.
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Chapter 6: Structural Elucidation of a β-amino-γ-linked Cyclic 
Polyamide-DNA Complex and RNA Binding Studies
154
Abstract
 Chemical control of dysregulated gene expression poses a signifi cant challenge at 
the frontier of chemical biology. Py-Im polyamides are a class of small molecules that can be 
programmed to bind a broad repertoire of DNA sequences, disrupt transcription factor-DNA 
interfaces, and modulate gene expression pathways in cell culture experiments. Detailed structural 
information thus far has been limited to moderate resolution X-ray structures of unlinked 2:1 binding 
polyamides and NMR NOESY-restrained molecular dynamics models, with atomic resolution X-ray 
structures remaining elusive. Structural elucidation of polyamide-DNA complexes is fundamental 
to understanding the recognition properties at the molecular level and this chapter reports a high 
resolution (0.95 Å) X-ray crystal structure of a cyclic Py-Im polyamide bound to the central six 
base pairs of the sequence d(5’-CCAGTACTGG-3’)
2
, revealing the hydrophobic, electrostatic, and 
shape selective recognition interactions responsible for DNA binding.  Additionally, a structural 
basis for the allosteric modulation of transcription-factor DNA interfaces with β-amino turn linked 
cyclic polyamides is reported and a combination of biophysical, structural, and modeling studies 
are presented which explain the inability of polyamides to bind double helical A-form RNA.
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6.1 Introduction
 Pyrrole-imidazole polyamides are a class of small molecules that bind the minor groove 
of DNA sequence specifi cally.1,2  Encoded by side-by-side arrangements of N-methylpyrrole (Py) 
and N-methylimidazole (Im) carboxamide monomers, Im/Py pairs distinguish G•C from C•G base 
pairs, whereas Py/Py pairs are degenerate for T•A and A•T.3-6  Polyamides have been shown to 
bind a broad repertoire of DNA sequences,7 permeate cell membranes and traffi c to the nucleus,8-15 
access chromatin, 16,17and disrupt protein-DNA interactions.2 Polyamide inhibition of transcription 
factor-DNA binding of HIF-1α,18,19,20 androgen receptor (AR),21 and AP-122,23 has been exploited 
for controlling expression of medically relevant genes such as VEGF, PSA, TGF-β1 and LOX-1 
in cell culture experiments. X-ray crystallography has provided structures of unlinked 2:1 binding 
polyamides to a resolution of 2.00 Å, providing valuable insight into the polyamide-DNA molecular 
recognition process.5,6,24 Structural studies of hairpin polyamides bound to the nucleosome core 
particle have also provided structural proof that polyamides can bind biologically relevant higher 
order structure, however a combination of resolution limits and high B-factors prevented a detailed 
picture of the polyamide-DNA interactions beyond confi rmation of the binding location.16,25 Much 
insight has been gleaned from NMR studies where NOESY-restrained molecular dynamics models 
have provided structures of 1:1 and 6-ring cyclic polyamides.26,27 Despite these successes, atomic 
resolution X-ray structures of this important class of compounds and in general minor groove 
binders have remained elusive. 
 The ability of DNA to undergo bending, twisting, and stretching motions as well as the 
long-range propagation (allosteric effect) of these perturbations coupled with DNA recognition 
by proteins and small molecules can have profound infl uences over important processes such as 
gene transcription and modulation of eukaryotic gene networks.28-32 Allosteric communication 
along and through the DNA helix has been the subject of intense study and forms the basis for 
cooperative interactions among transcription factor regulatory networks such as the interferon-β 
enhanceosome, where transcription factor binding induced DNA conformational changes led to 
cooperative enhancer occupancy. This potential for short and long range allosteric control over the 
transcriptional machinery provides a powerful concept for the design of small molecules that can 
bind to topographically distinct locations on DNA with the possibility of modulating transcription 
factor-DNA binding by allosteric perturbation of the DNA structure.30,31 Recent studies (Chapter 3) 
of cyclic polyamide 1 and analogous hairpin polyamides revealed they possessed high DNA binding 
affi nities and could regulate endogenous androgen receptor-activated gene expression (prostate 
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specifi c antigen) in cell culture, from 
which we infer cell permeability. 
Additionally, In vitro ADMET studies of 
cycle 1 and hairpin polyamides revealed 
favorable drug-like properties for both 
classes of compounds and excellent 
metabolic stability.
 Reported, is the atomic resolution 
structure (0.95 Å resolution) of an 8-ring 
cyclic polyamide in complex with double 
helical DNA. The cyclic polyamide 1 is 
comprised of two antiparallel ImPyPyPy 
strands capped by (R)-β-amino-γ turn 
units. Polyamide 1, which codes for 
the sequence 5’-WGWWCW-3’ was 
cocrystallized with the palindromic 
DNA oligonucleotide sequence 
5’-CC
I
AGTACTGG-3’ 10 base pairs in 
length (Fig. 6.1). We observe signifi cant 
allosteric structural perturbations of 
the DNA helix induced upon binding 
of substituted GABA (γ-aminobutyric 
acid) turn-linked polyamides in the DNA 
minor groove. In addition to amide and 
imidazole recognition with the DNA 
minor groove fl oor, a detailed view of 
the β-amino-γ-turn conformation and 
hydration reveals a network of well-
ordered water-mediated interactions between the polyamide and DNA. Signifi cantly, we fi nd that 
a conformational inversion occurs at the turn position upon moving the amino substituent from the 
α to β positions of the GABA turn. The allosteric modulation of the DNA  structure induced by 
polyamide binding is also shown and a structural basis for the inability of polyamides to bind A-form 
Figure 6.1 Structure of cyclic polyamide 1 presented 
with its ball-and-stick model superimposed over the 
binding site on the dsDNA oligonucleotide sequence 
used for crystallization. Closed circles designate N-
methylimidazole, open circles designate N-methylpyr-
role, and half open circles substituted with ammoniums 
designate β-amino substituted γ-turn unit. b. Electron 
density map contoured at the 1.0 σ level for the X-ray 
crystal structure of cyclic polyamide 1 complexed to ds-
DNA (0.95 Å  resolution).
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RNA is presented with UV-melting 
temperature data.
6.2 Overall Structure
 The structure of cyclic 
polyamide 1 in complex with d(5’-
CC
I
AGTACTGG)
2
 was solved by direct 
methods to 0.95 Å resolution with 
synchrotron radiation (Fig. 6.1). One 
cyclic polyamide bound to a single DNA 
duplex is present in the asymmetric 
unit of the crystal in the P4
1
2
1
2 space 
group. The fi nal structure was refi ned 
anisotropic and unrestrained to an 
R-factor of 11.2% and an R
free
 of 12.4% 
(Table 6.1). The average B-factor for 
the polyamide was 6.7 Å2 and 7.2 Å2 for 
DNA. The asymmetric unit contains one 
full polyamide-complexed DNA double 
helix. In the DNA complex, the aromatic 
amino acids are bound with an N- to C- 
orientation of each ImPyPyPy strand of 
the cycle adjacent to the 5’ to 3’ direction of the DNA. The conformational constraints imposed by 
the turn unit result in ring placement that is ring-over-ring as opposed to ring-over-amide. Greater 
than 40% of the polyamide surface area is buried leaving only the top of the methyl groups on 
the heterocycles, the amide carbonyl oxygens, and the chiral β-ammonium turn solvent exposed. 
Alternate conformations are observed for 7 of the 18 nucleotides of the DNA duplex. The cyclic 
pyrrole-imidazole polyamide 1 was co-crystallized with the palindromic DNA oligonucleotide 
sequence shown in Figure 6.1. The polyamide selectively binds to the sequence, 5’-WGTACW-3’, 
and previous studies have demonstrated that the equilibrium binding constants are sub-nanomolar 
and outside the measurement range of DNase I footprinting methods (see Chapter 3).
Table 6.1 Data collection and refi nement statistics.
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6.3 Overall structure of DNA-polyamide complex
 The cyclic pyrrole-imidazole polyamide is bound in an antiparallel head-to-tail turn-linked 
fashion with the N- to C-terminal orientation of each PyPyPyIm strand of the polyamide directly 
adjacent to a DNA strand oriented in a 5’ to 3’ direction. Figure 6.1 shows the overall structure of 
the complex with the electron density map contoured to the 1.0 σ level. Figure 6.2b shows a view 
of the complex looking directly down the minor groove at the polyamide turn linkage. From this 
view it can be seen that signifi cant stabilization of the complex is derived from van der Waals 
Figure 6.2 Molecular recognition details from the X-ray structure of cyclic polyamide 1. a. Con-
formation of the β-amino substituted GABA turn linkage. Conformation A (left) is the conforma-
tion observed in the previously determined α-amino turn X-ray crystal structure. Conformation B 
(right) shows the preferred conformation for the β-amino turn determined by X-ray crystallography 
in this report. The β-methine conformational preference is puckered up and away from the DNA 
minor-groove fl oor, aligning the β-ammonium along the groove fl oor. b. Structural view looking 
down the DNA minor groove showing the bound cyclic polyamide with electron density contoured 
at the 1.0 σ level. c. Geometry of the alpha-amino turn interacting with the adenine and guanine 
base pairs in the fl oor of the DNA minor groove through water-mediated hydrogen bonds. d. Iso-
lated view of one half of the polyamide (split along a plane through the long axis of the polyamide 
and the DNA helical axis) showing hydrogen bond distances made to the DNA minor groove fl oor. 
Hydrogen bonding interactions of the DNA-polyamide complex with electron density contoured at 
the 1.0 σ level. (Im = imidazole and Py = pyrrole)
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interactions between the outside face of the pyrrole-imidazole heterocyclic strands and the walls of 
the minor groove, which form a deep binding pocket for the polyamide. Greater than 40% of the 
polyamide surface area is buried and not solvent exposed, leaving only the top of the methyl groups 
of the heterocycles, the amide carbonyl oxygens, and the chiral β-amino turn linkage solvated. 
The turn linkage adds a conformational constraint to the ends of the polyamides preventing the 
heterocycle strands from slipping past each other as observed in the slipped orientations found in 
some 2:1 binders such as distamycin. 
6.4 Turn conformation
 The β-methine conformational preference is puckered up and away from the DNA 
minor-groove  fl oor,  aligning  the  β-ammonium along the groove. Conformation  A  (left) is 
the conformation observed in the previously determined α-amino turn X-ray crystal structure. 
Conformation B (right) shows the preferred conformation for the β-amino turn determined by 
Figure 6.3 DNA minor and major groove dimensions in the absence and presence of polyamide. 
Native DNA structure d(5’-CCAGTACTGG-3’)
2
 solved by Rees and coworkers (PDB: 1d8g, 0.74 
Å resolution). a. Comparison of the minor groove width for DNA in the absence of polyamide 
(yellow curve and structure) and in the presence of bound polyamide (blue curve and structure). b. 
Comparison of the major groove width for DNA in the absence of polyamide (yellow curve and 
structure) and in the presence of bound polyamide (blue curve and structure). note: polyamide has 
been removed from the blue complex for clarity.
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X-ray crystallography in this report. The hydration pattern around the turn is highly conserved at 
both ends of the structure and there are two water-mediated hydrogen bonds within 2.79 - 2.87 Å 
from the ammonium to the DNA minor-groove fl oor (Fig. 6.2c). The amide NH’s and imidazole 
lone-pairs form a continuous series of direct hydrogen bonds to the fl oor of the DNA minor-groove, 
while the imidazoles impart specifi city for the exocyclic amine of guanine through relief of steric 
interaction and a G(N2-hydrogen)-Im (lone pair) hydrogen bond (Fig. 6.2c-d). The amides linking 
the aromatic rings and the turns contribute hydrogen bonds to the purine N3 and pyrimidine O2 
lone pairs where they all are within hydrogen bonding distance of a single DNA base. In total 
there are 10 direct amide hydrogen bonds (2.86–3.08 Å), 2 direct imidazole hydrogen bonds (3.15 
and 3.16 Å), and 4 (R)-β-ammonium turn water-mediated hydrogen bonds (two per turn, average 
distance from amine to water = 2.79 Å–2.87 Å) to the fl oor of the DNA minor groove with at least 
one interaction for all 12 DNA base-pairs in the 6 bp binding site. There are a total of 16 hydrogen 
bond interactions between the cyclic polyamide and the fl oor of the DNA minor-groove, utilizing 
every hydrogen-bond donor and acceptor of the ligand (Fig. 6.2).
6.5 Allosteric Perturbations
 Polyamide binding induces large structural changes in DNA and Figure 6.3 shows a 
Figure 6.4 Allosteric distortion upon polyamide binding. (left) DNA bending is observed for 
polyamide-bound DNA (blue structure) versus unbound-DNA (yellow structure). (right) Helical 
parameters for DNA in the absence and presence of polyamide showing an increase in positive 
roll and signifi cant changes in twist angles upon polyamide binding. (Polyamide has been removed 
from the blue complex for clarity)
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slice through the short axis of the DNA 
helix showing the minor and major 
groove geometry at the center of the 
polyamide binding site for uncomplexed 
and complexed DNA. Figure 6.3 reveals a 
>4 Å widening of the DNA minor groove 
upon polyamide binding and a compression 
of the major groove by more than 4 Å. 
Additionally, Figure 6.3 shows a major 
perturbation in the major groove depth 
upon polyamide binding converting the 
wide shallow surface of the major groove 
from a functionally exposed protein 
recognition domain to a narrow deep cleft less likely  to accomodate the width of a standard protein 
alpha-helical domain or beta-sheet from a transcription factor. Figure 6.4 shows the polyamide 
induced bending of the DNA helix. The helix is bent toward the major groove by >15º resulting in 
major groove compression. The base-pair step parameters in Figure 6.4 show a large positive roll 
throughout the polyamide binding site which contributes to the signifi cant bend in the DNA helix. 
Additionally, polyamide binding induces a more uniform helical twist resulting in less variability as 
the base-pair step changes. The helical twist values for polyamide bound DNA range from 29.68-
35.93º. Values for the helical twist are highly sequence dependent in native DNA and range from 
21.04 to 50.50º depending on step sequence. Major perturbations in the DNA base pair buckle and 
opening are also observed upon polyamide binding. At the central 4 base pairs of the binding site 
the buckle is signifi cantly reduced upon binding and the base pairs are opened toward the DNA 
major groove with the largest variations occuring at the central AT base pairs. [Note: For a full set 
of helical parameters and defi nitions see Figures 6.6, 6.7, and 6.8.]
6.6 Solvation
 The structure has a cell volume of 134,162 Å3 and a Matthews Coeffi cient of 2.24 with a 
solvent content of 51%. There are 130 out of 239 water molecules within 3.0 Å of the polyamide-
DNA complex and 76 of the 130 water molecules localized around the DNA phosphates.  The solvent 
exposed surface of the polyamide is hydrated by 22 of the 130 waters found within 3.0 Å of the complex. 
Table 6.2 Buckle and opening values.
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These waters cluster and form bridges across the carbonyl oxygens of adjacent amides linking ring 
pairs,   resulting in stripes of well ordered water across the polyamide surface.    Additionally,  6 
waters hydrate the polyamide ammonium turns  (3 at each turn) with 4 of the 6 anchoring the 
polyamide to the fl oor of the 
DNA minor groove through 
bridging hydrogen bonds.
6.7 RNA Binding Studies
 The minor groove 
binding of polyamides to 
B-form DNA has been 
extensively studied,  however 
the ability of polyamides to 
bind double helical RNA has 
received little attention. There 
are two major differences in 
helical RNA versus DNA. 
First, thyamine (T) is replaced 
by uracil (U) presenting the 
addition of a 5’ methyl group 
to the major groove of the 
helix. However, the hydrogen 
Table 6.3 Polyamide-DNA and Polyamide-RNA melting temperatures.
Figure 6.5 a. Crystal structure of DNA-polyamide complex 
showing shape complementary and favorable hydrophobic inter-
actions with the sugar-phosphate backbone. b. Coordinates of the 
cyclic polyamide docked within van der Waals radius of the puta-
tive binding site on a model of ideal A-form double helical RNA.
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bonding functionality of the minor groove remains identical to that of B-form DNA. The second 
and most important difference is the addition of a 2’–OH on the sugar resulting in ribose as opposed 
to deoxyribose for DNA. This extra hydroxyl has a profound effect on the overall helical RNA 
structure and rigidity primarily due to the enforcement of a C3’–endo ribose sugar pucker. This 
pucker forces the RNA helix into an A or A’-form conformation due to the steric incompatibility 
of the 2’–OH with a DNA B-form conformation, which prefers a C2’–endo sugar conformation. 
The conformational rigidity leads to less sequence dependent microstructure than DNA and a 
dramatically different minor and major groove geometry. Additionally, the DNA helix has been 
shown to be highly conformationally mobile in contrast to the RNA helix. The structure of A-form 
RNA has an 11-fold helix with a narrow, deep major groove and shallow, wide minor groove in stark 
contrast to B-form DNA. The base pairs of A-form RNA are inclined and drastically displaced from 
the helix axis causing an overall expansion of the helix width, which in turn leads to a dramatically 
shallow curvature of the minor groove fl oor. The criteria required for polyamide binding and, in 
general, small molecule binding relies on the minimization of water exposed hydrophobic surfaces, 
the complementary pairing of buried hydrogen bond donors and acceptors, the maximization of 
van der Waals interactions, the solvation or neutralization of all charges, and the maximization of 
attractive and minimization of repulsive interactions. Our results show that the polyamides in this 
study provide a large thermal stabilization to DNA as opposed to RNA, which does not have an 
increased melting temperature for any of the compounds studied. The thermal stabilization for the 
DNA duplex ranges from 4 ºC for the unlinked polyamide (2:1 complex at saturating concentrations) 
to 23 ºC for the cyclic polyamide.
6.8 Conclusion
 The crystal structure presented highlights the molecular recognition of β-amino turn-linked 
polyamides in the minor-groove of DNA and provides insight into the allosteric modulation of 
B-form DNA by Py-Im polyamides. The DNA structural distortion induced upon polyamide minor-
groove binding provides an allosteric model for disrupting DNA:transcription factor interfaces in 
the promoters of selected genes. The ability of DNA to undergo short and long-range allosteric 
effects coupled with DNA binding by proteins can have infl uence over important processes such as 
modulation of eukaryotic gene networks. The potential for allosteric control over the transcriptional 
machinery provides a powerful concept for the design of small molecules that can bind to distinct 
locations on DNA with the possibility of modulating transcription factor activity. The RNA binding 
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studies demonstrate that this class of Py-Im polyamides are completely selective for binding dsDNA 
over dsRNA.
6.9 Experimental
6.9.1 Synthesis
Polyamides 1–3 were synthesized by standard solution-phase synthesis methods presented in 
Chapter 2 and 3 of this thesis. Synthetic deoxyoligonucleotides were purchased HPLC purifi ed 
from Trilink Biotechnologies and desalted using a 5 gram sep-pak C18 cartridge (Waters) followed 
by lyophilization to dryness.
6.9.2 Oligonucleotide purifi cation and Crystallization
Oligonucleotides were purchased HPLC purifi ed from Trilink Biotechnologies (San Diego, CA). 
Prior to use the oligonucleotides were de-salted using a 5 gram sep-pak C18 cartridge (Waters) and 
lyophilized to dryness. 
 Single stranded DNA was quantitated by UV-Vis spectroscopy and incubated with a 2:1 
ratio of DNA to polyamide prior to crystallization. Crystals were obtained from a solution of 0.6 
mM duplex DNA, 0.75 mM polyamide, 24% 2-methyl-2,4-pentanediol (MPD), 35 mM calcium 
acetate, 10 mM Tris pH 7.5 equilibrated in sitting drops against a reservoir of 35% MPD at 4ºC 
and crystals were fl ash cooled at 100 K prior to data collection. DNA crystals grew in space group 
P4
1
2
1
2 with unit cell dimensions  a = 39.8270Å, b = 39.8270Å, c = 84.5718Å, α = 90.00º, β = 
90.00º, γ = 90.00º. 
6.9.3 Data collection, Structure determination, and refi nement
Polyamide-DNA crystals grew in space group P4
1
2
1
2 with unit cell dimensions  a = 39.8270Å, b 
= 39.8270Å, c = 84.5718Å, α = 90.00º, β = 90.00º, γ = 90.00º, and one polyamide-duplex DNA 
complex in the asymmetric unit. This data set was collected at Stanford Synchrotron Radiation 
Laboratory (SSRL) beamline 12-2 with a MAR Research imaging plate plate detector at wavelength 
0.97 Å.
 Data was processed with Mosfl m33 and scaled with the CCP434 program suite. Solution of 
both structures was obtained using SHELXD35,36 direct methods. All atoms were visible in initial 
maps from direct methods solution. Refi nement was performed using Refmac37 and model building 
using Coot.38 
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6.9.4 Structure Analysis
DNA helical parameters were calculated using the program Curves39 and 3DNA.40 Figures were 
prepared and measurements made using UCSF Chimera.41
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6.11 Supplemental Information
Figure 6.6 Comparison of Local base-pair step parameters for DNA with and without polyamide 
complexed. Parameters were calculated using 3DNA.
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Figure 6.7 Comparison of Local base-pair parameters and sugar conformations for DNA with and 
without polyamide complexed. Parameters were calculated using 3DNA.
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Figure 6.8 Comparison of Local base-pair helical parameters for DNA with and without poly-
amide complexed. Parameters were calculated using 3DNA.
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Chapter 7: Programmable Oligomers Targeting 5’-GGGG-3’ in the 
Minor Groove of DNA and NF-κB Binding Inhibition
The text of this chapter was taken in part from a manuscript coauthored with Julie A. Poposki, 
Michael A. Marques and Peter B. Dervan* (Caltech)
(Chenoweth, D.M., Poposki, J.A., Marques, M.A., Dervan, P. B. Bioorg. Med. Chem. 2007, 15, 
759-770.)
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Abstract
 A series of hairpin oligomers containing benzimidazole (Bi) and imidazopyridine (Ip) rings 
were synthesized and screened to target 5’-WGGGGW-3’, a core sequence in the DNA-binding site 
of NF-κB, a prolifi c transcription factor important in biology and disease. Five Bi and Ip containing 
oligomers bound to the 5’-WGGGGW-3’ site with high affi nity. One of the oligomers (Im-Im-Im-
Im-γ-Py-Bi-Py-Bi-β-Dp) was able to inhibit DNA binding by the transcription factor NF-κB.
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7.1 Introduction
 DNA-binding polyamides based on the architecture of the natural products netropsin 
and distamycin A have emerged as a promising class of gene modulators.1,2 These molecules are 
capable of distinguishing the four Watson-Crick base pairs in the DNA minor groove and have 
been the subject of intense study along with other classes of minor groove binders for interfering 
with specifi c protein–DNA interfaces.3c,d–f,4,5 Sequence-specifi c recognition of the minor groove of 
DNA by polyamides arises from the pairing of three different aromatic amino acids, pyrrole (Py), 
imidazole (Im), and hydroxypyrrole (Hp).4,5 The direct readout, or information face, on the inside 
of the crescent-shaped polyamide may be programmed by the incremental change of atoms on the 
corners of the ring pairs presented to the DNA minor groove fl oor. Stabilizing and importantly, 
destabilizing interactions with the different edges of the four Watson-Crick bases are modulated by 
shape complementarity and specifi c hydrogen bonds.4–6,7 For example, the Im/Py pair distinguishes 
G•C from C•G, T•A, and A•T. Im presents a lone pair of electrons to the DNA minor groove and 
can accept a hydrogen bond from the exocyclic amine of guanine.5 Additionally, the Hp/Py pair 
distinguishes T•A from A•T, G•C, and C•G.4–6 Hp projects an exocyclic OH group toward the minor 
groove fl oor that is sterically accommodated in the cleft of the T•A base pair, preferring to lie over 
T not A.5 Since the development of these pairing rules based on the fi ve-membered heterocyclic 
carboxamides Py, Im, and Hp, hundreds of DNA sequences have been successfully coded for using 
polyamides.3,5 Yet, due to sequence dependent alterations in the shape of the DNA minor groove, 
there remain DNA sequences that prove diffi cult to target with high affi nity and specifi city.
 There has been an ongoing effort to broaden the repertoire of heterocycles with improved 
DNA recognition, stability, and cellular traffi cking profi les. We recently reported that the 
benzimidazole ring can be an effective platform for modular paired recognition elements in the 
minor groove of DNA.8,9 The benzimidazole 6–5 bicyclic ring structure, while having slightly 
different curvature from the classic fi ve-membered N-methyl pyrrole–carboxamides, presents an 
‘inside edge’ with a similar atomic readout to the DNA minor groove fl oor, effectively mimicking 
Py, Im, and Hp (Figure 7.1).8,9 The imidazopyridine/pyrrole pair Ip/Py distinguishes G•C from C•G 
and the hydroxybenzimidazole/pyrrole pair Hz/Py distinguishes T•A from A•T, providing a solution 
to the unanticipated hydroxypyrrole instability limitation.8,9 This second generation solution to 
DNA recognition can be elaborated further, deleting incrementally almost all carboxamide linkages 
in the backbone of the hairpin motif creating an oligomer comprised of four dimer units capable 
of binding the site 5’-GTAC-3’, a sequence formally containing all four Watson-Crick base pairs.10 
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A key strategic issue for for small-molecule 
gene regulation is interfering with protein–
DNA interfaces in the promoter of important 
genes. The new oligomer architecture has 
been successful in targeting the hypoxia 
inducible factor (HIF-1) binding site on the 
promoter of the VEGF gene.11 This recent 
success spurred our interest in using these 
new oligomers to target another prolifi c 
transcription factor, NF-κB, important 
in biology and disease.12 Guanine rich 
sequences are highly prevalent and partially 
conserved in the promotor region of NF-
κB driven genes (Figure 7.2).12a,13 Previous 
studies from our laboratory have established 
the ability of polyamides, targeting the 
sequence 5’-GGGACT-3’, to inhibit DNA 
binding by NF-κB, however targeting the 
Figure 7.1 Structures of the (a) pyrrole-benzimi-
dazole internal dimer (-Py-Bi-), (b) imidazole-imi-
dazopyridine internal dimer (-Im-Ip-), and (c) imi-
dazole-imidazopyridine cap (Im-Ip-) in comparison 
with their respective fi ve-membered ring systems. 
Hydrogen-bonding surfaces to the DNA minor-
groove fl oor are bolded.
Figure 7.2 Crystal structure of the p50/p65 NF-κB heterodimer bound to the DNA duplex 5’-TG-
GGGACTTTCC-3’.13 The p50 and p65 monomers are represented as gold and dark blue ribbons, 
respectively. a) Top view looking down the DNA double helix. b) Side view showing the 5’-
GGGG-3’ oligomer binding site. GC rich regions are shown in red and AT rich regions are shown 
in light blue. c) Sequence of DNA bound to NF-κB.
175
four consecutive guanines was less successful due to the modest affi nity of pyrrole/imidazole 
polyamides for this sequence.14,15 The question arises whether a second generation oligomer 
architecture can target 5’-GGGG-3’ recognition sequences with improved affi nity.
 We report the synthesis, DNA binding properties, and NF-κB:DNA binding inhibition 
properties of a new class of DNA binding oligomers targeted at the DNA sequence 5’-WGGGGW-3’ 
containing 4-consecutive guanines (Figure 7.3). Oligomers vary by incorporation of benzimidazole–
pyrrole into various positions in the parent polyamide 1, resulting in oligomers 2–6. From previous 
studies, we expect the BiPy dimer to be a good mimic for the traditional Py-Py recognition elements.16 
The Ip-Im moiety is introduced as a new mimic for the traditional Im-Im recognition motif (Figure 
7.1). Quantitative DNase I footprinting titration experiments17 were used to determine the binding 
affi nities and specifi cities against single base-pair mismatch sites of oligomers 2–6 (Figure 7.3) 
as compared to their parent polyamide 1. We found that in oligomers 2–6, the 6–5 fused rings are 
effective mimics of their respective fi ve-membered ring systems and that these oligomers target the 
binding-site 5’-WGGGGW-3’ without loss of affi nity as compared to parent hairpin polyamide 1. 
In addition, we report the inhibition of DNA binding by the transcription factor NF-κB using this 
new class of minor groove binding oligomers (Figures 7.3 and 7.4).
7.2 Results and Discussion
7.2.1 Heterocycle Synthesis
 Dimeric units Im-Ip-OH (9) and Boc-Im-Ip-OH (12) were synthesized by oxidative 
condensation of aldehydes 7 and 10, respectively, with previously  reported diaminopyridine 8. 
Mixing 7 and 8 in DMF at 80 º C for 1 h followed by 12 h of heating at 100 º C in the presence of 
FeCl
3
 and air afforded 9 after purifi cation by precipitation from water and saponifi cation using a 
mixture of KOH (4 M) in MeOH at 40 º C (Scheme 7.1). Nitroimidazole (10) was synthesized from 
7 using a mixture of H
2
SO
4
 + SO
3
 and neat red fuming nitric acid.18 10 was then added to a mixture 
of 8 in nitrobenzene and refl uxed at 140 º C open to the atmosphere overnight to provide NO
2
-Im-
Ip-OMe (11) after precipitation from water. Compound 11 was reduced using Pd/C in the presence 
of hydrogen followed by Boc protection using a mixture of Boc
2
O and DMAP in DMF to provided 
the fi nal dimer Boc-Im-Ip-OH (12) after saponifi cation and precipitation (Scheme 7.1).
7.2.2 Oligomer Synthesis
 Oligomers 1–6 were synthesized using manual solid phase synthesis methodology on 
176
commercially available β-Ala-PAM resin as previously described (Scheme 7.2).19 Starting from 
base resin (BR1), monomeric and dimeric heterocyclic units were appended onto the resin in 
stepwise fashion using HBTU activation. Couplings were allowed to proceed for several h between 
Figure 7.3 Postulated hydrogen-bonding models for the 1:1 polyamide–DNA complexes with their 
matched sequence and the ball-and-stick representation for compounds 1 and 6 over the 6-base-pair 
matched binding site (variable region W = A or T). (a) Im-Im-Im-Im-γ-Py-Py-Py-Py-β-Dp (1), (b) 
Im-Im-Im-Im-γ-Py-Bi-Py-Bi-β-Dp (2), Im-Im-Im-Ip-γ-Py-Bi-Py-Bi-β-Dp (3), Im-Im-Ip-Im-γ-Py-
Bi-Py-Bi-β-Dp (4), Im-Ip-Im-Im-γ-Py-Bi-Py-Bi-β-Dp (5), Im-Ip-Im-Ip-γ-Py-Bi-Py-Bi-β-Dp (6).
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25 and 40 º C. Unreacted amines were acylated 
between coupling rounds using acetic anhydride. 
Deprotection of the Boc-protected amines was 
accomplished using 80% TFA in DCM. After 
completion of solid phase synthesis, the resin 
was treated with dimethylaminopropylamine 
(Dp) and the oligomers were purifi ed by reverse-
phase preparatory HPLC: Im-Im-Im-Im-γ-Py-
Py-Py-Py-β-Dp (1), Im-Im-Im-Im-γ-Py-Bi-Py-
Bi-β-Dp (2), Im-Im-Im-Ip-γ-Py-Bi-Py-Bi-β-Dp 
(3), Im-Im-Ip-Im-γ-Py-Bi-Py-Bi-β-Dp (4), 
Im-Ip-Im-Im-γ-Py-Bi-Py-Bi-β-Dp (5), and Im-
Ip-Im-Ip-γ-Py-Bi-Py-Bi-β-Dp (6). Oligomers 
were characterized using MALDI-TOF mass 
spectrometry.
7.2.3 DNA affi nity and sequence specifi city
 Quantitative DNase I footprinting titrations were carried out for oligomers 1–6 on the PCR 
product of plasmid pEF16 (Figures 7.5, 7.6, and 7.7). Plasmid pEF16 was constructed containing 
two designed match sites (5’-XGGGGT-3’ X = A, T) and two mismatch sites (5’-AGGGAT-3’ 
and 5’-AGAGGT-3’) (Figures 7.5, 7.6, and 7.7). The fi rst two match sites 5’-TGGGGT-3’ and 
5’-AGGGGT-3’ were included to determine if there was an energetic penalty associated with 
a 5’-AG-3’ step. Previously, DNA sequences containing multiple 5’-AG-3’ transitions have 
proven more diffi cult to target at high affi nity and it has been shown that changes in fl anking 
sequence can affect binding at a proximal site.20 The second two binding sites, 5’-AGGGAT-3’ 
and 5’-AGAGGT-3’, were designed to elucidate the energetic penalty for the loss of a favorable 
hydrogen bond between the exocyclic amine of guanine and the lone pair nitrogen on the oligomer 
in question. Control compound 1 bound both 4-G match sequences (5’-XGGGGT-3’, X = A, T) 
with comparably low affi nity (K
a
 ~ 108 M -1), showing no bias for either site (Table 7.1). Compound 
1 distinguished against mismatch sequences (5’-AGGGAT-3’ and 5’-AGAGGT-3’) with roughly 
10-fold specifi city (Table 7.1). Oligomer 2 demonstrated a large increase in affi nity (K
a
 ~ 1010 M -
1) as compared to 1 for both match sites, but showed lower specifi city (4-fold) over the mismatch 
Figure 7.4 Illustration of NF-κB:DNA bind-
ing inhibition by oligomer 2.
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sites. Oligomer 5 showed a moderate increase 
in affi nity (K
a
 ~ 109 M -1) and demonstrated 
minor selectivity (3-fold) over the mismatch 
5’-atGGGAt-3’, however showed an 11-fold 
specifi city over the mismatch 5’-atGAGGt-3’. 
Oligomer 4 demonstrated high affi nity for 
the 4-G match sequences (K
a
 ~ mid 109 M -
1) with reasonable 5-fold selectivity over the 
mismatch sequences (5’-AGGGAT-3’ and 
5’-AGGAGT-3’). Compounds 3 and 6 bound 
all designed sequences with similar affi nity. 
Thermodynamic data for oligomers 1–6 are 
summarized in Table 7.1.
 In general, the global increase in affi nity 
for these novel oligomers is not altogether 
unexpected. In contrast to the 5-membered 
heterocyclic carboxamides, the 6–5 fused 
benzimidazole analogues have a larger 
hydrophobic surface, likely promoting their 
placement in the DNA minor groove.21 Aromatic stacking and van der Waals interactions  are also 
contributing factors.22,23 Furthermore, the benzimidazole derivatives are a more rigid structure with 
a lower degree of rotational freedom. Such pre-organization may decrease the entropic cost of DNA 
complexation.
7.2.4 NF-κB electrophoretic mobility gel shift assay
 The guanine rich region of the NF-κB binding element has been shown to be important in 
protein–DNA recognition (Figure 7.2).13,15,24,25 Polyamides targeted to this region have previously 
been shown to inhibit NF-κB binding.15 The possibility of steric or allosteric inhibition exists due 
to numerous contacts between the p50 protein and the phosphate backbone or direct protein–DNA 
contacts in the major groove, opposite the minor groove polyamide binding site.13,15 To test whether 
the second generation oligomer architecture would be successful at targeting 5’-GGGG-3’ in a 
biologically relevant context we employed an NF-κB electrophoretic mobility gel shift assay. The 
Scheme 7.1. Synthesis of imidazopyridine–im-
idazole dimers Im-Ip-OH (9) and Boc-Im-Ip-OH 
(12). Reagents and conditions: (i) 8, PhNO
2
, 140 
º C; (ii) oleum, red-fuming HNO
3
; (iii) 8, PhNO
2
, 
140 º C; (iv) H
2
, Pd/C, DMF; (Boc)
2
O, DIEA, 
DMAP, DMF, 4 N KOH, MeOH.
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NF-κB binding inhibition properties of compounds 1–6 were screened against a 40 bp DNA probe 
containing the 5’-WGGGGW-3’ sequence, which is part of an element from the intronic enhancer 
of the immunoglobulin κ light-chain gene recognized and bound by NF-κB (Figure 7.8).13 In the 
initial screen each oligomer was tested at two concentrations, 10 and 100 nM, for the ability to 
interfere with protein binding (Figure 7.8). At the higher concentration, 2 and 4 demonstrate a 
clear decrease in band intensity, whereas compounds 1, 3, 5, and 6 have little effect. This result 
agrees with the footprinting data, as protein inhibition appears to scale with compound affi nity 
for the 5’-WGGGGW-3’ site. At the 10 nM concentration compound 2 is the only compound to 
show signifi cant protein inhibition, reducing band intensity by more than 80% (Figure 7.8). Full 
titration of compound 2 over a concentration range of 500 pM–500 nM established an EC
50
 of 15.7 
nM for NF-κB inhibition as shown in Figure 7.9. In addition, the identity of the NF-κB band was 
confi rmed by antibody supershift and the data are shown in Figure 7.10.
Scheme 7.2. Representative solid-phase synthesis of polyamide 6 along with a table of the amino 
acid building blocks used for the synthesis. Reagents and conditions: (i) 80% TFA/DCM; (ii) Boc-
Py-Bi-OH (13), HBTU, DIEA, DMF; (iii) Ac
2
O, DIEA, DMF; (iv) repeat (i–iii); (v) 80% TFA/
DCM; (vi) Boc-c-OH (14), HBTU, DIEA, DMF; (vii) Ac
2
O, DIEA, DMF to provide BR1; (viii) 
80% TFA/DCM; (ix) Boc-Im-Ip-OH (12), HBTU, DIEA, DMF; (x) 80% TFA/DCM; (xi) Im-
Ip-OH, HBTU, DIEA, DMF; (xii) dimethylaminopropylamine (Dp), 80 º C 2 h; (xiii) preparative 
HPLC to give 6..
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Figure 7.5 Quantitative DNaseI footprinting experiments in the hairpin motif for polyamides 1 
and 2 respectively, on the 278 bp, 5’-end-labeled PCR product of plasmid pEF16: lane 1, intact 
DNA; lanes 2 and 3, G and A sequencing reaction; lane 4, DNase I standard; lanes 5–15, 1 pM, 3 
pM, 10 pM, 30 pM, 100 pM, 300 pM, 1 nM, 3 nM, 10 nM, 30 nM, and 100 nM polyamide concen-
tration, respectively. Each footprinting gel is accompanied by the following: (top) ball-and-stick 
models of the compound bound to its target DNA sequence; and (bottom) Binding isotherms for 
the four designed sites. θ
app
 values were obtained according to published methods. Imidazoles and 
pyrroles are shown as fi lled and non-fi lled circles, respectively; dimer units are represented as 
rectangles containing either Bi enclosed in a circle representing benzimidazole or Ip in a black box 
representing imidazopyridine; beta alanine is shown as a diamond; the gamma-aminobutyric acid 
turn residue is shown as a semicircle connecting the two subunits.
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Figure 7.6 Quantitative DNaseI footprinting experiments in the hairpin motif for polyamides 3 
and 4 respectively, on the 278 bp, 5’-end-labeled PCR product of plasmid pEF16: lane 1, intact 
DNA; lanes 2 and 3, G and A sequencing reaction; lane 4, DNase I standard; lanes 5–15, 1 pM, 3 
pM, 10 pM, 30 pM, 100 pM, 300 pM, 1 nM, 3 nM, 10 nM, 30 nM, and 100 nM polyamide concen-
tration, respectively. Each footprinting gel is accompanied by the following: (top) ball-and-stick 
models of the compound bound to its target DNA sequence; and (bottom) Binding isotherms for 
the four designed sites. θ
app
 values were obtained according to published methods. Imidazoles and 
pyrroles are shown as fi lled and non-fi lled circles, respectively; dimer units are represented as 
rectangles containing either Bi enclosed in a circle representing benzimidazole or Ip in a black box 
representing imidazopyridine; beta alanine is shown as a diamond; the gamma-aminobutyric acid 
turn residue is shown as a semicircle connecting the two subunits.
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Figure 7.7 Quantitative DNaseI footprinting experiments in the hairpin motif for polyamides 5 
and 6 respectively, on the 278 bp, 5’-end-labeled PCR product of plasmid pEF16: lane 1, intact 
DNA; lanes 2 and 3, G and A sequencing reaction; lane 4, DNase I standard; lanes 5–15, 1 pM, 3 
pM, 10 pM, 30 pM, 100 pM, 300 pM, 1 nM, 3 nM, 10 nM, 30 nM, and 100 nM polyamide concen-
tration, respectively. Each footprinting gel is accompanied by the following: (top) ball-and-stick 
models of the compound bound to its target DNA sequence; and (bottom) Binding isotherms for 
the four designed sites. θ
app
 values were obtained according to published methods. Imidazoles and 
pyrroles are shown as fi lled and non-fi lled circles, respectively; dimer units are represented as 
rectangles containing either Bi enclosed in a circle representing benzimidazole or Ip in a black box 
representing imidazopyridine; beta alanine is shown as a diamond; the gamma-aminobutyric acid 
turn residue is shown as a semicircle connecting the two subunits.
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7.3 Conclusion
 While traditional Py, Im, and Hp containing polyamides have been successful at recognizing 
hundreds of pre-determined DNA sequences with high affi nity and specifi city, a host of target 
sequences such as 5’-GGGG-3’ have proven diffi cult to code for using polyamides. A series of novel 
oligomers containing the 6–5 fused benzimidazole (Bi) and imidazopyridine (Ip) heterocycles were 
developed. These oligomers, composed of 5-membered heterocyclic carboxamides, demonstrated a 
substantial increase in affi nity (10- to 100-fold) for the 5’-GGGG-3’ sequence. The marked increase 
in affi nity could be attributed to a combination of oligomer properties including a larger hydrophobic 
surface, a high degree of ligand pre-organization, or differential solvation/desolvation effects. The 
ability of this class of new oligomers to inhibit protein–DNA binding was demonstrated by the 
inhibition of NF-κB. We are encouraged by the fact that these oligomers demonstrate improved 
affi nity for guanine rich DNA sequences and future work directed toward improving sequence 
specifi city and examination of the nuclear traffi cking ability is a priority.
7.4 Experimental
7.4.1 General
N,N-Dimethylformamide (DMF), N,N-diisopropylethylamine (DIEA), N,N-
dimethylaminopropylamine (Dp), triethylamine (TEA), nitrobenzene (NO
2
Ph), 2-formyl-N-
Table 7.1 Affi nities of 5’-GGGG-3’ binding oligomers K
a
 (M -1)a,b
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Figure 7.8 a) Match DNA sequence with the p50 protein of NF-κB overlapping the oligomer 
binding site. Asterisks indicate the location of radio-labeled nucleotides in the probe sequence. b) 
Mismatch DNA sequence. c) Gel shift screen for compounds 1–6 at concentrations of 10 and 100 
nM. d) Plot of relative NF-κB inhibition for compounds 1–6.
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methylimidazole, red fuming nitric acid, 1,3-dichloro-4-nitropyridine, 30% bromine in acetic acid, 
palladium acetate Pd(OAc)
2
, and 10% palladium on carbon were purchased from Aldrich. Boc-
β-alanine-(4-carbonylaminomethyl)-benzyl-ester-copoly(styrene–divinylbenzene) resin (Boc-β-
Pam-resin), dicyclohexylcarbodiimide (DCC), hydroxybenzotriazole (HOBt), 2-(1H-benzotriazol-
1-yl)-1,1,3,3-tetramethyluronium hexafl uorophosphate (HBTU), N,N-dimethylaminopyridine 
(DMAP), and Boc-β-alanine were purchased from NOVA Biochem. Trifl uoroacetic acid (TFA) was 
Figure 7.9 (Top) ball-and-stick model for 2 and 
EC
50
 value from gel shift experiment. (Middle) rep-
resentative NF-κB titration gel (n = 3) for 2. (Bot-
tom) binding isotherm for 2.
Figure 7.10 Antibody supershift on match 
DNA. The NF-κB band is shifted in the 
presence of anti-p50 or anti-p65 antibody.
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purchased from Halocarbon. All other solvents were reagent grade from EM. Oligonucleotide inserts 
were synthesized by the Biopolymer Synthesis Center at the California Institute of Technology. 
Precoated silica gel plates 60F
254
 for TLC and silica gel 60 (40 μm) for fl ash chromatography 
were from Merck. Glycogen (20 mg/ml), dNTPs (PCR nucleotide mix), and all enzymes, unless 
otherwise stated, were purchased from Boehringer–Mannheim. pUC19 was purchased from New 
England Biolabs and deoxyadenosine [γ-32P] triphosphate was provided by ICN. Calf thymus 
DNA (sonicated, deproteinized) was obtained from Amersham Pharmacia. DNase I (7500 U/
ml, FPLC pure) was purchased from Roche. AmpliTaq DNA polymerase was from Perkin-Elmer 
and used with the provided buffers. Tris–HCl, DTT, RNase-free water, and 0.5 M EDTA were 
from United States Biochemical. Calcium chloride, potassium chloride, and magnesium chloride 
were purchased from Fluka. Tris–borate–EDTA was from Gibco and bromophenol blue was from 
Acros. All reagents were used without further purifi cation. NMR spectra were recorded on a Varian 
spectrometer at 300 MHz in DMSO-d
6
 or CDCl
3 
with chemical shifts reported in parts per million 
relative to residual solvent. UV spectra were measured on a Hewlett–Packard (model 8452 A) 
diode array spectrophotometer. High resolution FAB and EI mass spectra were recorded at the 
Mass Spectroscopy Laboratory at the California Institute of Technology. Matrix-assisted, laser 
desorption/ionization time of fl ight mass spectrometry (MALDI-TOF-MS) was conducted at the 
Mass Spectroscopy Laboratory at the California Institute of Technology.
7.4.2 Heterocycle Synthesis
Heterocyclic building blocks Boc-Im-OH and Boc-Py-Bi-OH were synthesized as reported.8,19 
Im-Im-OH (1-methyl-4-(1-methyl-1H-imidazole-2-carboxamido)-1H-imidazole-2-carboxylic 
acid, CAS [464892-44-2]) and Boc-Im-Im-OH (4-(4-(tert-butoxycarbonylamino)-1-methyl-1H-
imidazole-2-carboxamido)-1-methyl-1H-imidazole-2-carboxylic acid, CAS [502170-49-2]), are 
commercially available.
7.4.2.1 1-methyl-4-nitro-1H-imidazole-2-carbaldehyde (NO
2
-Im-CHO) (10).
A cooled fl ask (0 ºC) of 1-methyl-2-imidazole-carboxaldehyde (7) (8g, 72.6 mmol, Aldrich) 
was treated dropwise with a precooled (0 ºC) solution of red fuming nitric acid (75 ml) in conc. 
H
2
SO
4
•SO
3
 (30%) (75 ml). The mixture was warmed to room temperature and stirred for 12 h open 
to the atmosphere. Next, the mixture was poured over ice, neutralized with solid sodium carbonate, 
extracted 4 times with dichloromethane, dried over anhydrous sodium sulfate, and concentrated in 
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vacuo to give a brownish-yellow oil. The oil was recrystallized from iPrOH/Et
2
O or EtOH/Et
2
O 
to give 1-methyl-4-nitro-1H-imidazole-2-carbaldehyde (10) as a tan crystalline solid (4.5 g, 40% 
Yield).  TLC (1:1 EtOAc/Hex) R
f
  = 0.4; 1H NMR (300 MHz, DMSO-d
6
) δ 9.74 (s, 1H), 8.71 (s, 
1H), 3.99 (s, 3H); 13C (75 MHz, DMSO-d
6
) δ 182.31, 146.14, 140.56, 127.33, 35.70; HR-MS (EI+): 
calculated for C
5
H
5
O
3
N
3
: 155.0330; found: 155.0350.
7.4.2.2 2-(1-Methyl-4-nitroimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid methyl 
ester (NO
2
-Im-Ip-OMe) (11).
1-Methyl-4-nitro-1H-imidazole-2-carbaldehyde (2.01 g, 13.0 mmol) (10) and methyl 
5,6-diaminopyridine-2-carboxylate (8) (2.17 g, 13.0 mmol) suspended in 120 ml of nitrobenzene 
was heated to 140 ºC for 48 h open to the atmosphere. The reaction mixture was cooled to 23 ºC and 
the precipitate collected by vacuum fi ltration. The solid was washed with diethyl ether and dried 
under high vacuum to provide 2-(1-methyl-4-nitroimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-
carboxylic acid methyl ester (11) (3.6 g, 92% Yield) as a powdery tan solid.  1H NMR (300 MHz, 
DMSO-d
6
) δ 14.02 (broad s, 1H), 8.03-8.06 (m, 2H), 4.27 (s, 3H), 3.91 (s, 3H); 13C (75 MHz, 
DMSO-d
6
) δ 166.01, 146.44, 142.95, 136.59, 135.80, 130.36, 127.35, 123.81, 121.17, 121.04, 
52.85, 37.43; HR-MS (EI+): calculated for C
12
H
10
N
6
O
4
: 302.0760; found: 302.0760.
7.4.2.3 2-{4-Amino-1-methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid methyl 
ester (H
2
N-Im-Ip-OMe).
2-(1-Methyl-4-nitroimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid methyl ester (11) 
(3 g, 9.9 mmol) was dissolved in anhydrous DMF (150 ml) and the solution was degassed with 
Ar. After the addition of Pd/C (10 wt. %, 600 mg) the reaction mixture was purged 3 times with 
hydrogen and then left to stir at 23ºC for 9 h under a hydrogen balloon atmosphere. After fi ltering 
through a pad of Celite and washing with copious amounts EtOAc the fi ltrate was concentrated in 
vacuo to give 2-{4-amino-1-methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid 
methyl ester, without further purifi cation (2.7 g, 100% Yield). 13C NMR (75 MHz, DMSO-d
6
) δ 
166.17, 149.03, 148.21, 141.40, 131.50, 120.12, 107.77; HR-MS (EI+): calculated for C
12
H
12
N
6
O
2
: 
272.1020; found: 272.1030.
7.4.2.4 2-{4-[(tert-Butoxy)carbonylamino]-1-methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-
carboxylic acid methyl ester (Boc-Im-Ip-OMe).
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2-{4-amino-1-methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid methyl ester 
(11) (2.0 g, 7.3 mmol) dissolved in DMF (25 ml) was treated with Boc
2
O (5.3 g, 24.3 mmol), DIEA 
(5.2 ml), and DMAP (95 mg, 0.73 mmol). The reaction mixture was then heated to 80 ºC for 72 h, 
cooled to 23 ºC, and fl ashed through a plug of silica gel eluting with EtOAc to give a mixture of 
mono- and di-bocked (2-{4-[(tert-butoxy)carbonylamino]-1-methylimidazol-2-yl)-3-[(tert-butoxy)
carbonylamino]-imidazo[4,5-b]pyridine-5-carboxylic acid methyl ester) products which were 
carried on for saponifi cation.
7.4.2.5 2-{4-[(tert-Butoxy)carbonylamino]-1-methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-
carboxylic (Boc-Im-Ip-OH) (12).
2-{4-[(tert-Butoxy)carbonylamino]-1-methylimidazol-2-yl)-3-[(tert-butoxy)carbonylamino]-
imidazo[4,5-b]pyridine-5-carboxylic acid methyl ester dissolved in MeOH (10 ml) and NaOH (1 
N, 25 ml) was heated to 50 ºC for 4 h. The reaction mixture was cooled to 0 ºC and the pH adjusted 
slowly to pH = 4 with 1 N HCl. The reaction mixture was then extracted with ethyl acetate (4 
times), dried over anhydrous sodium sulfate, concentrated in vacuo, and dried under high vacuum 
to give 2-{4-[(tert-butoxy)carbonylamino]-1-methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-
carboxylic (12) (258 mg, 60% Yield) as a light yellow solid.  1H NMR (300 MHz, DMSO-d
6
) δ 
13.19 (broad s, 2H), 9.53 (s, 1H), 8.00 (m, 2H), 7.36 (s, 1H), 4.15 (s, 3H), 1.47 (s, 9H); 13C (75 
MHz, DMSO-d
6
) δ 166.61, 152.92, 147.81, 142.48, 138.38, 132.01, 128.91, 119.74, 113.50, 79.07, 
35.35, 28.12; HR-MS (EI+): calculated for C
16
H
18
N
6
O
4
: 358.1390; found: 358.1370.
7.4.2.6 2-(1-Methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid methyl ester (Im-
Ip-OMe).
1-Methylimidazole-2-carbaldehyde (7) (214 mg, 1.85 mmol)  and  methyl 5,6-diaminopyridine-2-
carboxylate (8) ( 310 mg, 1.85 mmol) were suspended in  17 ml of DMF and heated to 80 ºC for 
1 hour open to the atmosphere. Next, FeCl
3
•6H
2
O (24mg, 0.09 mmol) was added and the reaction 
mixture was heated to 100 ºC for 12 hrs while air was bubbled through the reaction mixture. 
The reaction mixture was then cooled to room temperature and poured over ice. The precipitate 
was collected by fi ltration and washed with cold diethyl ether. The material was dissolved in hot 
iso-propanol, cooled to room temperature and re-precipitated with diethyl ether. The solid was 
washed with diethyl ether and dried under high vacuum to provide 2-(1-methylimidazol-2-yl)-3H-
imidazo[4,5-b]pyridine-5-carboxylic acid methyl ester (Im-Ip-OMe) (240 mg, 50% Yield) as a tan 
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solid.  1H NMR (300 MHz, DMSO-d
6
) δ 7.99 (s, 2 H), 7.51 (s, 1H), 7.20 (s, 1H), 4.18 (s, 3H), 3.88 
(s, 3H); 13C (75 MHz, DMSO-d
6
) δ 147.7, 142.0, 137.1, 131.8, 129.6, 126.9, 119.9, 109.3, 52.8, 
35.8; HR-MS (EI+): calculated for C
12
H
11
N
5
O
2
: 257.0910; found: 257.0920. 
7.4.2.7 2-(1-Methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid (Im-Ip-OH) (9).
2-(1-Methylimidazol-2-yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid methyl ester (Im-Ip-
OMe) (250 mg, 0.97 mmol) dissolved in MeOH (2 ml) and KOH (4 N, 3 ml) was heated to 50 
ºC for  4 h. The methanol was removed in vacuo and the aqueous layer washed with EtOAc (2 
x 10 mL) to remove any starting material and trace impurities. The pH of the aqueous layer was 
then adjusted slowly to pH = 4 with 1 N HCl upon which time a cloudy beige precipitate formed. 
The mixture was placed in a falcon tube and the precipitate concentrated by centrifugation. The 
supernatant was decanted and the solid dried under high vacuum to give 2-(1-methylimidazol-2-
yl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid (9) (154 mg, 65% Yield) as a brown solid. 1H 
NMR (300 MHz, DMSO-d
6
) δ 7.99 (s, 2H), 7.51 (d, 1H, J = 0.9 Hz), 7.20 (d, 1H, J = 0.9 Hz), 4.18 
(s, 3H); HR-MS (EI+): calculated for C
11
H
9
N
5
O
2
: 243.0750; found: 243.0740.
7.4.3 Oligomer Synthesis
Oligomers were synthesized on solid support using Boc-β-PAM resin (0.59 meq/g). Stepwise 
elongation of the oligomers was done according to previously published protocols.19 The synthesis 
of compound 1 has been previously reported.14
7.4.3.1 Preparation of Base Resin R-β-Bi-Py-Bi-Py-γ-NHBoc (BR1).
To a manual solid phase synthesis vessel was added Boc-β-PAM resin (0.3 g). The resin was washed 
with DMF (15 mL) and allowed to swell for 15 min while shaking at room temperature. The 
resin was then washed with DCM (~30 mL), followed by 80% TFA in DCM (~30 mL) to remove 
the Boc-group. The resin was then agitated at room temperature in 80% TFA/DCM for another 
25 min to provide the deprotected resin bound amine (R−β-NH
2
). Following Boc-deprotection, 
the resin was washed with DCM and 10% DIEA in DMF to neutralize and prepare for coupling. 
Simultaneously, in a separate reaction vessel, Boc-Py-Bi-OH (189 mg, 531 μM), HBTU (191 mg, 
504 μM), DIEA (137 mg, 185 μL, 1.06 mM) and DMF (1.2 mL) was mixed and allowed to activate 
at room temperature for 25 min. This mixture was then added to the solid phase synthesis vessel 
containing R−β-NH
2
. Coupling was allowed to proceed at room temperature with agitation for 3-6 
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h. Initial loading of the resin requires elongated coupling times.  Following coupling, the resin was 
acylated by the addition of acetic anhydride to the mixture and shaking for 15 min. The addition of 
the next Boc-Py-Bi-OH (25) dimer was incorporated and deprotected as described above to provide 
the resin bound fragment (R-β-Bi-Py-Bi-Py-NH
2
).  To this fragment was added a preactivated 
mixture of Boc-γ-OH (180 mg, 885 μM), HBTU (319 mg, 841 μM), DIEA (229 mg, 308 μL, 1.77 
mM). Coupling was allowed to proceed for 3 h at room temperature with agitation. The resin was 
then capped with acetic anhydride as described above to provide the base resin R-β-Bi-Py-Bi-Py-
γ-NHBoc (BR1). BR1 was then washed with DCM followed by MeOH and Et2O.  The resin was 
then dried under high vacuum and stored for subsequent use.
7.4.3.2 Im-Im-Im-Im-γ-Py-Bi-Py-Bi-β-Dp (2).
BR1 (50 mg) was added to a manual solid phase synthesis vessel. The resin was washed with 
DCM (~15 mL), followed by deprotection with 80% TFA in DCM. The resin was shaken at room 
temperature in the 80% TFA solution for 25 min. The resin was then drained, washed with DCM, 
and neutralized with 10% DIEA in DMF. A pre-activated mixture of Boc-Im-Im-OH (54 mg, 148 
μM), HBTU (53 mg, 140 μM), DIEA (38 mg, 52 μL, 295 μM) and DMF (400 μL) was then added 
to the reaction vessel and coupling was allowed to proceed for 3 h at room temperature, followed 
by capping with acetic anhydride as described for BR1 to give R-β-Bi-Py-Bi-Py-γ-Im-Im-NHBoc. 
Following resin deprotection as described above, Im-Im-OH was activated as described for Boc-Im-
Im-OH. Coupling of Im-Im-OH to the resin was allowed to proceed overnight at room temperature 
to provide R-β-Bi-Py-Bi-Py-γ-Im-Im-Im-Im. The resin was treated with the cleavage protocol 
outlined below to provide Im-Im-Im-Im-γ-Py-Bi-Py-Bi-β-Dp (2) in 5% yield. MALDI-TOF-MS: 
calculated for C
58
H
66
N
23
O
8
: 1212.55; found 1212.50 [M+H]+.
7.4.3.3 Im-Ip-Im-Im-γ-Py-Bi-Py-Bi-β-Dp (5).
BR1 (50 mg) was added to a manual solid phase synthesis vessel and R-β-Bi-Py-Bi-Py-γ-Im-Im-
NHBoc was prepared as described above for 2. Following deprotection, washing and neutralization 
as described above, a pre-activated mixture of Im-Ip-OH (14) (21.5 mg, 88.5 μM), HBTU (32 mg, 
84 μM), DIEA (23 mg, 31μL, 177 μM), DMF (400 μL) was added to the vessel containing R-β-
Bi-Py-Bi-Py-γ-Im-Im-NH
2
. Coupling was allowed to proceed overnight at room temperature to 
provide R-β-Bi-Py-Bi-Py-γ-Im-Im-Ip-Im. The resin was treated with the cleavage protocol outlined 
below to provide Im-Ip-Im-Im-γ-Py-Bi-Py-Bi-β-Dp 5 in 2.2% yield. MALDI-TOF-MS: calculated 
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for C
59
H
64
N
23
O
7
: 1206.54; found 1206.60 [M+H]+.
7.4.3.4 Im-Im-Im-Ip-γ-Py-Bi-Py-Bi-β-Dp (3).
BR1 (50 mg, 0.81 meq/g) was added to a manual solid phase synthesis vessel. The resin was treated 
with the cleavage protocol outlined below to provide Im-Im-Im-Ip-γ-Py-Bi-Py-Bi-β-Dp 3 in 3% 
yield. MALDI-TOF-MS: calculated for C
59
H
64
N
23
O
7
: 1206.50; found 1206.50 [M+H]+.
7.4.3.5 Im-Im-Ip-Im-γ-Py-Bi-Py-Bi-β-Dp (4).
BR1 (70 mg, 0.59 meq/g) was added to a manual solid phase synthesis vessel. The resin was washed 
with DCM (~15 mL), followed by deprotection with 80% TFA in DCM. The resin was shaken at 
room temperature in the 80% TFA solution for 25 min. The resin was then drained, washed with 
DCM, neutralized with 50% DIEA in DCM, and washed with DMF. A pre-activated mixture of 
Boc-Im-OH (50 mg, 207 μmol), HBTU (79 mg, 208 μmol), DIEA (53 mg, 72 μL, 413 μmol) and 
DMF (900 μL) was then added to the reaction vessel and coupling was allowed to proceed for 12 
h at room temperature, followed by capping with acetic anhydride as described for BR1 to give 
R-β-Bi-Py-Bi-Py-γ-Im-NHBoc. Following resin deprotection as described above, Boc-Im-Ip-OH 
(12) was activated as described for Boc-Im-OH. Coupling of 12 to the resin was allowed to proceed 
overnight at room temperature to provide R-β-Bi-Py-Bi-Py-γ-Im-Ip-Im-NHBoc.  Following resin 
deprotection as described above, Im-CCl
3
 (2-Trichloroacetyl-1-methylpyrrole) (47 mg, 207 μmol) 
and DIEA (53 mg, 72 μL, 413 μmol) were dissolved in NMP (900 μL) and added to the reaction 
vessel. Coupling of Im-CCl
3
 to the resin was allowed to proceed overnight at 32 ºC to provide 
R-β-Bi-Py-Bi-Py-γ-Im-Ip-Im-Im. The resin was treated with the cleavage protocol outlined below 
to provide Im-Im-Ip-Im-γ-Py-Bi-Py-Bi-β-Dp 4 in 3% yield. MALDI-TOF-MS calculated for 
C
59
H
64
N
23
O
7
: 1206.54; found 1206.50  [M+H]+.
7.4.3.6 ImIp-ImIp-γ-PyBi-PyBi-β-Dp (6).
BR1 (50 mg) was added to a manual solid phase synthesis vessel. The resin was treated with 
the cleavage protocol outlined below to provide Im-Ip-Im-Ip-γ-Py-Bi-Py-Bi-β-Dp 6 in 2% yield. 
MALDI-TOF-MS calculated for C
60
H
62
N
23
O
6
: 1200.52; found 1200.50  [M+H]+.
7.4.4 Resin Cleavage Procedure  
A sample of resin (20-100 mg) was washed with DCM followed by the addition of 
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dimethylaminopropylamine (Dp) (1 mL). The mixture was heated to 80 ºC for 2 h with occasional 
agitation. The resin was then fi ltered and washed with 0.1% TFA in water (7 mL). The combined 
fi ltrate was collected and subjected to purifi cation by reverse phase preparatory HPLC using a 
Waters C
18
 column and 0.1% TFA/ACN solvent system.  Appropriate fractions from the HPLC 
purifi cation were checked for purity by analytical HPLC and characterized by MALDI-TOF 
spectroscopy. Pure fractions were then pooled, fl ash frozen using liquid nitrogen and lyophilized to 
a dry solid for later use.
7.4.5 Footprinting Experiments
Plasmids pEF16 was constructed using standard methods. DNase I footprint titrations were 
performed according to standard protocols.17
7.4.6 NF-κB Electrophoretic Mobility Shift Assay
7.4.6.1 Materials
Jurkat Nuclear Extract containing activated NF-κB was purchased from Active Motif (36013) and 
diluted as necessary just prior to use with Buffer C (20 mM Hepes pH 7.9, 420 mM KCl, 1.5 
mM MgCl
2
, 25% glycerol, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF, 1 μg/ml aprotinin). The 
fi nal working concentration was 0.5-2.5 μg/μl. The identity of the NF-κB band was confi rmed by 
antibody supershift (Figure 7.9) using antibodies against p50 (sc-7178, sc-114) and p65 (sc-372) 
from Santa Cruz Biotechnology.
7.4.6.2 Antibody Supershift
The NF-κB antibody supershift data is shown in Figure 7.9. NF-κB antibodies (sc-7178 and sc-114 
against p50 and sc-372 against p65) came from Santa Cruz Biotechnology. The actin antibody was 
purchased from Sigma-Aldrich (A5441). Antibodies were diluted to 0.1 μg/μl just prior to use with 
ice cold PBS. Complete binding reactions contained 0.1 ng labeled probe, 10 mM Tris•HCl pH 
7.5, 50 mM NaCl, 10% glycerol, 1% NP-40, 1 mM EDTA, 0.1 mg/ml poly(dI-dC), 1 μl antibody 
(0.1 μg), and 4 μg (2 μl) nuclear extract in a total volume of 10 μl. Nuclear extract was incubated 
with antibody at 4 ºC for 1 hour followed by addition of binding buffer and probe. The complete 
reactions were allowed to incubate a further 30 min at room temperature, loaded onto pre-run 5% 
acrylamide, 5% glycerol gels, and resolved for 2 h at 150 volts. Gels were pre-run for 15-45 min 
prior to loading. The gel and running buffer was 24.8 mM Tris Base, 190 mM glycine, 1 mM 0.5 
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M EDTA.
7.4.6.3 Sequence of Gel Shift Probes
Oligonucleotides were purchased from Integrated DNA Technologies.  The size of both probes 
following labeling was 40 basepairs. The match probe contained an imbedded κB site from the 
intronic enhancer of the immunoglobulin κ light-chain gene (underlined below). As a control, the 
sequence of the mismatch probe contained a mutated κB that prevented NF-κB binding (changes 
bolded below).
 Match Probe:
  5’  AATTCATGCAGTTGAGGGGACTTTCCCAGGCATGCA  3’
 Match Complementary Sequence:
  5’  AGCTTGCATGCCTGGGAAAGTCCCCTCAACTGCATG  3’
 Mismatch Probe: 
  5’  AATTCATGCAGTTGAGGTTACTTTCCCAGGCATGCA  3’
 Mismatch Complementary Sequence:
  5’  AGCTTGCATGCCTGGGAAAGTAACCTCAACTGCATG  3’
7.4.6.4 Preparation of 3’ Labeled Probes
In separate reactions, 1.1 pmol of match or mismatch oligonucleotide was annealed to an equal 
amount of its complementary sequence by heating at 95 ºC for 1 minute and cooling slowly to room 
temperature.  The 3’ ends were radiolabeled with 32P using Sequenase Version 2.0 (Amersham) 
and α32P dATP (PerkinElmer). The resulting labeled probes were purifi ed with G-50 Microspin 
Columns (Amersham). Probe concentration was estimated at 0.8 ng/μl assuming 100% recovery 
based on a calculated molecular weight of 24,662 g/mol. Just prior to use, labeled probes were 
diluted in water to 0.1 ng/μl.
7.4.6.5 Gelshift Screen
Dry HPLC purifi ed aliquots of polyamide were dissolved in water and their concentration determined 
by measuring the absorbance at 310 nm (ε= 69,520 M-1 C-1).  10x solutions (1 μM and 100 nM) of 
each polyamide were prepared from serial dilutions of the concentrated stock. Binding reactions 
contained 0.1 ng labeled probe, 10 mM Tris•HCl pH 7.5,  50 mM NaCl, 10% glycerol, 1% NP-40, 
1 mM EDTA, 0.1 mg/ml poly(dI-dC), 1 μl  10x polyamide (fi nal concentration 10 nM or 100 nM), 
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and 3 μg (1-2 μl) nuclear extract in a total volume of 10 μl. Reactions were allowed to equilibriate 
at room temperature without nuclear extract for 3 h, followed by addition of protein. After a 
further 30 min at room temperature, the reactions were loaded and resolved on non-denaturing 5% 
acrylamide, 5% glycerol gels for 2-2.5 h at 150 volts. The gels were immediately dried and exposed 
to a phosphoimage storage plate for at least 8 h. The gel and running buffer was 24.8 mM Tris Base, 
190 mM glycine, 1 mM 0.5 M EDTA. Gels were pre-run for 15 to 45 min prior to loading.
7.4.6.6 Gelshift Titration
Reactions were prepared as described above with a constant 0.1 ng probe and 3 μg nuclear extract, 
except that 10x solutions of polyamide were prepared to give a fi nal concentration range of 500 
pM to 500 nM.
7.4.6.7 Data Analysis
A Typhoon 8600 Variable Mode Imager was used to visualize the gels and band intensity was 
quantifi ed using ImageQuant software version 5.1 from Molecular Dynamics.  The fraction of 
DNA bound to NF-κB was calculated as the intensity ratio of the NF-κB shifted band to the sum 
total of all bands, shifted and unshifted. EC
50
 values were determined graphically as the polyamide 
concentration required to reduce NF-κB band intensity to half its value. The data was plotted vs. 
polyamide concentration and fi t to the Hill equation (n=1) using Kaleidagraph software. 
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Chapter 8: Fluorescent Sequence-Specifi c dsDNA Binding Oligomers
The text of this chapter was taken in part from a manuscript coauthored with Anne Viger and Peter 
B. Dervan* (Caltech)
(Chenoweth, D.M., Viger, A., Dervan, P. B. J. Am. Chem. Soc. 2007, 129, 2216-2217.)
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Abstract
 Sequence-specifi c detection methods for double-stranded DNA that obviate the need for 
denaturation would provide a powerful tool for bioorganic chemistry and genetics. As part of a 
sustained effort to develop sequence-specifi c fl uorescent DNA detection methods, two programmable 
oligomers have been synthesized which target their respective sequences 5‘-WTACGW-3‘ and 
5‘-WGGGGW-3‘ (W = A or T). The two oligomers were found to fl uoresce weakly in the absence 
of DNA but showed signifi cant fl uorescence enhancement by the addition of match DNA. The 
fl uorescence is shown to increase in a concentration-dependent manner, and the intensity varies 
depending on the number of mismatch sites incorporated into the DNA hairpins. This new class of 
oligomers provides a method to detect DNA sequences without denaturation and in the absence of 
conjugation to a dye molecule. This is a fi rst step toward sequence-specifi c DNA-binding molecules 
containing a fl uorescent switch integrated as part of the recognition modules.
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8.1 Introduction
 Sequence-specifi c detection methods for double-stranded DNA (dsDNA) that obviate the 
need for denaturation would provide useful tools for bioorganic chemistry and genetics.1 Previous 
efforts, such as molecular beacons2 or peptide nucleic acid-thiazole orange (PNA-TO) conjugates,3 
require harsh denaturation conditions for hybridization to single-stranded DNA.2-4 Previous efforts 
from our laboratory for the sequence-specifi c detection of dsDNA have focused on pyrrole-
imidazole (Py-Im) polyamide-fl uorophore conjugates, such as tetramethylrhodamine (TMR) or 
thiazole orange (TO), that bind in the minor groove of DNA.5-7 TMR fl uorescence was shown to be 
quenched when the fl uorophore was covalently linked to the ring nitrogen of a pyrrole recognition 
element within a polyamide.5 Remarkably, fl uorescence was restored in a sequencedependent 
manner upon binding to dsDNA.5 Similarly, polyamide-TO intercalator conjugates also demonstrate 
fl uorescence enhancement in the presence of match dsDNA.6 
 Having established Py-Im polyamide-dye conjugates as a suitable platform for sequence-
specifi c fl uorescent dsDNA detection,5,6 we sought to develop a new class of fl uorescent DNA 
binders wherein the fl uorescent moiety is an 
integrated part of the recognition modules. We 
report here the design of sequence-specifi c 
fl uorescent dsDNA-binding oligomers 
(Figure 8.1) which incorporate multiple 
6-5 fused dimer recognition modules8 and 
show a marked fl uorescent enhancement 
upon excitation at 340 nm in the presence of 
dsDNA.
8.2 Results and Discussion
 Oligomer O1 contains the 
chlorothiophene-benzimidazole (Ct-Bi-), 
pyrrole-imidazopyridine (-Py-Ip-), and 
imidazolehydroxybenzimidazole (-Im-Hz-) 
recognition modules, whereas oligomer O2 
contains imidazole-imidazopyridine (Im-Ip-) 
and two pyrrole-benzimidazole (-Py-Bi-) 
Figure 8.1 Structure of oligomers. a) Oligomer 
O1 containing Ct-Bi-, -Py-Ip-, and -Im-Hz- recog-
nition modules. b) Oligomer O2 containing Im-Ip 
and two -Py-Bi- recognition modules.
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modules. The binding affi nities of O1 and O2 targeted to two biologically important sequences, 
5’-ATACGT-3’ (O1) and 5’-WGGGGW-3’ (O2), were determined to be K
a
 = 1.6 x 109 M-1 and 2.6 
x 109 M-1, respectively, by quantitative DNase I footprinting.9-11 
 A library of dsDNA hairpins containing six base-pair match and mismatch binding sites for 
O1 and O2 was used to investigate their emission properties (Figure 8.2). The dsDNA library for 
O1 and O2 contained match sites (1 and 8, respectively), single base-pair (bp) mismatch sites (2–5 
and 10–12, respectively), double bp mismatch sites (6 and 13, respectively), and full mismatch sites 
(7 for both oligomers). The dsDNA 9 contains the 4-G match site of oligomer O2; however, the 
fl anking sequence has been changed to emphasize the effect on binding. The presence of G•C bp 
under the tail is expected to 
lower the binding affi nity 
of O2 as compared to that 
of dsDNA 8.12
 Oligomers O1 and 
O2 (1 μM concentration) 
were each incubated 
with an increasing 
concentration (1 nM to 1 
μM) of dsDNA, and their 
emission spectra were 
recorded after excitation 
at 340 nm. The oligomers 
exhibited a marked increase in fl uorescence upon addition of dsDNA containing their match 
site 1 and 8, respectively (Figures 8.3 and 8.4).13 Oligomer O1 showed a moderate decrease in 
fl uorescence intensity in the presence of dsDNA 2, but proved to be much more sensitive to the 
incorporation of single base-pair mismatches at the alternate positions in dsDNAs 3–5 (Figure 
8.4a). The incorporation of multiple base-pair mismatches in dsDNAs 6 and 7 showed a signifi cant 
reduction in fl uorescence intensity for O1. Oligomer O2 exhibited a similar trend in sequence 
specifi city, with a moderate decrease in fl uorescence intensity observed upon incorporation of 
single base-pair mismatches (9–12) and a more signifi cant decrease with multiple mismatches (13 
and 7, Figure 8.4b).
Figure 8.2 Design of dsDNA library. a) dsDNA sequences used for 
O1. b) dsDNA sequences used for O2.
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8.3 Conclusion
 Sequence-specifi c DNA binding 
molecules containing a fl uorescent switch 
integrated as part of the recognition modules 
provides a method to detect DNA sequences 
without denaturation and in the absence of 
conjugation to a dye molecule. Fluorescent 
oligomers may be useful as site-specifi c 
chromosome paints for telomeric and 
centromeric repeats14 and could provide 
insight into cellular traffi cking of DNA 
binding compounds.
8.4 Experimental
Calcium chloride, potassium chloride, and 
magnesium chloride were purchased from 
Fluka. Tris-HCl was purchased from United 
States Biochemical. All reagents were used 
without further purifi cation. Water (18 
MΩ) was obtained from a Millipore MilliQ 
water purifi cation system, and all buffers were 0.2 μm fi ltered. Reagent-grade chemicals were 
used as received, unless otherwise stated. Oligomers O1 and O2 were prepared by literature 
procedures.9,10
 UV spectra were measured on a Agilent model 8453 diode-array spectrophotometer (Figure 
8.5). Fluorescence spectra were measured with a Jobin Yvon/SPEX Fluorolog spectrofl uorimeter 
(Model FL3-11) equipped with a Hamamatsu R928 PMT. Samples were excited at 340 nm using 
8 nm emission and excitation slits and luminescence was observed from 400 to 600 nm at room 
temperature.
 All measurements were performed in TKMC buffer [10 mM Tris•HCl (pH 7.0), 10 mM 
KCl, 10 mM MgCl
2
, and 5 mM CaCl
2
]. The concentration of O1 or O2 was 1 μM and the volume 
of solution used was 50 μL for fl uorescence measurements. The extinction coeffi cients for O1 and 
O2 were ε = 58,700 cm L mol-1 at 330 nm and ε = 69,200 cm L mol-1 at 340 nm respectively. The 
Figure 8.3 Fluorescence emission spectra of O1 
and O2 (1 μM) after 12 h incubation with their 
match binding site dsDNA (λ
Ex
) 340 nm). a) Data 
for compound O1. b) Data for compound O2. The 
emission was shown to plateau beyond 1 equiv 
DNA. (See Section 8.6 Spectra and Supplemental 
Information for plots.)
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concentration of hairpin DNA 
was varied from 1 nM to 1 μM. 
Solutions containing O1 and 
O2 in the presence of varying 
concentrations of hairpin DNA 
were allowed to equilibrate 
for 12 h prior to fl uorescence 
measurements.
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8.6 Spectra and Supplemental Information
Figure 8.5 UV spectra for compounds O1 and O2.
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Figure 8.6 Flourescence emission as a function of equivalents of DNA for compounds O1 and 
O2.
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Figure 8.7 Flourescence emission spectra compound O1.
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Figure 8.8 Flourescence emission spectra compound O2.
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Chapter 9: Polyamide/NCP Ligation and Profl uorescent Azido-
Carbostyrils
The research in this chapter on the NCP templated ligation of azide and alkyne containing 
polyamides was done in collaboration with Justin D. Cohen (Caltech).
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Abstract
 The nucleosome core particle (NCP) represents a physiologically relevant fundamental 
repeating unit of chromatin. The ability to modulate the structure of chromatin using sequence 
specifi c DNA binding small molecules could have potential applications in gene regulation, 
biotechnology, physical biology, and macromolecular structure studies. The possibility of self-
assembling small molecules inside living cells using biological architectures represents a novel 
approach to molecular recognition. Small molecule probes may be used to report on dynamic 
information, regulate structural changes, and provide stabilization for structure determination of 
inherently dynamic macromolecules. Sequence-specifi c polyamides are a modular platform and 
could be used as DNA-binding building blocks to template the self-assembly of larger polyamides 
that target higher order structures such as the NCP, the tetra-NCP, the chromatin fi ber, or other diverse 
nanometer scale structures inside the cell. This study provides a proof-of-principle experiment 
demonstrating that polyamides can be self-assembled using a high-order nucleoprotein structure 
(NCP) as a template.
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9.1 Introduction
9.1.1 Templated Dimerization of Polyamides
 The ability to use double stranded DNA as a template for the ligation of two polyamides 
with bioorthogonal functionality has recently been demonstrated.1,2 The 1,3-dipolar cycloaddition 
between an azide and alkyne was employed, resulting in a triazole linked tandem hairpin polyamide 
capable of targeting >10 base pairs of DNA with rate increases of 20,000-fold.1,2 The ability to 
template the dimerization of two cell permeable molecules for the targeted downregulation of 
a gene represents a powerful strategy for the control of transcriptional regulated processes in 
biological systems. The Dervan laboratory has also shown that polyamides are capable of binding 
the nucleosome core particle (NCP) and that a polyamide clamp constructed from two 8-ring 
polyamides connected at the turns by a linker is capable of locking the DNA onto the histone 
octamer (Figure 9.1).3,4 This NCP clamp was able to lock a complete turn of DNA onto the octamer 
signifi cantly improving in vitro stability. Unfortunately, NCP clamps are very high molecular weight 
branched oligomers (MW > 2500) and often have poor cell permeability profi les.5,6 The ability to 
template the dimerization of two hairpin polyamides across the supergroove between the two gyres 
of DNA on the NCP would allow for the introduction of two lower molecular weight polyamides 
potentially obviating cell permeability and size issues. 
 Incorporation of reporting strategies into the ligation event such as a profl uorescent 
linker, where fl uorescence would be activated by the dimerization process, would allow for the 
direct monitoring of reaction kinetics and cellular localization. The clamp dimerization strategy 
is illustrated in Figure 9.2 and would provide an important tool for the study of nucleosome core 
Figure 9.1 High resolution crystal structure of an NCP bound polyamide clamp. Clamp is shown 
in red.  DNA backbone shown in blue with minor and major grooves in gray. Side view (left) show-
ing histone octamer core (orange, yellow, tan, and pink). Top view (right) with clamp bound in a 
minor supergroove on the proximal face. (PDB 1S32)
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particle recognition and gene regulation in addition to serving as a macromolecular structural probe. 
The potential for gene regulation at the NCP level represents a unique physiologically relevant 
recognition platform distinct from that of linear DNA. In addition, NCP’s tend to be sensitive 
to radiation damage and this along with dynamic DNA dissociation signifi cantly reduce crystal 
diffraction quality.4 Polyamide clamps provide a unique tool for structural biology due to their 
ability to increase the size, order, and resolution of NCP crystals, as evidenced by the 2 Å resolution 
structure in Figure 9.1, providing the potential for crystallization of larger physiologically relevant 
structures.4 One could dream of the possibility of crystallizing structures such as multiply linked 
histone octamers or NCP’s with bound transcription factors and clamps of this sort could be just the 
Figure 9.2 Illustration of the overall clamp dimerization strategy. Nucleosomal DNA shown with-
out histone octamer present for clarity.  Initial polyamide binding is a reversible process along with 
unwinding and winding of the DNA from the histone octamer.  Dimerization of the two polyamides 
via a bioorthogonal reaction templated by the NCP is irreversible resulting in a large, sequence 
specifi c, high affi nity clamp. The clamp can serve to stabilize the NCP for structural studies or po-
tentially downregulate gene expression.   Direct kinetic information and cellular localization data 
can be obtained via dimerization induced profl uorescent linker activation.
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tool needed to gain structural insight into these complex biological architectures.
Figure 9.3 a) Sequence of the 146 base pair fragment of α-satellite DNA used for crystallographic 
studies with the nucleosome clamp. In those structures, the clamp was found to bind in the homodi-
meric “supergroove” highlighted in yellow. Each of the other four supergrooves on the NCP are 
highlighted in purple, green, blue and red. a) Highlight of the sequences to which the nucleosome 
clamp was bound (left). At right is shown the two base pair mutation (in red) introduced so that 
the supergroove becomes heterodimeric. Located above each highlighted site is the polyamide de-
signed to target that site. b) Analysis of the linker dependence of NCP templated ligations. Crystal 
structure view of the supergroove. The predicted distance between the amines of the turn are shown 
in green for binding at the original site, and in red if the sites are moved one base pair back. c) 
Modeling of the linkers and the calculated turn-to-turn length. 
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9.2 Results and Discussion
 In order to ascertain whether the NCP could be used to template ligation reactions (Figure 
9.3), a series of three azide containing polyamides and two alkyne containing polyamides were 
synthesized. Several linker lengths were used in order to examine the distance dependence of the 
reaction (Figure 9.4). Examination of the previous crystal structure data and computational modeling 
showed that only the azide containing the longest linker was expected to be capable of reacting. In 
addition, the previous study of DNA ligation had demonstrated that alkyne had reacted over 20,000 
times faster than the alkyne containing an extra carbon unit and was expected to perform similarly 
in our experiments. The alkynes were purchased commercially and then coupled directly to the 
appropriate polyamides as 
described previously. The 
azides were synthesized using 
the scheme shown in Figure 
9.5, 9.6, and 9.7.
 The NCP was 
reconstituted as outlined in 
the supplemental information. 
A control sample containing 
only the 146 bp DNA and a 
second control containing 
Figure 9.4 Analysis of the linker dependence of NCP templated ligations. Models and structure 
of the linkers with the calculated turn-to-turn length listed below each. 
Figure 9.5 Synthesis of alkyl azido linkers.6
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only the histone octamer were prepared as well. Next, 200 pmol each of 4 and 5 was added to 
40 pmol of the reconstituted NCP and the reaction was incubated for 5 h at 37°C. MALDI-TOF 
MS was used to analyze the reaction, and after 5 h peaks were observed corresponding to the 
expected mass of the ligation product ([M+Na]+ at 2687.77 and [M+H]+ at 2664.88, which is in 
agreement with the calculated mass of 2664.23) (Figure 9.8). Control samples were run under the 
same conditions containing either just the DNA, just the histone octamer, or only buffer. In all three 
cases the target mass was not observed upon addition of the polyamide azide and alkyne, indicating 
that the ligation reaction was dependent upon the presence of the fully reconstituted NCP (Figure 
9.9). The lack of product observed in the DNA only control reaction is promising, indicating there 
is reaction specifi city dependent on DNA geometrical constraints imposed by assembly of the NCP. 
This is a DNA binding-site proximity-based reaction, dependent on the proper assembly of a higher 
order macromolecular structure with complete specifi city over linear DNA. This study provides 
evidence that our reaction is taking place in a templated format and the sequence specifi city of the 
polyamide reagents is ensuring that the reaction only takes place when the two targeted binding 
site sequences are properly aligned in 
3-dimensional space.
 The same ligation reaction was 
performed using all three azides and 
both alkynes. Of the six potential 
ligation reactions, product was only 
observed in the case of compounds 
4 and 5. This result agrees with both 
computational work indicating the 
linkers for compounds 2 and 3 were 
too short to react, as well as prior work 
demonstrating that the alkyne used in 
6 was signifi cantly less reactive.
 These results demonstrate the 
ability to perform templated ligation 
reactions on the NCP as confi rmed by 
MALDI-MS analysis, however the 
small scale of the reaction  prevented 
Figure 9.6 Synthesis of azido-polyamides.
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the quantitation of ligation yield. As previously discussed, a fl uorescent reporter strategy utilizing 
pro-fl uorescent probes could provide an alternative to MALDI-MS analysis, with far less background 
noise.
 Coumarins have enjoyed widespread use as platforms for the discovery of fl uorescent 
molecules (e.g. laser dyes).  Reports of profl uorescent coumarins, which upon chemical modifi cation 
or reaction give rise to a fl uorescent coumarin based molecules have been reported.7  Azido coumarins 
have been shown to react with alkynes via 1,3-dipolar cycloadditions giving rise to highly fl uorescent 
products due to a change in donor acceptor properties of appended functionality (Figure 9.10).7  In 
addition, maleimide-functionalized coumarins are similarly non-fl uorescent until conjugate addition 
with a thiol yields a fl uorescent product.8  These reactions could potentially be used in a bioorthogonal 
profl uorescent ligation strategy for templating the dimerization of polyamides on the nucleosome 
core particle as illustrated in Figure 9.2.  The ability of the linker to act as a fl uorescent switch 
offers the unique possibility of monitoring reaction progress and cellular localization using highly 
sensitive fl uorescent techniques. To 
establish linker requirements for 
the coumarins, molecular modeling 
was done using Spartan ES software 
package9 and energy-minimized using 
an AM1 model, followed by ab initio 
calculations by means of the Hartree-
Fock method using the 6-31G* 
Pople basis set.10 As shown in Figure 
9.10, the fully compacted, shortest 
triazole-coumarin spans 13 Å, which 
is 2 Å longer than the 11.0 Å distance 
between the two 8-ring polyamide 
turn amines in the crystal structure 
(Figure 9.3). This posed a potential 
problem due to the rigidity of the of 
the coumarin system.  When 6-ring 
hairpin polyamides were modeled 
in for the 8- ring polyamides on the 
Figure 9.7 Synthesis of alkynyl-polyamides.
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crystal structure, the distance between turn amines increased to 17.8 Å.  Replacement of 8-ring 
polyamides for 6-ring polyamides was a potential solution to the problem, but not ideal since all 
structural data to date has been generated for 8-ring polyamides bound to the NCP.  After surveying 
the literature for potential profl uorescent replacements the aza-analogues of coumarins (carbostyrils) 
were discovered.  Carbostyrils4,11 exhibit photophysical properties similar to coumarins and can 
Figure 9.8 DNA templated ligation on the NCP. The reaction of 4 and 5 with the NCP leads to 
dimer 7 which was observed by MALDI mass spectrometry. NCP templated ligation between dif-
ferent length azides and alkynes. The reaction product was only detected with polyamides 4 and 5. 
N.R. = no reaction.
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be electronically tuned by substitution with electron withdrawing and donating functionality.8,12 
Figure 9.11 shows the structure and linker distance comparison for carbostyrils versus coumarins. 
It appears that the carbostyril based linkers will be able to accommodate both 6- and 8-ring systems. 
In addition, synthetic ease, compact size, and a nitrogen handle for derivatization makes the 
carbostyrils an ideal candidate for use as a coumarin alternative. Preliminary efforts towards the 
synthesis of carbostyril (17) are presented in Figure 9.12.
 Synthesis of carbostyril (17) (Figure 9.12) started with condensation of commercially 
available N,N-dimethyl-m-phenylenediamine (8) with dimethyl malonate at 200 ºC to give 
2,4-dihydroxy-7-(dimethylamino)quinoline (14) in 50% isolated yield after a single recrystallization. 
Chlorination of 14 under refl uxing POCl
3
 afforded 2,4-dichloro-7-(dimethylamino)quinoline (15) 
in 80% yield following recrystallization.  Quinoline 15 was hydrolyzed under refl uxing conditions 
in 6M HCl to afford 4-chloro-7-(dimethylamino)carbostyril (16) in 90% yield.  Selective hydrolysis 
of the chlorine at position 2 is often explained by the observation that the 2 position is more 
reactive toward nucleophilic substitution than the 4 position.  After comparing the proton NMR 
of compound 16 to that reported in the literature, an apparent discrepancy was realized. Since 
there was a possibility of displacement of chlorine at two different positions and NMR would not 
unambiguously resolve the regioselectivity issue, the compound was recrystallized from hot DMF 
Figure 9.9 Control reactions for the NCP templated ligation. The ligation reaction does not occur 
in the presence of just buffer, just the histone octamer, or just 146 bp DNA.
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and the crystal structure solved.  The crystal structure and unit cell are shown in Figure 9.12.  After 
unambiguously proving the identity of compound 16 it was subjected to azidifi cation.  Compound 
16 was treated with excess sodium azide in d
6
-DMSO and the reaction monitored by proton NMR. 
After heating for exactly 10.5 h at 120 ºC complete conversion to azide 17 was achieved by NMR. 
Compound 17 can be N-alkylated to provide a functional handle for conjugation to small molecules 
and macromolecules. Initial investigations into the photophysical properties of compound 17 are 
shown in Figure XX and demonstrate the ability of the probe to fl uoresce upon cycloaddition with 
an alkyne substrate.
9.3 Conclusion
 These studies have demonstrated the feasibility of the NCP templated ligation approach for 
the self assembly of polyamide dimers. Additionally, the development of a pro-fl uorescent azido 
carbostyril provides a new tool for monitoring ligation reactions using fl uorescence. This strategy 
offers an exciting opportunity for modifying gene expression in cells by the targeted self-assembly 
of polyamides on NCP’s.
Figure 9.10 a) Reaction of a profl uorescent azido coumarin giving rise to a fl uorescent triazole 
product.  b) Linker distances for incorporation of the profl uorescent coumarin.
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9.4 Experimental
9.4.1 Materials and General Methods 
 Dicyclohexylcarbodiimide (DCC), 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafl uorophosphate (HBTU), N-Hydroxybenzotriazole (HOBt), Fmoc-Dab(Boc)-OH and Boc-β-
Ala-Pam resin were purchased from Peptides International. Benzotriazole-1-yl-oxy-tris-pyrrolidino-
phosphonium hexafl uorophosphate (PyBOP) was purchased from Novabiochem. Flouro-N,N,N’,N’-
tetramethylformamidinium hexafl uorophosphate (TFFH) was purchased from Advanced ChemTech. 
O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’,-tetramethyluronium hexafl uorophosphate (HATU), 
4-(dimethylamino)-pyridine (DMAP), N-hydroxysuccinimide (NHS), N,N-dimethylformamide 
(DMF), N-methylpyrrolidinone (NMP), N,N-dimethylpropylamine (Dp), N,N-diisopropylethylamine 
(DIEA), ethylene diamine, piperidine, and other miscellaneous chemicals were purchased from 
Aldrich and used without further purifi cation. All other solvents were purchased from EM Sciences 
and were reagent grade. Trifl uoroacetic acid (TFA) was purchased from Halocarbon. 
 1H NMR spectra were recorded using a 300MHz General Electric-QE NMR spectrometer. 
CDCl
3
 was obtained from Cambridge Isotope Laboratories. UV spectra were recorded in water using 
a Beckman Coulter DU 7400 Spectrophotometer. Matrix-assisted LASER desorption/ionization 
time of fl ight mass spectrometry (MALDI-TOF MS) was performed using an Applied Biosystems 
Voyager DE Pro Spectrometer. Electrospray ionization (ESI) mass spectrometry was performed by 
the Protein and Peptide Microanalytical Facility at the California Institute of Technology. Analytical 
High-Pressure Liquid Chromatography (HPLC) was performed with a Beckman Gold system using 
a Varian Microsorb-MV 100 C18 column ( 5μm particle size, 250 x 4.6mm). Preparative HPLC 
was performed using a Beckman Gold system with either a Waters Bondapak C18 column ( 15-
Figure 9.11 a) Coumarin linker length presented for comparison against carbostyril.  b) Car-
bostyril linker distance shows a decrease in length of ~3.7 angstroms.
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20 μm particle size, 25 x 100mm) or a Phenomenex Gemini C18 column ( 5 μm particle size, 
250 x 21.2 mm). For both HPLC systems Solvent A was 0.1% (v/v) aqueous TFA and solvent B 
was acetonitrile. Analytical HPLC was done using a gradient of 1.85%/min of Solvent B starting 
from 0% over 35 min with a fl owrate of 1.5mL/min. Preparative HPLC was typically done using a 
gradient of 1%/min of Solvent B for 20 min followed by a gradient of 0.3%/min for an additional 
100min at a fl owrate of 8mL/min. Radioactive gels were imaged using a Molecular Dynamics 400S 
PhosphorImager.
 Restriction endonucleases, deoxyribonucleotide triphosphates, DNAse I, Polynucleotide 
kinase (PNK), and glycogen were purchased from Roche. [α-32P]-Thymidine-5’-triphosphate (≥ 
3000 Ci/mmol) and  [α-32P]-Deoxyadenosine-5’-triphosphate (≥ 6000 Ci/mmol) were purchased 
from Perkin Elmer. [γ-32P]-Adenosine-5’-triphosphate (≥ 7000 Ci/mmol) was purchased from 
MP Biomedicals. Water was purifi ed from a Millipore Mill-Q purifi cation system for general use. 
Figure 9.12 a) Progress toward the synthesis of profl uorescent azide 18.  b) X-ray crystal structure 
and unit cell for structural proof of compound 16.
222
Figure 9.13 Photophysical properties of compound 17 before and after cycloaddition with alkynes 
18 and 20.
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Ultrapure RNAse/DNAse free water from USB was used for biological work. All buffer reagents 
used were molecular biology grade. Buffers were sterilized using a Nalgene 0.2μm cellulose 
fi ltration device.
9.4.2 Plasmids
 pJDC1 and pJDC2 were constructed using 80mer oligonucleotides purchased from 
Integrated DNA Technologies. pUC19 plasmid was purchased from Sigma. JM109 Competent 
Cells (>108 cfu/μg) were purchased from Promega. A Rapid DNA ligation kit was purchased from 
Roche. Purifi cation was done using a Promega Wizard Plus Midipreps DNA purifi cation system. 
Sequence analysis was performed by the Sequence Analysis Facility at the Caltech.
9.4.3 Polyamide Synthesis
Polyamide synthesis was performed as previously reported.13 All polyamides were synthesized 
using Boc-β-Ala-PAM resin (~0.59 meq/g). The resin was initially swelled in DMF for 5 min in 
a glass reaction vessel fi tted with a glass fi lter and stopcock. The vessel was drained and the resin 
washed twice with DCM. Deprotection with 80% TFA:DCM  was performed for 20 min while the 
resin was shaken. Following deprotection, the resin was washed 2 x DCM, 1 x 4:1 DMF:DIEA, 
and 1 x DMF. Coupling of the Boc-Py-OBt pre-activated ester was performed using 1.8 eq of 
monomer in ~1 mL of NMP. Coupling of Boc-Im-OH, Boc-PyIm-OH, and other acids was done 
by fi rst preactivating 1.8 eq of the monomer with 1.7 eq of HBTU, 5.4 eq of DIEA in ~2mL of 
NMP. The activation mixture was shaken for 20min before being fi ltered and added to the resin. 
Couplings were allowed to proceed for 2h except in the case of Im-OH which was allowed to react 
overnight. After each coupling step the resin was washed 2 x DMF and then 2 x DCM before the 
next deprotection step. Polyamides were cleaved from resin using 1.5 mL of Dp for 200 mg of resin 
at 55°C for eight h. Crude products were purifi ed by preparative HPLC.
2: MALDI-TOF-MS calculated [M+H]+: 1348.63, observed 1348.54
3: MALDI-TOF-MS calculated [M+H]+: 1362.65, observed 1362.61
4: MALDI-TOF-MS calculated [M+H]+: 1376.66, observed 1376.73
5: MALDI-TOF-MS calculated [M+H]+: 1289.58, observed 1289.67
6:  MALDI-TOF-MS calculated [M+H]+: 1317.61, observed 1317.6
7:  MALDI-TOF-MS calculated [M+H]+: 2664.23, observed 2664.88 
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9.4.4 Reconstitution of NCP
The NCP was reconstituted following 
established protocols. Briefl y, 10 μg of 
the 146 bp DNA was 5’ radiolabelled as 
described above using Polynucleotide 
Kinase and purifi ed using a Chroma Spin 
STE 10 column from BD Biosciences. 
Histone octamer which was obtained 
from the Luger lab was diluted to 1 μg 
/ μL using 2 M NaCl TE Buffer. 5 μL 
of the DNA was added to 5 μL of 4M 
NaCl, 10 mM Tris, 1 mM EDTA solution 
to make a sample of 10 μL of DNA in 
2 M NaCl TE buffer. Five samples were 
made up and 0, 0.6, 0.8, 1.0, or 1.2 μL of octamer (1 μg / μL) was added to each sample. The total 
volume was brought to 2 μL using 2M NaCl TE buffer. The samples were incubated for 1 hr before 
the addition of 12 μL, 6 μL, 6 μL, and 84 μL of dilution buffer (TE) with each addition followed 
by a 1 h incubation. The sample was heated to 37°C for 2 h before a fi nal addition of 120 μL of 
dilution buffer to give a fi nal NaCl concentration of .1 M. Reconstituted NCP samples were stored 
at 4°C. Non-denaturing PAGE was done on a 6% polyacrylamide TBE gel. 1 μL of each sample 
was diluted to 10 μL with 10 mM Tris, 20 mM NaCl, 10% glycerol, and .1% Igapal. The gel was 
run at 150 V for 20 min, dried and imaged.
9.4.5 NCP Templated Ligation Reactions
 The NCP was reconstituted as described above with the sole difference that non-radiolabelled 
DNA was used. For each ligation reaction 200 pmol of each polyamide was lyophilized into an 
eppendorf tube and 40 pmol of the reconstituted NCP was added. Samples containing only the 146 
bp DNA and or the histone octamer were prepared as negative controls. The reaction was incubated 
for 5 h at 37°C before MALDI-TOF analysis.
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Appendix A: Next Generation Hairpin Polyamides with (R)-3,4-
Diaminobutyric Acid Turn Unit
The text of this chapter was taken in part from a manuscript coauthored with Christian Dose, 
Michelle E. Farkas, and Peter B. Dervan* (Caltech)
(Dose, C., Farkas, M.E., Chenoweth, D.M., and Peter B. Dervan J. Am. Chem. Soc., 2008, 130, 
6859-6866.)
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Abstract
 The characterization of a new class of pyrrole–imidazole hairpin polyamides with β-amino-
γ-turn units for recognition of the DNA minor groove is reported. A library of eight hairpins 
containing (R)- and (S)-3,4-diaminobutyric acid (β-amino-γ-turn) has been synthesized, and the 
impact of the moleculesn on DNA-duplex stabilization was studied for comparison with the parent 
γ-aminobutyric acid (γ-turn) and standard (R)-2,4-diaminobutyric acid (α-amino-γ-turn)-linked 
eight-ring polyamides. For some, but not all, sequence compositions, melting temperature analyses 
have revealed that both enantiomeric forms of the β-amino-γ-turn increase the DNA-binding 
affi nity of polyamides relative to the (R)-α-amino-γ-turn. The (R)-β-amine residue may be an 
attractive alternative for constructing hairpin polyamide conjugates. Biological assays have shown 
that (R)-β-amino-γ-turn hairpins are able to inhibit androgen receptor-mediated gene expression in 
cell culture similar to hairpins bearing the standard (R)-α-amino-γ-turn, from which we infer they 
are cell-permeable.
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A.1 Introduction
 The ability to modulate the expression of eukaryotic gene networks by small molecules 
is a challenge in the fi eld of chemical biology. Hairpin pyrrole-imidazole polyamides are a class 
of programmable small molecules that bind to the minor groove of DNA with affi nities similar to 
transcription factors and have been shown to inhibit gene expression in living cells by interfering 
with transcription factor/DNA interfaces.1 The DNA sequence specifi city of polyamides arise from 
interactions of pairs of the aromatic amino acids N-methylpyrrole (Py), N-methylimidazole (Im), 
and N-methylhydroxypyrrole (Hp) with the edges of the Watson-Crick base pairs.2 The generality 
of the polyamide pairing rules has been demonstrated by numerous studies3 and applications of 
polyamide conjugates include DNA alkylations,4 DNA-templated ligations,5 sequence-specifi c 
DNA intercalators,6 fl uorescent DNA paints,7 DNA nanoarchitectures,8 and transcription factor 
mimics.9 Efforts have been made to improve the DNA-binding properties of hairpin polyamides 
with modifi ed turn units.10 Substitution of γ-aminobutyric acid (γ-turn) by (R)-2,4-diaminobutyric 
acid (α-amino-γ-turn) increases the DNA-binding affi nity by ~15-fold.10b,11 In contrast, hairpins 
containing the opposite enantiomer, (S)-α-amino-γ-turn, result in diminished binding affi nities. 
This decrease is most likely caused by an unfavorable steric clash of the amine residue with the 
DNA minor groove.10b Sugiyama and co-workers have introduced polyamides containing the 
α-hydroxy-γ-turn.10c These hairpins provide discrimination for A•T/T•A base pairs at the turn 
position, although a ~70-fold reduced DNA-binding affi nity relative to analogue (R)-α-amino-γ-
turn-linked polyamides has been observed.
 Here we introduce a new class of hairpin polyamides which are linked by 3,4-diaminobutyric 
acid which results in a β-amine residue at the turn unit (β-amino-γ-turn) (Figure A.1). DNA-binding 
affi nities of four different eight-ring polyamide core sequences (with incrementally increasing Im/
Py pairs) have been investigated and were compared to analogue hairpins bearing the parent γ-turn 
and the standard (R)-α-amino-γ-turn. We show that, for certain series of hairpin polyamides, both 
enantiomers of the β-amino-γ-turn are able to increase the relative DNA-binding affi nity. However, 
this is sequence context dependent. Biological assays revealed that hairpin polyamides bearing the 
(R)-β-amino-γ-turn are able to inhibit specifi c gene expression in cell culture, which is taken as 
evidence for cell permeability.
A.2 Results and Discussion
A.2.1 Thermal stabilization of DNA duplexes by hairpin polyamides
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 Hairpin polyamides 1-16 were 
synthesized with different Im/Py and 
Py/Py compositions targeted to the 
four DNA sequences with increasing 
G/C content 5’-TGTTCA-3’, 
5’-TGGTCA-3’, 5’-TGGGCA-3’, and 
5’-TGGGGA-3’ (Figure A.2). The 
energetics of DNA-binding properties of 
polyamides are typically characterized 
by quantitative DNase I footprint 
titrations.12 These measurements 
provide precise information regarding 
the affi nity and specifi city of DNA/
polyamide complexes. Unfortunately, 
quantitative footprinting experiments 
revealed similar equilibrium association 
constants (K
a
 values ~ 2 × 1010 M-1) for 
hairpins 1-8, reaching an upper limit of 
the standard procedure12,13 (see Section 
A.6 Supplemental Information). Prior 
results have shown that the increase 
in melting temperature (ΔT
m
) of DNA 
duplexes bound by hairpin polyamides correlates with DNA-binding affi nity and can be utilized 
to detect single base pair mismatched DNA/polyamide complexes.14 Accordingly, we have used 
melting temperature analysis for dissecting differences in DNA affi nities of hairpin polyamides. 
Spectroscopic analyses were performed on 12mer DNA duplexes containing the appropriate match 
sequence in the absence and presence of polyamides in order to derive the desired ΔT
m
 values 
(Figure A.3). Table A.1 shows that all hairpins provided an increase in melting temperature, relative 
to the individual DNA duplexes, confi rming the formation of DNA/polyamide complexes. As 
expected, spectroscopic analysis with (R)-α-amino-γ-turn hairpins revealed stronger stabilizations 
than the parent γ-turn analogues; for example, achiral polyamide 1 targeted to DNA sequence 
5’-TGTTCA-3’ resulted in a ΔT
m
 value of 15.9°C, while chiral hairpin (R)-α-2 led to a 3.6°C higher 
Figure A.1 Schematic representation of hairpin poly-
amides with increased DNA-binding affi nity caused by 
different γ-turn units. Hairpin polyamides targeted to 
DNA sequence 5'-TGGTCA-3' are shown as ball-and-
stick models. Ball-and-stick representation legend: black 
and white circles represent N-methylimidazole and N-
methylpyrrole units, respectively, half-circles represent 
γ-aminobutyric acid, white diamonds represent β-alanine 
units, and half-circles containing a cross represent 
3-(dimethylamino)-1-propylamine (Dp) as tail.
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melting temperature (ΔT
m
 = 19.5°C). 
Remarkably, melting temperature 
analyses in the presence of β-amino-γ-
turn hairpins (S)-β-3 (ΔT
m
 = 20.9°C) 
and (R)-β-4 (ΔT
m
 = 22.2°C) revealed 
higher ΔT
m
 values compared to those 
for the α-series hairpin (R)-α-2 (ΔT
m
 = 
19.5°C). The same trend was observed 
for hairpins 5-8 targeted to DNA 
sequence 5’-TGGTCA-3’ (Table A.1, 
Figure A.2). First, it is noteworthy that 
both the (R)- and (S)-β-amino-γ-turn 
generated higher melting temperatures 
than the standard (R)-α-amino-γ-turn. 
Second, the enhancement (relative to 
achiral hairpins) observed for the (R)-
β-series is almost twice that of the (R)-
α-series targeted to DNA sequences 
5’-TGTTCA-3’ and 5’-TGGTCA-3’; 
for example, polyamide (R)-β-8 
provided a ΔΔT
m
 value of 6.9°C, 
while the α-series (R)-α-6 led to a 
ΔΔT
m
 value of 3.5°C relative to achiral 
hairpin 5. Interestingly, by further 
increasing the amounts of Im/Py 
pairs in the polyamides, signifi cantly 
less DNA duplex stabilizations have 
been observed. For example, achiral 
polyamide 9 and chiral hairpin (R)-
α-10 targeted to DNA sequence 
5’-TGGGCA-3’ yielded ΔT
m
 values 
of 8.6 and 13.2°C, while the β-series 
Figure A.2 Chemical structures for hairpins 1-16 tar-
geted to DNA sequences: (A) 5'-TGTTCA-3', (B) 5'-TG-
GTCA-3', (C) 5'-TGGGCA-3', and (D) 5'-TGGGGA-3'.
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(S)-β-11 and (R)-β-12 led to ΔT
m
 values 
of 13.3 and 13.6°C, respectively (Table 
A.1). Even lower melting temperatures 
were observed for hairpins 13-16 designed 
to bind DNA sequence 5’-TGGGGA-3’. 
Both β-amino-γ-turns, as in (S)-β-15 (ΔT
m
 
= 6.7°C) and (R)-β-16 (ΔT
m
 = 6.8°C), 
resulted in signifi cantly lower ΔT
m
 values 
than the α-series analogue (R)-α-14 (ΔT
m
 
= 9.1°C). These results imply that the 
impact of polyamide turn units on DNA-
duplex stabilization is sequence context 
dependent.
 The general increase in DNA-binding 
affi nity for polyamides containing the (R)-α-substitued γ-turn, relative to achiral hairpins, is most 
likely caused by a superposition of favorable noncovalent interactions of the positively charged 
substituent and conformational preferences of the turn unit.10b The (R)-α-amino-γ-turn can exist in 
two different conformations, one orienting the α-ammonium in a pseudoequatorial position (Figure 
A.4A), which directs the substituent toward the wall of the minor groove with the potential of 
steric interactions. The alternate conformation places the α-amine residue in a pseudoaxial position 
out of the minor groove, orienting the β-methylene to the fl oor of the double helix (Figure A.4B). 
Modeling of the (S)-β-amino-γ-turn conformations suggests that the -ammonium in a pseudoaxial 
position is directed out of the minor groove (Figure A.4C) relieving the potential steric interactions 
with the wall in comparison to the α-series. In contrast, the (S)-β-amine in a pseudoequatorial 
orientation is following the curvature of the minor groove (Figure A.4D). The possibility for 
favorable noncovalent interactions should exist in both conformations without the detriment of steric 
interactions. As shown in Figure A.4E, the pseudoequatorial β-amine residue of the (R)-β-amino-γ-
turn is well accommodated in the DNA minor groove, while the pseudoaxial position should result 
in a steric clash of the substituent with the groove fl oor (Figure A.4F). Previous results have shown 
that polyamides constructed with several continuous Im/Py pairs are overcurved with respect to the 
DNA minor groove, signifi cantly infl uencing the DNAbinding affi nity and sequence specifi city.15 
We assume that this curvature affects the alignment of the turn units in the DNA minor groove. 
Figure A.3 Normalized UV denaturation profi les 
of 12mer DNA duplex 5'-CGATGGTCAAGC-3'/5'-
GCTTGACCATCG-3' in the absence and
presence of hairpin polyamides 5-8.
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This is supported by the observation 
that the presence of fewer continuous 
Im’s improves the DNA affi nity of 
β-amino-γ-turns while diminishing the 
affi nity for α-amino-γ-turns, and vice 
versa. However, illustrative modeling 
is not suffi cient to explain the sequence 
context dependence of chiral hairpin 
polyamides, highlighting the pressing 
need for highresolution structural 
studies.
A.2.2 Sequence apecifi city at the turn 
position
 Hairpin polyamides containing 
the γ-turn have been shown to possess 
an equal preference for A•T/T•A over 
G•C/C•G base pairs at the turn position, 
presumably for steric reasons.16 
Sugiyama’s α-hydroxy-γ-turns have 
been demonstrated to discriminate A•T 
versus T•A at the turn position.10c In 
order to study the sequence specifi city 
for polyamides 5-16, we performed 
melting temperature analyses in the 
presence of DNA duplexes bearing 
a T•A base pair at the turn position. 
Experiments involving hairpins 1-4 
have been omitted due to the palindromic core sequence specifi ed by the polyamides. As shown in 
Table A.1, most γ-turn and (R)-α-amino-γ-turn hairpins provided similar ΔT
m
 values for T•A and 
A•T base pairs. In contrast, signifi cantly lower thermal stabilizations for T•A over A•T base pairs 
were observed for β-amino-γ-turn-linked polyamides targeting DNA sequences 5’-TGGTCA-3’ 
Table A.1 Melting temperatures of DNA/polyamide 
complexes for A•T and T•A base pairs at the turn posi-
tion of hairpin polyamides.a 
a All values reported are derived from at least three 
melting temperature experiments with standard 
deviations indicated in parentheses (n.d. = not de-
termined). ΔT
m
 values are given as T
m
(DNA/polyamide) – 
T
m
(DNA).
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Figure A.4 Illustrative models of different turn conformations for hairpin polyamides containing 
the (R)-α-amino-γ-turn (A and B), (S)-β-amino-γ-turn (C and D), and the (R)-β-amino-γ-turn (E 
and F) bound to the minor groove of DNA (dark gray = carbons, white = hydrogen, blue = nitrogen, 
red = oxygen).
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(5-8) and 5’-TGGGCA-3’ (9-12). Even more diminished duplex stabilizations were observed in 
presence of C•G and G•C base pairs (see Section A.6 Supplemental Information). These observations 
suggest that polyamides containing β-amino-γ-turns prefer A•T > T•A >> C•G > G•C base pairs 
at the turn position. However, sequence specifi city studies by thermal denaturation measurements 
require binding enthalpies (ΔH
b
) of DNA/polyamide complexes in order to determine equilibrium 
association constants.14a One could also imagine using six-ring hairpin polyamides with lower DNA-
binding affi nities in order to discriminate sequence specifi cities at the turn position by quantitative 
DNase I footprint titration methods.
A.2.3 Acetylated chiral hairpin polyamides
 Several approaches 
have been reported wherein 
the (R)-α-amino-γ-turn was 
utilized as a position for 
synthetic modifi cations of 
hairpin polyamides.4,5,17 It has 
been shown that acetylation 
of the (R)-α-amine in six-ring 
hairpin polyamides results 
in ~15-fold reduced DNA-
binding affi nity.10b To study 
the tolerance of synthetic 
modifi cations for eight-ring 
polyamides containing the 
-amino-γ-turns, we examined 
acetylated hairpins 17-19 by 
melting temperature analysis 
(Figure A.5). Indeed, hairpin 
17 containing the acetylated 
(R)-α-amino-γ-turn yielded 
a markedly lower ΔT
m
 value 
(12.8°C) than nonacetylated 
Figure A.5 Chemical structures and ball-and-stick models of 
acetylated hairpin polyamides 17-19 targeted to DNA sequence 
5'-TGGTCA-3'.
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analogue 6 (ΔT
m
 = 16.9 °C, Table A.2). Even more pronounced was the decrease in DNA duplex 
stabilization for acetylated (S)-β-amino-γ-turn hairpin 18 leading to a ΔT
m
 value of 11.7°C. 
Remarkably, the opposite enantiomer (R)-β-19 resulted in signifi cantly less destabilization (ΔT
m 
= 17.8°C). All hairpins lose the positive charge at the turn unit by acetylation. This implies that 
the cationic state of the amine residue is not the 
only contribution impacting the energetics of the 
DNA/polyamide complexes, as evidenced by 
the differences in melting temperatures between 
hairpins 17-19. Increased steric demands of the 
acetylated substituents may also be responsible 
for differing binding affi nities, due to the 
restricting DNA minor groove and alternate 
conformations of the γ-turn units (Figure A.4).
A.2.4 Biological assay for cell permeability
 Hairpin polyamide conjugates bearing 
the standard (R)-α-amino-γ-turn have been 
shown to modulate the expression of certain 
gene pathways in living cells by interfering 
with transcription factor/DNA interfaces.1 
Recently, a hairpin designed to bind DNA 
sequence 5'-AGAACA-3', found in the 
androgen response element (ARE), has been 
demonstrated to inhibit androgen receptor-
mediated expression of prostate specifi c 
antigen (PSA) in LNCaP cells (Figure A.6).1b 
We utilized this cell culture transcription 
assay to investigate the cell permeability of 
(R)-β-amino-γ-turn hairpins because small 
structural changes within polyamides can 
infl uence nuclear uptake properties.18 Hairpin 
polyamide 21 was examined in comparison to 
the previously used (R)-α-amino-γ-turn hairpin 
a All values reported are derived from at least three 
melting temperature experiments with standard devi-
ations indicated in parentheses. ΔT
m
 values are given 
as T
m
(DNA/polyamide) – T
m
(DNA).
Table A.2 Melting temperatures for DNA com-
plexes containing nonacetylated and acetylated 
hairpin polyamides targeted to DNA sequence 
5'-TGGTCA-3'.a 
Figure A.6 Schematic representation of the 
androgen receptor (AR)-mediated transcription 
complex with the androgen response element 
(ARE).
236
20 (Figure A.7A). Chiral polyamides 22 and 23, designed to target different DNA sequences, have 
been used as controls. Melting temperature analyses for polyamide conjugates 20-23 confi rmed 
the results obtained for hairpins 1-4, revealing highest DNA-duplex stabilizations for (R)-β-
amino-γ-turn hairpins (see Section A.6 Supplemental Information). The induction of PSA mRNA 
by dihydrotestosterone (DHT) in LNCaP cells for matched and mismatched polyamides 20-23 
was measured by quantitative real-time RT-PCR. As shown in Figure A.7B, hairpin 21 provided 
signifi cant inhibition of AR-mediated expression of PSA mRNA, KLK2, FKBP5, and TMPRSS2 
mRNA (see Section A.6 Supplemental Information) which supports cell-permeable properties for 
(R)-β-amino-γ-turn hairpins.
Figure A.7 (A) Chemical structures and ball-and-stick models of matched and mismatched poly-
amides 20-23, targeted to DNA sequence 5'-AGAACA-3'. (B) Inhibition of DHT-induced PSA and 
KLK2 expression by 20-23 measured by quantitative real-time RT-PCR
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A.3 Conclusion
 Herein we have introduced (R)- and (S)-β-amino-γ-turn hairpin polyamides. Eight new 
polyamides targeting different DNA-binding motifs have been synthesized, and their impact on 
DNA duplex stabilization in relation to hairpins containing the parent γ-turn and the standard (R)-
α-amino-γ-turn was investigated. It was found that changing the turn unit from the (R)-α-amino-
γ-turn to either enantiomeric forms of the β-amino-γ-turn increases the relative DNA-binding 
affi nity of polyamides targeted to 5'-TGTTCA-3' and 5'-TGGTCA-3' but not to 5'-TGGGCA-3' 
and 5'-TGGGGA-3' sequences, rendering the impact of -amino-substituted γ-turns sequence 
context dependent. Acetylation of the (S)-β-amino-γ-turn has been demonstrated to signifi cantly 
impact the DNA-binding affi nity but has minimal effect for the (R)-β-amino-γ-turn, which makes 
the (R)-β-amino residue attractive for synthetic modifi cations and conjugate design. Upper limits 
presented by DNase I footprinting titrations of high affi nity binders rendered melting temperature 
analysis a more practical choice for dissecting improvements by structural changes of new turn 
units in hairpin polyamides. Due to the strong thermal stabilizations, reported for eight-ring hairpin 
polyamides 1-8 targeted to 5'-TGTTCA-3' and 5'-TGGTCA-3' sequences, it is not unreasonable to 
estimate that the DNA-binding equilibrium association constants are markedly higher than K
a
 ~ 2 
× 1010 M-1. Biological experiments have demonstrated that (R)-β-amino-γ-turn hairpins possess 
biological activity to inhibit AR-mediated gene expression within a human cancer cell line and may 
have similar uptake properties as polyamides bearing the standard (R)-α-amino-γ-turn. Ongoing 
work is focused on the use of the next generation hairpins in biological investigations as well as 
turn unit sequence specifi city and high-resolution crystallographic studies for DNA/chiral hairpin 
polyamide complexes. These efforts will be reported in due course.
A.4 Experimental
A.4.1 General
Chemicals and solvents were purchased from Sigma-Aldrich and were used without further 
purifi cation. Boc-γ-Abu-OH was purchased from Novabiochem. (R)-2,4-Fmoc-Dbu(Boc)-OH and 
Boc-β-Ala-PAM resin were purchased from Peptides International. (R)-3,4-Cbz-Dbu(Boc)-OH 
and (S)-3,4-Cbz-Dbu(Boc)-OH were purchased from Senn Chemicals AG. All DNA oligomers 
were purchased HPLC purifi ed from Integrated DNA Technologies. Water (18 MΩ) was purifi ed 
using a Millipore MilliQ purifi cation system. The pH of buffers was adjusted using a Beckman 
340 pH/temp meter. Analytical HPLC was performed on a Beckman Gold system equipped with a 
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diode array detector using a Phenomenex Gemini column (5 μm particle size, C18 110A, 250 × 4.6 
mm, 5 μm). Preparative HPLC was performed on a Beckman Gold system equipped with a single-
wavelength detector monitoring at 310 nm using a Phenomenex Gemini column (5 μm particle 
size, C18 110A, 250 × 21.2 mm, 5 μm). For both analytical and preparative HPLC, solvent A was 
0.1% (v/v) aqueous trifl uoroacetic acid (TFA) and solvent B was acetonitrile. Solvent gradients 
were adjusted as needed. Polyamide concentrations were measured in 0.1% (v/v) aqueous TFA on a 
Hewlett-Packard diode array spectrophotometer “Model 8452 A” and were determined by using an 
extinction coeffi cient of 69200 M-1 ·cm-1 at λ
max
 near 310 nm. Matrix-assisted, LASER desorption/
ionization time-of-fl ight mass spectrometry (MALDI-TOF MS) was performed on an Applied 
Biosystems Voyager DR Pro spectrometer using α-cyano-4-hydroxycinnamic acid as matrix.
A.4.2 Synthesis of polyamides
Polyamide monomers and oligomers were synthesized as described previously.19 All β-amino-
γ-turn hairpins were synthesized by performing the following procedure: the polyamide was 
cleaved from the resin with 3-(dimethylamino)-1-propylamine, purifi ed by preparative HPLC, 
and characterized by MALDI-TOF MS, UV-vis spectroscopy, and analytical HPLC. A 500 nmol 
fraction of the Cbz-protected hairpin polyamide was dissolved in a 9:1 mixture (500 μL) of TFA 
and trifl uoromethanesulfonic acid (TFMSA). After 5 min reaction time, the solution was fl ash-
frozen by liquid N
2
 and overlaid with N,N'-dimethylformamide (1 mL). The thawed solution was 
diluted with 20% aqueous acetonitrile (8 mL), purifi ed by preparative HPLC, and characterized 
by MALDI-TOF MS, UV-vis spectroscopy, and analytical HPLC. Acetylated polyamides 17-19 
were synthesized by performing the following procedure: A 500 nmol fraction of the polyamide 
was dissolved in N,N'-dimethylformamide (900 μL) and a 9:1 mixture of pyridine/acetic anhydride 
(100 μL) was added. After 5 min reaction time, the solution was diluted with 10% aqueous TFA (8 
mL), purifi ed by preparative HPLC, and characterized by MALDI-TOF MS, UV-vis spectroscopy, 
and analytical HPLC. Polyamide conjugates 20-23 were synthesized as described previously.20 
Polyamide 1: MALDI-TOF [M + H]+ calculated for C
58
H
72
N
21
O
10
+ = 1222.6, observed = 1222.7. 
Polyamide 2: MALDI-TOF [M + H]+ calculated for C
58
H
73
N
22
O
10
+ = 1237.6, observed = 1237.8. 
Polyamide 3: MALDI-TOF [M + H]+ calculated for C
58
H
73
N
22
O
10
+ = 1237.6, observed = 1237.8. 
Polyamide 4: MALDI-TOF [M + H]+ calculated for C
58
H
73
N
22
O
10
+ = 1237.6, observed = 1237.8. 
Polyamide 5: MALDI-TOF [M + H]+ calculated for C
57
H
71
N
22
O
10
+ = 1223.6, observed = 1223.5. 
Polyamide 6: MALDI-TOF [M + H]+ calculated for C
57
H
72
N
23
O
10
+ = 1238.6, observed = 1238.6. 
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Polyamide 7: MALDI-TOF [M + H]+ calculated for C
57
H
72
N
23
O
10
+ = 1238.6, observed = 1238.5. 
Polyamide 8: MALDI-TOF [M + H]+ calculated for C
57
H
72
N
23
O
10
+ = 1238.6, observed = 1238.5. 
Polyamide 9: MALDI-TOF [M + H]+ calculated for C
56
H
70
N
23
O
10
+ = 1224.6, observed = 1224.8. 
Polyamide 10: MALDI-TOF [M + H]+ calculated for C
56
H
71
N
24
O
10
+ = 1239.6, observed = 1239.6. 
Polyamide 11: MALDI-TOF [M + H]+ calculated for C
56
H
71
N
24
O
10
+ = 1239.6, observed = 1239.5. 
Polyamide 12: MALDI-TOF [M + H]+ calculated for C
56
H
71
N
24
O
10
+ = 1239.6, observed = 1239.6. 
Polyamide 13: MALDI-TOF [M + H]+ calculated for C
56
H
70
N
23
O
10
+ = 1224.6, observed = 1224.6. 
Polyamide 14: MALDI-TOF [M + H]+ calculated for C
56
H
71
N
24
O
10
+ = 1239.6, observed = 1239.7. 
Polyamide 15: MALDI-TOF [M + H]+ calculated for C
56
H
71
N
24
O
10
+ = 1239.6, observed = 1239.4. 
Polyamide 16: MALDI-TOF [M + H]+ calculated for C
56
H
71
N
24
O
10
+ = 1239.6, observed = 1239.5. 
Polyamide 17: MALDI-TOF [M + H]+ calculated for C
59
H
74
N
23
O
11
+ = 1280.6, observed = 1280.6. 
Polyamide 18: MALDI-TOF [M + H]+ calculated for C
59
H
74
N
23
O
11
+ = 1280.6, observed = 1280.7. 
Polyamide 19: MALDI-TOF [M + H]+ calculated for C
59
H
74
N
23
O
11
+ = 1280.6, observed = 1280.6. 
Polyamide 20: MALDI-TOF [M + H]+ calculated for C
65
H
77
N
22
O
12
+ = 1357.7, observed = 1357.6. 
Polyamide 21: MALDI-TOF [M + H]+ calculated for C
65
H
77
N
22
O
12
+ = 1357.6, observed = 1357.7. 
Polyamide 22: MALDI-TOF [M + H]+ calculated for C
64
H
76
N
23
O
12
+ = 1358.6, observed = 1358.6. 
Polyamide 23: MALDI-TOF [M + H]+ calculated for C
64
H
76
N
23
O
12
+ = 1358.6, observed = 1358.6.
A.4.3 UV Absorption Spectrophotometry
Melting temperature analysis was performed on a Varian Cary 100 spectrophotometer equipped 
with a thermocontrolled cell holder possessing a cell path length of 1 cm. The buffer for the 
spectroscopic measurements was chosen to match as closely as possible the conditions of DNase I 
footprinting experiments. We used 10 mM sodium cacodylate since the temperature dependence of 
Tris-HCl makes it poorly suited for melting temperature analyses.14a A degassed aqueous solution 
of 10 mM sodium cacodylate, 10 mM KCl, 10 mM MgCl
2
, and 5 mM CaCl
2
 at pH 7.0 was used 
as analysis buffer. DNA duplexes and hairpin polyamides were mixed in 1:1 stoichiometry to a 
fi nal concentration of 2 μM for each experiment. Prior to analysis, samples were heated to 90 
°C and cooled to a starting temperature of 25°C with a heating rate of 5°C/min for each ramp. 
Denaturation profi les were recorded at λ = 260 nm from 25 to 90°C with a heating rate of 0.5°C/
min. The reported melting temperatures were defi ned as the maximum of the fi rst derivative of the 
denaturation profi le.
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A.4.4 Molecular Modeling
DNA/polyamide models are based on coordinates derived from NMR structure studies using 
standard bond length and angles.3c The molecular graphics images are nonminimized and have 
been created by introducing ammonium residues to the appropriate position of the turn unit using 
the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at 
the University of California, San Francisco (supported by NIH P41 RR-01081).21
A.4.5 Measurement of Androgen-Induced PSA mRNA
Experiments were performed as described previously.1b
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A.6 Supplemental Information
Construction of Plasmids pCDMF-1 and pCDMF-2: Oligonucleotides were purchased from 
Integrated DNA Technologies. The plasmids pCDMF-1 and pCDMF-2 were constructed by 
annealing the oligonucleotides: 5’-AGCTGCGGCTCGAGACGGCTAACCCATCGAGACGGC
TAGCCCATCG-AGACGGCTATCCCATCGAGACGGCTACCCCATCGAGAGGATC-3’ and 
5-GATCGATCCTCT-CGATGGGGTAGCCGTCTCGATGGGATAGCCGTCTCGATGGGCTA
GCCGTCTCGATGGGTTA-GCCGTCTCGAGCCGC-3’; 5’-AGCTGCGAGACGGCTCGAGA
CGGCTTGAACATCGAGACGG-CTCGAGACGGCTTGACCATCGAGACGGCTCGAGAC
GGCTC-3’ and 5-GATCGAGCCGTCTCG-AGCCGTCTCGATGGTCAAGCCGTCTCGAGC
CGTCTCGATGTTCAAGCCGTCTCGAGCCGTCTCGC-3’, respectively, followed by ligation 
into the BamHI/HindIII restriction fragment of pUC19 using T4 DNA ligase. The plasmid was 
then transformed into Escherichia coli JM109 competent cells. Ampicillin-resistant white colonies 
were selected from 25 mL Luria–Bertani (LB) agar plates containing 50 mg/mL ampicillin treated 
with XGAL and isopropyl-β-D-thiogalactopyranoside (IPTG) solutions and grown overnight at 
37°C. Cells were harvested the following day and purifi cation of the plasmid was performed with a 
Wizard Plus Midiprep DNA purifi cation kit (Promega). DNA sequencing of the plasmid insert was 
performed by the sequence analysis facility at the California Institute of Technology. 
 DNase I Footprinting Titrations: Polyamide equilibrations and DNase I footprint titrations 
were conducted on the 5´ end-labeled PCR product of pCDMF-1 and pCDMF-2 according to 
standard protocols.12 DNA was incubated with polyamides or water (control) for 12 h at room 
temperature prior to reaction with DNase I.
Table A.3 Melting temperatures of DNA/polyamide complexes for all four base pair variations at 
the turn position of hairpin polyamides.a  
a All values reported are derived from at least three melting temperature experiments with standard deviations 
indicated in parentheses (n.d. = not determined). ΔT
m
 values are given as T
m
(DNA/polyamide) – T
m
(DNA).
244
Table A.4 Equilibrium association constants for hairpin polyamides determined by quantitative 
DNase I footprint titrations.a 
a Equilibrium association constants reported are mean values from at least three quantitative DNase I foot-
print titration experiments. Standard deviations are shown in parentheses. b Equilibrium association constants 
have been reported previously11 (n. d. = not determined). 
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Figure A.8 Quantitative DNase I footprint titration experiments for polyamides 2, 3, and 4 on 
the 285 base pair, 5´ end-labeled PCR product of plasmid pCDMF-2: lanes 1-11, 100 nM, 30 nM, 
3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 12, 
DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.
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Figure A.9 Quantitative DNase I footprint titration experiments for polyamides 6, 7, and 8 on 
the 285 base pair, 5´ end-labeled PCR product of plasmid pCDMF-2: lanes 1-11, 100 nM, 30 nM, 
3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 12, 
DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.
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Figure A.10 Quantitative DNase I footprint titration experiments for polyamides 10, 11, and 12 
on the 285 base pair, 5´ end-labeled PCR product of plasmid pCDMF-2: lanes 1-11, 100 nM, 30 
nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 
12, DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.
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Figure A.11 Quantitative DNase I footprint titration experiments for polyamides 14, 15, and 16 
on the 293 base pair, 5´ end-labeled PCR product of plasmid pCDMF-1: lanes 1-11, 100 nM, 30 
nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 
12, DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.
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a All values reported are derived from at least three melting 
temperature experiments with standard deviations indicated in 
parentheses. ΔT
m
 values are given as T
m
(DNA/polyamide) – T
m
(DNA).
Table A.5 Melting temperatures of polyamides target-
ed to DNA-sequence 5´-AGAACA-3´ in complex with 
DNA.a 
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Figure A.12 A) Chemical structures and ball-and-stick models of matched and mismatched 
polyamides 20-23, respectively, targeted to 5´-AGAACA-3´. B) Inhibition of DHT-induced PSA, 
KLK2, FKBP5, and TMPRSS2 expression by 20-23 measured by quantitative real-time RT-PCR.
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Appendix B: Apredica ADMET Report 
(Supplemental Information Continued from Chapter 3)
252
Figure B.1 Polyamides 1 and 5 were subjected to preclinical ADMET testing by contract service 
at Apredica (Watertown, MA). Shown in Chapter 3 of this thesis (Table 3.2-3.7) are summaries of 
the ADMET results taken directly from the fi nal report provided by Apredica. The full ADMET 
report, which includes experimental conditions, is contained on the following pages.
253
? ? ?
? ?
?
?
??
????????????????????????????????
?
????????????????????????????????
?
?????????????
?
?
????????? ????????????????????????????????????
???????????????????????????????????????????????
???????????????????????? ?????????
??????????????????????????
????????????????????????? ????????????????????
??????????????????????
???????????? ?????????????
????????????????? ?????????
????????????????????
?????????????????????
???????????????????????????????
??????????????? ????????????
????????????????????????????
?????????????????
?????????????????
?
?
????????????? ? ? ? ?
? ? ?
?
?????? ? ? ????????? ? ? ? ? ?
?
254
? ? ?????????????
? ?????????????
??????????????????
?? ????????? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
???? ????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?? ????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?? ???????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
???? ?????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ???????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
???? ???????????????????????? ???????????????? ??????????????????????????????????????????????????????????????????????????????? ??
?????? ???????????????????????????????????? ???????????????? ??????????????????????????????????????????????????????? ??
?????? ??????????????????? ???????????????? ??????????????????????????????????????????????????????????????????????????????????????? ??
?????? ????????????????????????????????????????????? ???????????????? ?????????????????????????????????????????? ??
?????? ??????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ??????????????????????? ???????????????? ???????????????????????????????????????????????????????????????????????????????? ??
?????? ????????????????????????????? ????????????????????????????????????????????????????????????????????????????????????? ??
?????? ????????????????????? ???????????????? ?????????????????????????????????????????????????????????????????????????????? ??
?? ??????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
???? ?????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
???? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ??????????????????????????? ???????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ???????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ?????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ?????????????????????????????????????? ???????????????????????????????????????????????????????????????????????????????? ??
?????? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
?????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??
???? ????????????????????????????????? ???????????????????????????????????????????????????????????????????????????????????????????? ???
?????? ??????????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????? ???
?????? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???
?????? ?????????????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????? ???
?????? ?????????????????????????????????????????????????????? ??????????????????????????????????????????????????????? ???
?????? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???
?????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???
?????? ?????????????????????????????????????? ????????????????????????????????????????????????????????????????????????????????? ???
?? ?????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???
?? ???????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????? ???
?? ?????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???
???? ?????????????????????????????????????? ???????????????????????????????????????????????????????????????????????????????? ???
???? ???????????????????????????????????????????????????????????????? ??????????????????????????????????? ???
?
255
? ? ?????????????
? ?????????????
?? ??????????
?????????????????????????????????????????????????????????????????????????????????
???? ??????????????????????
????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????
?? ???????????????
???????????? ??????????
?????????
?????
??????????
???
???????
??? ????????????????
??????????? ???????? ?????? ????? ????? ??? ???????
??????????? ????????? ?????? ???????? ??????? ??? ???????
??????????????????????????????????????????????????????????????????????????????????
?
256
? ? ?????????????
? ?????????????
?? ?????????????
????????????????????????????????????? ??????????????
???? ???????????????????
?????? ???????????????????
??????????????????? ??????????????????????????????????????????????????????????????
?????????? ??????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????? ???????????????????????????
???????????????????????????????????????????????????????????????????????????????????
?????? ?????????
???????????????????????????? ?? ?????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????? ?????????????????????????????????
???????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????? ???????
??????????????????????????????????????????????????????????????????????????????????? ????
?????????????????????????????????????????????? ?????
???? ???????????????????????? ?????????????????
?????????????????????????????????????????????????????
?????? ??????? ???????????????????????????? ?????????????????
???????????? ??????????
?????
??????
??????
?? ??? ??????????
??????????
??????????
???????????
???????
???????????
???????????
????????
????????? ?????? ?????
?????
?????
?????????
??????????? ??? ?? ??
?
?????? ??????????????????? ?????????????????
?????????
??? ??????????
?????
??????
??????
?? ??
?????
??????? ????????
??????????
?????????
???????????
???????
????????
???
????????
???
????????
?????
????
?????
????
????
?????
?????
?????
?????
??????
?????
??? ??????
??????
????????
????????
????
???????????????
????????????
????????????
??????
???????
?
257
? ? ?????????????
? ?????????????
?????? ????????????????????????????????????????????? ??????
???????????
???????????? ??????????
?????
?????? ????????????
??????????
?????????
???????????
???????
???????????
???????????
????????
?????????
????
??????
??????????
??????????
??????
????????
???????????
???????????
???????????
????????????
????????????
???????????
???????????
?????????????????
?????????????
????????????????
????????????????
??????????
?????????????
?????????????
????????????
??????
???????
?
?????? ??????????????????????????? ?????????????????
???????????? ??????????
?????
??????
??????
?????
???????
????????
??????
??????
??????
?????
??????
???????????
???????
???????????
???????????
????????
????????? ?????
??????
????????
?????
??? ??
???????
????????
???????
????
??????
??????????
????????? ?????????
?
?????? ??????????????????????? ?????????????????
???????????? ??????????
?????
??????
???????
???????
??????
??????
??????????
??????????
???????????
???????
???????????
???????????
????????
????????? ??????
??????
????????
???????
????????
???? ???
?????? ?????????????? ??? ?? ??
?
?????? ????????????????????????????? ??????????????????
?????????
??? ??????????
?????
?????
???????
????????
??????
??????
?????
???????
?????
?????????
???????????
???????
????????
???
????????
???
????????
?????
????
???
???
??????
????????
?????
??????
????????????
?????????
??????????
????????? ?????????
?
?????? ????????????????????? ?????????????????
???????????? ??????????
?????
????? ??????? ???????????? ???????????
???????????
???????
???????????
???????????
????????
?????????
?????????
??????????
??????????
????????
??????
??????????
???????
?? ???
????????
?????? ???????
????????
???????????
?
258
? ? ?????????????
? ?????????????
?? ????????
???? ???????????
?????? ???????????????????
?????????? ???
???????
???????
??????????
????
????????
????
??????????
???????????
???????????
????????????????
???????? ????? ???? ?????? ???? ??? ??
????????? ??????? ???? ?????? ???? ??? ??
??????????????????????????????
?????????????????????
?????????????????????????????
??????????????????????
?
?????????????? ??????????????????????????????????????????????????????????????????????
?????????????????????
259
? ? ?????????????
? ?????????????
???? ??????????????????????????
?????? ????????????????????????????
??????????
?????
?????
?????
??????
?????????
?????
??????????
???????
??????????????
??????????
???????
??????????????
??????????
??????? ????????
????????? ??? ?? ????? ???? ????
??????????????????
????????
??????????? ??? ?? ???? ???? ???? ?????????????????????????
???????? ??? ?? ??? ????? ??? ?
????????? ??? ?? ??? ??? ??? ?
???????????????????????
?????????????????????????
???????????????????????????????????????????????
?????? ?????????????????????
?????????? ??????????
?????
????? ????????
??????????????? ?????? ??? ????????????????????????
???????????? ?????? ??? ??????????????????????
???????? ?????? ????? ?
????????? ?????? ????? ?
?
?????? ?????????????????????????????
? ??????????
??????????
?????????
????
????????
???
?????????
????
??????????
????
?????????
?????
?????????
????
?????????
????
????????? ???? ???? ???? ???? ????? ????? ?????
? ??????????????????
???????????
??
???????
??????????
???????
??????????
??????????? ???????????
??
???????????
??
???????? ???? ???? ???? ???? ???? ????? ????
?????
???? ???? ???? ???? ???? ???? ????? ????
?
?????? ???????????????????????
?????????? ?????????? ????????
???????
???????????
??? ?????????????????
???????? ????? ??
????????? ????? ??
?????????????????? ?????????????????? ???????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????
260
? ? ?????????????
? ?????????????
?????? ???????????????????????????????????????
??????????
?????
?????
?????
?????
????????
???????
??????????
????????
???? ????? ?????
???????
??????????
???????
??????
???????????
????????
???? ????? ?????
??????
????????????
?????? ????????
?????????? ?? ?????? ?????? ???? ???? ?????
????????????
????????
?????????? ?? ???? ????? ?? ???? ?????
????????????
????????
????????? ?? ?????? ???? ????? ???? ?????
????????????????
????????
????????? ?? ???? ???? ????? ???? ?????
????????????????
????????
???????? ?? ?????? ???? ????? ???? ????? ?
???????? ?? ???? ???? ????? ???? ????? ?
????????? ?? ?????? ???? ????? ???? ????? ?
????????? ?? ???? ???? ????? ???? ????? ?
????????????????????????????????
???????????
?
?????? ?????????????????????????
?????????
?????
?????
????? ??????? ???????????
?????????
???????????
?????? ?????? ????????
?????????????? ?????
??????
??????? ????? ????? ????????
?????????????? ?????
????
??????? ?????? ?????? ????????
???????? ?????
??????
??????? ????? ?????? ??
???????? ?????
????
??????? ????? ?????? ??
????????? ?????
??????
??????? ????? ??????? ??
????????? ?????
????
??????? ????? ??????? ??
???????????
?????? ???????????????????????????????
??????????
?????
?????
?????
??????
????????? ????????
??????????
??????????
???? ????????
????????? ??? ????? ?????? ?????? ?????????????????????
????????? ??? ????? ???? ?????? ?????????????????????
????????? ??? ????? ?????? ?????? ????????????????????
????????? ??? ????? ???? ?????? ????????????????????
???????? ??? ????? ?????? ???????? ?
???????? ??? ????? ???? ???????? ?
????????? ??? ????? ?????? ???????? ?
????????? ??? ????? ???? ???????? ?
?
261
? ? ?????????????
? ?????????????
?
262
? ? ?????????????
? ??????????????
???? ??????????????????????????????????
?????? ????????????????????????????????????
??????????
?????
?????
????? ?????????? ?????? ????? ????? ????? ????????
???????? ??? ????? ??????? ??? ??? ??? ?
? ? ????? ???? ???? ???? ???? ??
? ? ????? ??????? ???????? ???????? ???????? ?
?? ? ????? ???? ???? ???? ???? ??
????????? ??? ????? ??????? ??? ??? ??? ?
? ? ????? ???? ????? ????? ???????? ?
? ? ????? ??????? ??? ??? ??? ?
? ? ????? ???? ???? ???? ???????? ?
???????????????????????????????????????????????
????????????????????????????????????????
?
?????? ?????????????????????????????
???????????????????????????????????????????
????
????
??
???
???
???
???
????
???? ??? ? ?? ???
??????????????
??
???
???
???
???
???
?
?
????????????????????????????????????????????
????
????
??
???
???
???
???
????
???? ??? ? ?? ???
???????????????
??
???
???
???
???
???
?
?
?
263
? ? ?????????????
? ??????????????
?????? ???????????????????????????????
????????
?????
264
? ? ?????????????
? ??????????????
?
?
265
? ? ?????????????
? ??????????????
?????? ???????????????????????????????????????????????????????
????? ???????????????????????????????? ????? ?????????????????????????????????
??????????? ??????? ?????? ??????? ??????????? ???????? ?????? ???????
???? ??? ??????????? ??? ???? ??? ??????????? ???
??? ?? ??? ???? ??? ??? ??? ????
???? ????? ????? ???? ???? ???? ????? ????? ???? ????
???? ??? ??? ??? ??? ???? ??? ??? ??? ???
????? ??? ??? ??? ??? ????? ??? ??? ??? ???
???? ??? ??? ?? ??? ???? ?? ??? ??? ???
????? ?? ??? ?? ??? ????? ??? ?? ?? ???
????? ?? ?? ?? ?? ????? ??? ??? ??? ???
?????? ??? ??? ??? ?? ?????? ??? ??? ??? ???
?????? ?? ??? ?? ?? ?????? ??? ?? ??? ???
??????? ??? ??? ??? ?? ??????? ??? ??? ??? ???
????????????????????????????????
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
??????????????????????????????
???
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?
????? ???????????????????????????????? ????? ?????????????????????????????????
??????????? ??????? ?????? ??????? ??????????? ???????? ?????? ???????
???? ??? ??????????? ??? ???? ??? ??????????? ???
??? ?? ??? ???? ??? ??? ??? ????
???? ????? ????? ???? ???? ???? ????? ????? ???? ????
???? ??? ??? ??? ??? ???? ??? ??? ??? ???
????? ??? ?? ?? ?? ????? ?? ??? ??? ??
???? ??? ?? ?? ?? ???? ??? ??? ??? ??
????? ???? ?? ??? ??? ????? ??? ???? ??? ??
????? ??? ???? ??? ??? ????? ??? ?? ?? ???
?????? ??? ?? ??? ??? ?????? ?? ?? ?? ???
?????? ??? ?? ??? ??? ?????? ??? ??? ??? ???
??????? ?? ?? ?? ??? ??????? ?? ?? ?? ???
????????????????????????????????
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
??????????????????????????????
???
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?
266
? ? ?????????????
? ??????????????
????? ???????????????????????????????? ????? ?????????????????????????????????
??????????? ??????? ?????? ??????? ??????????? ???????? ?????? ???????
???? ??? ??????????? ??? ???? ??? ??????????? ???
??? ?? ??? ???? ??? ??? ??? ????
???? ????? ????? ???? ???? ???? ????? ????? ???? ????
???? ??? ??? ??? ??? ???? ?? ??? ??? ??
????? ?? ??? ?? ??? ????? ??? ??? ?? ??
???? ??? ?? ?? ??? ???? ??? ?? ??? ??
????? ??? ??? ??? ??? ????? ??? ?? ?? ??
????? ?? ?? ?? ??? ????? ?? ??? ?? ??
?????? ???? ???? ???? ??? ?????? ???? ?? ??? ??
?????? ??? ??? ??? ??? ?????? ??? ??? ??? ??
??????? ?? ?? ?? ??? ??????? ??? ?? ??? ??
????????????????????????????????
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
??????????????????????????????
???
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?
????? ????????????????????????????????? ????? ??????????????????????????????????
??????????? ??????? ?????? ???????? ??????????? ???????? ?????? ????????
???? ??? ??????????? ??? ???? ??? ??????????? ???
??? ?? ??? ???? ??? ??? ??? ????
???? ????? ????? ???? ???? ???? ????? ????? ???? ????
???? ??? ??? ??? ??? ???? ??? ??? ??? ???
????? ??? ??? ??? ??? ????? ??? ??? ??? ???
???? ?? ??? ?? ??? ???? ?? ?? ?? ???
????? ??? ??? ??? ??? ????? ?? ?? ?? ???
????? ??? ??? ??? ??? ????? ??? ??? ??? ???
?????? ??? ??? ??? ??? ?????? ??? ??? ??? ???
?????? ??? ??? ??? ??? ?????? ??? ??? ??? ???
??????? ??? ??? ??? ??? ??????? ??? ??? ??? ???
?????????????????????????????????
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
???????????????????????????????
???
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?
267
? ? ?????????????
? ??????????????
????? ????????????????????????????????? ????? ??????????????????????????????????
??????????? ??????? ?????? ???????? ??????????? ???????? ?????? ????????
???? ??? ??????????? ??? ???? ??? ??????????? ???
??? ?? ??? ???? ??? ??? ??? ????
???? ????? ????? ???? ???? ???? ????? ????? ???? ????
???? ?? ??? ??? ??? ???? ??? ??? ??? ???
????? ??? ??? ??? ??? ????? ??? ?? ??? ???
???? ?? ??? ??? ??? ???? ??? ??? ??? ???
????? ?? ?? ?? ??? ????? ??? ?? ?? ???
????? ??? ?? ??? ??? ????? ?? ?? ?? ???
?????? ??? ??? ??? ?????? ??? ?? ??? ???
?????? ???? ??? ??? ??? ?????? ?? ?? ?? ???
??????? ??? ??? ??? ??? ??????? ??? ??? ??? ???
???????????????????????????????
??
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
???????????????????????????????
???
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?
????? ???????????????????????????????? ????? ?????????????????????????????????
??????????? ??????? ?????? ??????? ??????????? ???????? ?????? ???????
???? ??? ??????????? ??? ???? ??? ??????????? ???
??? ?? ??? ???? ??? ??? ??? ????
???? ????? ????? ???? ???? ???? ????? ????? ???? ????
???? ?? ?? ?? ?? ???? ??? ?? ?? ??
????? ?? ?? ?? ?? ????? ?? ?? ?? ??
???? ??? ?? ??? ?? ???? ?? ?? ?? ??
????? ??? ?? ?? ?? ????? ?? ??? ?? ??
????? ?? ??? ?? ?? ????? ?? ?? ?? ??
?????? ??? ?? ?? ?? ?????? ??? ?? ?? ??
?????? ?? ?? ?? ?? ?????? ?? ??? ??? ??
??????? ?? ??? ??? ?? ??????? ?? ?? ?? ??
????????????????????????????????
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?????????????????????????????????
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?
268
? ? ?????????????
? ??????????????
????? ???????????????????????????????? ????? ?????????????????????????????????
??????????? ??????? ?????? ??????? ??????????? ???????? ?????? ???????
???? ?? ??????????? ??? ???? ?? ??????????? ???
??? ?? ??? ???? ??? ??? ??? ????
???? ????? ????? ???? ???? ???? ????? ????? ???? ????
???? ??? ??? ??? ??? ???? ??? ??? ??? ???
????? ??? ??? ??? ??? ????? ??? ??? ??? ???
???? ??? ??? ??? ??? ???? ??? ??? ??? ???
????? ??? ??? ??? ??? ????? ??? ??? ??? ???
????? ?? ??? ?? ??? ????? ??? ?? ?? ??
?????? ??? ???? ??? ??? ?????? ???? ???? ???? ??
?????? ?? ??? ?? ??? ?????? ?? ?? ?? ??
??????? ??? ??? ??? ??? ??????? ??? ??? ??? ??
????????????????????????????????
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?????????????????????????????????
????
????
??
???
???
???
???
????
????
???? ??? ? ?? ???
?????????????????
??
???
???
???
?
?
?
?????? ???????????????????????????????????????????????
????? ?????? ????????????????????????????? ????????????????????????????????????????????????
????????? ?????
?????????????????? ?????????? ???
???????? ?????
????? ? ???? ???? ????? ? ???? ????
?? ? ???? ???? ???? ???? ???? ???? ???? ????
???? ??? ??? ??? ???? ??? ??? ??? ????
?? ??? ???? ???? ???? ??? ??? ??? ????
?? ??? ??? ??? ???? ??? ???? ???? ????
?? ???? ???? ???? ???? ???? ???? ???? ????
?? ???? ???? ???? ???? ???? ???? ???? ????
??????? ?????????
?????????????????????????????
???????
??
???
???
???
???
????
????
? ?? ?? ??
????????????? ???????
??
???
???
???
???
??
?????????????????????????????
???????????????????
??
???
???
???
???
????
????
? ?? ?? ??
????????????? ???????
??
???
???
???
???
??
?
269
? ? ?????????????
? ??????????????
????? ?????????????????????????????????? ???? ?????????????????????????????????????????
????????? ?????
?????????????????? ?????????? ???
???????? ???
????? ? ???? ???? ????? ? ???? ????
?? ? ???? ???? ???? ???? ???? ???? ???? ????
???? ??? ??? ??? ???? ??? ??? ??? ????
?? ??? ???? ???? ???? ??? ??? ??? ????
?? ??? ???? ??? ???? ???? ??? ??? ????
?? ??? ???? ???? ???? ???? ???? ???? ????
?? ???? ???? ???? ???? ???? ???? ???? ???
??????? ?????????
???? ?????????????????????????
????
??
???
???
???
???
????
????
? ?? ?? ??
????????????? ???????
??
???
???
???
???
??
??????????????????????????????
????????????????
??
???
???
???
???
????
????
? ?? ?? ??
????????????? ???????
??
???
???
???
???
??
?
????? ?????? ?????????????????????????????? ?????????????????????????????????????????????????
????????? ??????
??????????????????? ?????????? ???
???????? ?????
????? ? ???? ???? ????? ? ???? ????
?? ? ???? ???? ???? ???? ???? ???? ???? ????
???? ???? ??? ???? ???? ??? ???? ??? ????
?? ??? ??? ??? ???? ??? ??? ??? ????
?? ??? ???? ???? ???? ??? ??? ??? ????
?? ???? ???? ???? ???? ??? ???? ???? ????
?? ???? ??? ???? ???? ???? ???? ???? ????
??????? ?????????
?????????????????????????????
????????
??
???
???
???
???
????
????
? ?? ?? ??
????????????? ???????
??
???
???
???
???
??
?????????????????????????????
????????????????????
??
???
???
???
???
????
????
????
? ?? ?? ??
????????????? ???????
??
???
???
???
???
??
?
270
? ? ?????????????
? ??????????????
????? ??????????????????????????????????? ???? ??????????????????????????????????????????
????????? ??????
??????????????????? ?????????? ???
???????? ???
????? ? ???? ???? ????? ? ???? ????
?? ? ???? ???? ???? ???? ???? ???? ???? ????
???? ???? ??? ??? ???? ??? ???? ??? ????
?? ???? ??? ??? ???? ??? ??? ??? ????
?? ???? ???? ???? ???? ???? ??? ??? ????
?? ??? ??? ??? ???? ??? ???? ???? ????
?? ???? ???? ???? ???? ???? ???? ???? ???
??????? ?????????
???????????????????????????
????????
??
???
???
???
???
????
????
? ?? ?? ??
????????????? ???????
??
???
???
???
???
??
???????????????????????????
????????????????????
??
???
???
???
???
????
????
????
? ?? ?? ??
????????????? ???????
??
???
???
???
???
??
?
?
271
? ? ?????????????
? ??????????????
?????? ?????????????????????????????????
????????? ?????
??? ??????? ??????????????? ??
????? ?????? ????????????
?????????? ???? ????????????? ? ?????
?? ? ???? ???? ??? ????
???? ???? ???? ???? ????
?? ??? ??? ??? ????
?? ??? ??? ??? ???
?? ???? ???? ???? ???
??? ??? ??? ??? ???
?????????????????????????????????
??
???
???
???
???
????
????
? ?? ??? ???
?????????????????
??
??
???
???
??
???
???
???
?
?
272
? ? ?????????????
? ??????????????
????????? ?????
??? ??????? ??????????????? ??
????? ?????? ??????????
?????????? ???? ????????????? ? ?????
?? ? ???? ???? ??? ????
???? ??? ??? ??? ????
?? ???? ???? ???? ???
?? ??? ??? ??? ???
?? ??? ??? ??? ???
??? ??? ??? ??? ???
???????????????????????????????
??
???
???
???
???
????
????
? ?? ??? ???
?????????????????
??
??
???
???
??
???
???
???
?
?
273
? ? ?????????????
? ??????????????
????????? ??????
??? ???????? ??????????????? ??
????? ?????? ????????????
?????????? ???? ????????????? ? ??????
?? ? ???? ???? ??? ????
???? ??? ??? ??? ????
?? ??? ??? ??? ????
?? ??? ??? ??? ????
?? ???? ???? ???? ????
??? ???? ???? ???? ????
??????????????????????????????????
??
???
???
???
???
????
????
????
? ?? ??? ???
?????????????????
??
??
???
???
??
???
???
???
?
?
274
? ? ?????????????
? ??????????????
????????? ??????
??? ???????? ??????????????? ??
????? ?????? ??????????
?????????? ???? ????????????? ? ??????
?? ? ???? ???? ??? ????
???? ??? ??? ??? ????
?? ??? ??? ??? ????
?? ??? ??? ??? ????
?? ???? ???? ???? ????
??? ???? ???? ???? ????
??????????????????????????????????
??
???
???
???
???
????
????
????
? ?? ??? ???
?????????????????
??
??
???
???
??
???
???
???
?
? ? ? ? ? ? ?? ? ? ?
???
???
???
???
????
??
??
???
???
??
???
???
???
?
?
?
?????? ???????????????????????????????????????
? ? ? ?????????????????? ?
??????????
?????
????????
?????
?????
????? ????? ????? ????? ????????
???????? ?????? ??? ????????? ???????? ???????? ?
???????? ???? ??? ????????? ???????? ???????? ?
????????? ?????? ??? ????????? ???????? ???????? ?
????????? ???? ??? ????????? ???????? ???????? ?
????????????????????????????????????????????????????
?
?
275
? ? ?????????????
? ??????????????
?? ???????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????
?
????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????? ????????????????
?
?????????????????????????????????????????????? ????????????????????????????????????? ?????????
?????????????????????????????????????????
?
???????? ??????????????????????????????????????????????????????????????????????????????????????????
???? ?????????????????????????????????????????????????????????
?
?
?
276
? ? ?????????????
? ??????????????
?? ?????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????
?
????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????
277
? ? ?????????????
? ??????????????
?? ???????????
???? ???????????????????????????????????????
??????? ??????????????????????
??????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????
?
?????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????? ?????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???????????????
?
?????????????????????????? ????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????? ??????????????????????
??????????
?
?????????????????????????????????????????????? ??
??
??
????
?
? ??
????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????
?
?????????????????????????????????????????????????????????????????????????????????????? ?
? ?????? ???
???
???
???
?
?? ??
????????????????????????????????????????????????????????????????????????????????
?????????????
?????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????? ????????????????????????????????
????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
??????????? ??????????????????????????????????????????????????????????????????
????????????????????????????? ????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
??????????? ???????????????????????????????????????????????????????????????????
????????????????????????????? ?????????????????????????????????????????
?
????????????????????????????????????????????????????????????????????????????????????
??????????????????????? ??????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
???????????????????? ????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????? ???????????????
?????????????????????????????
278
? ? ?????????????
? ??????????????
?
?????????????????????????? ???????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????
?
????????????????????????????????? ???????????????????????????????????????????????????
??????? ?? ?????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
??????? ?????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
???????????????????????
???????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
???????????????? ??????????? ????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????? ???????????
????????????????????????????????????????????????????????????????????????
?
?????????? ?????????? ?????????????
???? ????????? ?????????
???? ?????????????? ?????????
???? ?????????? ?????????
???? ????????? ?????????
???? ????????? ?????????
????? ????????? ?????????
???? ???????????? ?????????
???? ??????????? ?????????
???? ?????????? ?????????
???? ????????? ?????????
???? ?????????? ?????????
?????????? ??????????? ?????????
??????????????? ?????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????
??????????????? ?????????????????????????????????????????????????????????????????
??????????????????? ??????????????????????????? ???????????????????
????????????????????????????? ????????????????????????????????????????????????????
??????????????????? ???????????????????????????? ???????????????????
???????????????????????????????????????????????????????????????????????????????????
??????????????????? ????????????????????????????????????????????
??????????????? ?????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
???????????????
???????????????????????????????????????????????????????????????????????????
279
? ? ?????????????
? ??????????????
???????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
???????????????????? ????????????????????????????????????????? ??????????????
????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????? ???????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????? ??????????????????????????
??? ??????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????? ????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????
????? ?????????????????? ????????????????????????????????????????????????????????????
????????????????????
??????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????? ??????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????
?
?????????????????????????????????????
????????? ?????????? ??????????? ??
???????????????? ????????????????????? ??? ???
????????????????????????????? ????????????????????? ?? ???
????????????????????????????? ????????????????????? ?? ???
?
?????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????? ????????????????????????????????
???????????????
???????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????? ???????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
??????? ???????????????????????????????????????????????????????????????????????????????
????????????????????? ??????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????? ????????????????
??? ????????????????????????????????????????????????????????????????? ??????????????????
????????????????????????????????????????????????????????????? ??????????????????????????
?????????????????? ???????????????????????????????????????????????????????????????????????
??????????????????????????? ????????????????????????????????????????????????? ????????
????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????
???????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????? ????????????????????????
???????????????????????????????????????????????????????????????????????????????
?????????????????????????????? ?????????????????????????????????????????? ??????????
280
? ? ?????????????
? ??????????????
???????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????
?????????????????????? ???????????????????????????????? ?????????????????????????????
???????????????????????????????????? ?????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
???????????????????????
???????????????????????
????????????????????????????????????? ????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????
???????????????????? ?????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????
?????????????????
??????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????? ????????????????????????????????????
?????? ????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????
??????????????????????? ?????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????? ???????????????????????????????? ???????
??????????????????????????????????????????????????????????????????????????????????????????
?
?
281
?
?
??
??
??
??
???
??
?
??
??
???
???
???
?
???
??
??
??
???
??
????
??
???
??
??
???
???
??
??
??
??
???
??
??
???
???
??
???
???
??
??
???
? ??
??
??
??
???
???
???
??
??
??
?
?
282
?
?
??
??
??
??
???
??
?
??
??
???
???
???
?
??
??
??
????
???
??
???
???
??
??
??
?
?
283
?
?
??
??
??
??
???
??
?
??
??
???
???
???
?
??
??
???
??
???
???
???
??
???
??
??
???
?
?
?
??
? ?????????????????????????????????????????????????????????????????????????????????
???
??
???
??
???
???
??
???
???
??
??
??
??
???
???
??
??
??
??
?
?
??
??
???
??
???
??
???
????
???
??
???
??
??
???
???
???
?
???
???
???
???
???
???
???
???
???
?
???
???
???
???
???
???
???
???
???
?
???
???
???
???
???
???
???
???
???
284
?
?
??
??
??
??
???
??
?
??
??
???
???
???
?
??
??
??
??
???
???
???
??
???
??
?
?
285
?
?
??
??
??
??
???
??
?
??
??
???
???
???
?
??
??
??
????
???
??
???
???
??
???
??
?
?
286
?
?
??
??
??
??
???
??
?
??
??
???
???
???
?
??
??
???
??
???
???
???
??
???
??
??
???
??
?
?
??
? ?????????????????????????????????????????
???
??
???
??
???
???
??
???
???
??
??
??
??
???
?
???
??
??
??
??
?
?
??
??
???
??
???
??
???
????
???
??
???
??
??
???
???
???
?
???
???
???
???
???
???
???
???
???
?
???
???
???
???
???
???
???
???
???
?
???
???
???
???
???
???
???
???
???
287
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Abstract
 The four Watson-Crick base pairs of DNA can be distinguished in the minor groove by 
pairing side-by-side three fi ve-membered aromatic carboxamides, imidazole (Im), pyrrole (Py), 
and hydroxypyrrole (Hp), four different ways. On the basis of the paradigm of unsymmetrical 
paired edges of aromatic rings for minor groove recognition, a second generation set of heterocycle 
pairs, imidazopyridine/pyrrole (Ip/Py) and hydroxybenzimidazole/pyrrole (Hz/Py), revealed 
that recognition elements not based on analogues of distamycin could be realized. A new set of 
end-cap heterocycle dimers, oxazole-hydroxybenzimidazole (No-Hz) and chlorothiophene-
hydroxybenzimidazole (Ct-Hz), paired with Py-Py are shown to bind contiguous base pairs of 
DNA in the minor groove, specifi cally 5’-GT-3’ and 5’-TT-3’, with high affi nity and selectivity. 
Utilizing this technology, we have developed a new class of oligomers for sequence-specifi c DNA 
minor groove recognition no longer based on the N-methyl pyrrole carboxamides of distamycin.
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C.1 Introduction
 Aberrant gene expression is the cause of many diseases, and the ability to reprogram 
transcriptional pathways using cell-permeable small molecules may, one day, have an impact on 
human medicine.1 DNA-binding polyamides, which are based on the architecture of the natural 
products netropsin and distamycin A,2,3a,b are capable of distinguishing all four Watson-Crick base 
pairs in the DNA minor groove and have been the subject of intense study along with many other 
classes of minor groove binders.3c-f,4,5 Sequence-specifi c recognition of the minor groove of DNA by 
polyamides arises from the pairing of three different antiparallel fi ve-membered heterocyclic amino 
acids, pyrrole (Py), imidazole (Im), and hydroxypyrrole (Hp).4,5 The direct read out, or information 
face, on the inside of the crescent-shaped polyamide may be programmed by the incremental change 
of atoms on the corners of the ring pairs presented to the DNA minor groove fl oor. Stabilizing and, 
importantly, destabilizing interactions with the different edges of the four Watson-Crick bases are 
modulated by shape complementarity and specifi c hydrogen bonds.4-6,7l For example, the Im/Py pair 
distinguishes G•C from C•G, T•A, and A•T. Im presents a lone pair of electrons to the DNA minor 
groove and can accept a hydrogen bond from the exocyclic amine of guanine.5 Additionally, the Hp/
Py pair distinguishes T•A from A•T, G•C, and C•G.4-6 Hp projects an exocyclic OH group toward 
the minor groove fl oor that is sterically accommodated in the cleft of the T•A base pair, preferring 
to lie over T, not A.5 These pairing rules have proven useful for programmed recognition of a broad 
repertoire of DNA sequences; however, the hydroxypyrrole ring system has proven to be unstable 
over time and in the presence of acid, further prompting our search for new T•A/A•T recognition 
elements. In addition, sequence-dependent changes in the microstructure of DNA (intrinsic minor 
groove width, minor groove fl exibility, and inherent DNA curvature)7a-k combined with structural 
and conformational changes among polyamides make the targeting of certain sequences less than 
optimal, leading us to explore whether other novel heterocyclic recognition elements could be 
discovered for use in DNA groove recognition within the unsymmetrical pairing paradigm.7l,8-10 
Furthermore, from a medicinal chemistry point of view, a broader tool kit of sequence-specifi c 
recognition elements for DNA beyond polyamides would be useful as our artifi cial transcription 
factor program moves from cell culture11 to small animal studies.
 We recently reported that the benzimidazole ring can be an effective platform for the 
development of modular paired recognition elements for the minor groove of DNA.9,10 The 
benzimidazole 6-5 bicyclic ring structure, though having slightly different curvature from the classic 
fi ve-membered pyrrole-carboxamides, presents an “inside edge” with a similar atomic readout to 
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the DNA minor groove fl oor, effectively mimicking Py, Im, and Hp. We demonstrated that the 
imidazopyridine/pyrrole pair Ip/Py distinguishes G•C from C•G and the hydroxybenzimidazole/
pyrrole pair Hz/Py distinguishes T•A from A•T, providing a solution to the unanticipated 
hydroxypyrrole instability limitation.9,10 The question arises whether this second generation solution 
to DNA recognition can be elaborated further, deleting incrementally almost all carboxamide 
linkages in the backbone of the hairpin motif.12
 We report here a new set of heterocycle dimer pairs,12 which represents a step from single 
base-pair recognition toward a two letter approach to molecular recognition of the minor groove of 
DNA (Figure C.1). We move from single letters to syllables. New heterocycles were designed by 
combining the T-specifi c hydroxybenzimidazole (Hz) with oxazole (No) rings and chlorothiophene 
(Ct) caps8 to afford the recognition elements No-Hz and Ct-Hz, respectively (Figure C.1). 
Quantitative DNase I footprinting titrations were used to determine DNA binding affi nities of 
hairpin oligomers containing the No-Hz and Ct-Hz dimers paired with Py-Py dimer for each of the 
four Watson-Crick bases (Figure C.2). When positioned at the termini of hairpin polyamides, the 
No-Hz/Py-Py and Ct-Hz/Py-Py dimer pairs are found to target 5’-GT-3’ and 5’-TT-3’ sequences, 
respectively, with high affi nity and good specifi city. With the development of dimer pairs capable 
of recognizing a 5’-GT-3’ sequence of DNA, 
we could address the question whether 
a hairpin oligomer comprised of four 
dimer units will bind the site 5’-GTAC-
3’, a sequence formally containing all four 
Watson-Crick base pairs. Such a molecule 
represents our fi rst programmable oligomer, 
which demonstrates excellent DNA binding 
properties without containing a single 
pyrroleor imidazole-carboxamide based on 
the natural product distamycin, a design 
benchmark for biomimetic chemistry and 
the fi eld of DNA recognition.
C.2 Experimental
C.2.1 Polyamide Synthesis
Figure C.1 Structures of dimers. a) imidazole-
hydroxybenzimidazole (Im-Hz), b) oxazole-hy-
droxybenzimidazole (No-Hz), and c) chlorothio-
phenehydroxybenzimidazole (Ct-Hz) dimer caps 
in comparison with their respective fi ve membered 
ring systems. Hydrogen-bonding surfaces to the 
DNA minor-groove fl oor are bolded.
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 Hairpin polyamides were synthesized manually from Boc-β-PAM resin in a stepwise 
fashion using Boc-protected monomeric and dimeric amino acids according to established solid-
phase protocols.13 Base Resin 1 (BR1) (H
2
N-Py-Py-γ-Im-Py-Py-Py-β-Pam) was synthesized in 
gram quantities using the following amino acid building blocks: Boc-Py-OBt (4), Boc-Im-OH (5), 
and Boc-γ-OH (6) (Scheme C.1). The base resins were then split into smaller batches for coupling 
to the fi nal dimeric caps. Boc-protected amino acid monomers for Boc-Py-OBt (4) and Boc-Im-OH 
(5) were synthesized according to previously reported procedures.8,13,14 Dimeric cap synthesis for 
No-HzOMe-OH (7) and Ct-HzOMe-OH (8) are detailed in Section C.7 Supplemental Information. 
Couplings were achieved using preactivated monomers (Boc-Py-OBt) or HBTU activation in 
a DIEA and DMF mixture. Coupling times ran from 3 to 24 h at 25-40°C. Deprotection of the 
growing polyamide was accomplished using 80% TFA/DCM. Polyamides were cleaved from the 
resin by treatment with neat 3-(dimethylamino)-1-propylamine (Dp) at 80°C for 2 h and purifi ed 
by preparatory reverse phase HPLC. Deprotection of the methoxy-protected polyamides was done 
using a mix of thiophenoxide in DMF at 80°C to provide the free hydroxy derivatives after a second 
HPLC purifi cation: Im-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (1), No-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp 
(2), Ct-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (3). (See Section C.7 Supplemental Information for full 
experimental details.)
Figure C.2 Postulated hydrogen-bonding models for the 1:1 polyamide-DNA complexes with 
their matched sequence and their ball-and-stick representations. a) Im-Hz-Py-Py-γ-Im-Py-Py-Py-
β-Dp (1), b) No-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (2), and c) Ct-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp 
(3).
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C.3 Results
C.3.1 DNA Affi nity and Sequence Specifi city of Dimer Caps
 Quantitative DNase I footprinting titrations were carried out for polyamides 1-3. All 
polyamides were footprinted on the 285-base-pair PCR product of plasmid pCW15. In all cases, 
the DNA-sequence specifi city at the cap position (in bold) was determined by varying a single 
DNA base pair within the sequence, 5’-TXTACA-3’, to all four Watson-Crick base pairs (X = A, 
T, G, C) and comparing the relative affi nities of the resulting complexes. The variable base-pair 
position was designed to be adjacent to the Hz ring, which has been shown to specify for T when 
paired across from Py, so as to be able to determine the binding properties of each compound to the 
following two base-pair sequences: AT, TT, GT, and CT.
 The sequence specifi city of the Im-Hz and Ct-Hz dimers for 5’-TXTACA-3’ were evaluated 
in polyamides 1 and 3, respectively. As expected, polyamide 3 bound its designed match site 
5’-TTTACA-3’ (K
a
 = 2.4 x 109 M-1) (Figure C.3, Table C.1) with both the Ct and the Hz halves of 
the dimer preferring to rest over the less bulky T in the asymmetric cleft of a T•A base pair. Placing 
the Ct ring adjacent to the Hz resulted in a 10-fold specifi city for T > A using the Ct-Hz system. 
Polyamide 1, which contains the Im-Hz dimer, did not bind its designed match site 5’-TGTACA-3’ 
with any appreciable level of specifi city exhibiting affi nities of K
a
 = 1.6 x 108 and 4.0 x 108 M-1 for 
the GT and AT sites, respectively.
 Oxazole cap (polyamide 2) was incorporated into the dimer cap system, and the affi nity 
for its designed match site, 5’-TGTACA-3’, was examined. Polyamide 2 successfully targeted its 
designed match site with an appreciable level of specifi city (25-fold) and a match site affi nity of K
a
 
= 6.8 x 109 M-1 (Figure C.3, Table C.1). With the development of the chlorothiophene and oxazole 
dimer caps, the range of targetable sequences by polyamides has been expanded (Table C.1).
C.3.2 Design of a Programmable Oligomer for 5’-GTAC-3’
 The synthesis of oligomer 9 containing four dimer units was achieved via the stepwise 
addition of Boc-amino acid dimers in the same manner as previously described polyamide 
syntheses. This “third generation” oligomer’s binding properties were assessed in the same context16 
as previously reported for fi rst and second generation hairpin polyamides targeting the sequence, 
5’-GTAC-3’, containing the four Watson-Crick base pairs.4,10 Footprinting of the oligomer on the 
previously characterized plasmid DEH10 showed a binding affi nity of K
a
 = 2.3 x 1010 M-1 for the 
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match site 5’-GTAC-3’ and affi nities of K
a
 = 3.5 x 109 and 9.8 x 108 M-1 for the mismatch sites 5’-
GAAC-3’ and 5’-GATC-3’, respectively (Figure C.4). Such a result demonstrates that a compound 
consisting exclusively of 6-5 fused ring systems and minimal carboxamide linkages is able to 
maintain good levels of specifi city and excellent binding affi nity. 
C.4 Discussion
Scheme C.1 Representative solid-phase synthesis of polyamide 2 and 3 along with a table of 
the amino acid building blocks used. Reaction conditions: (i) 80% TFA/DCM; (ii) Boc-Py-OBt, 
DIEA, DMF; (iii) Ac
2
O, DIEA, DMF; (iv) repeat i-iii  2; (v) 80% TFA/DCM; (vi) Boc-Im-OH, 
HBTU, DIEA, DMF; (vii) Ac
2
O, DIEA, DMF; (viii) 80% TFA/DCM; (ix) Boc-γ-OH, HBTU, 
DIEA, DMF; (x) Ac
2
O, DIEA, DMF; (xi) repeat i-iii x 2; (xii) 80% TFA/DCM; (xiii) No-HzOMe-
OH, HBTU, DIEA, DMF; (xiv) 3-(dimethylamino)-1-propylamine (Dp), 80 °C, 2 h; (xv) prepara-
tive HPLC; (xvi) thiophenol, NaH, DMF; (xvii) preparative HPLC; (xviii) Ct-HzOMe-OH, HBTU, 
DIEA, DMF; (xix) same as steps xiv-xvii.
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 Recent advances in hairpin polyamide designs have traditionally focused on developing 
new modes of single base-pair recognition by heterocyclic ring pairings. Previous studies, however, 
have highlighted the fact that the microstructure of DNA depends on the sequence in question.17 In 
addition, structural and conformational changes among polyamides are thought to have an impact 
Figure C.3 Quantitative DNase I footprinting experiments in the hairpin motif for polyamides 1, 
2, and 3, respectively, on the 278 bp, 5’-end-labeled PCR product of plasmid CW15: (lane 1) intact 
DNA; (lane 2) A reaction; (lane 3) DNase I standard; (lanes 4-14) 1 pM, 3 pM, 10 pM, 30 pM, 100 
pM, 300 pM, 1 nM, 3 nM, 10 nM, 30 nM, 100 nM polyamide, respectively. Each footprinting gel is 
accompanied by the following: (top) Chemical structure of the pairing of interest; (bottom) binding 
isotherms for the four designed sites. θ
norm
 values were obtained according to published methods.15 
A binding model for the hairpin motif is shown centered at the top as a ball-and-stick model with 
the polyamide bound to its target DNA sequence. Imidazoles and pyrroles are shown as fi lled and 
nonfi lled circles, respectively; β-alanine is shown as a diamond; the γ-aminobutyric acid turn resi-
due is shown as a semicircle connecting the two subunits.
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on DNA affi nity and sequence specifi city. Thus, we have taken a more global view of molecular 
recognition, where our efforts have expanded from designing modules that distinguish the four 
DNA base-pairs (i.e., pairing rules) to designing those that target short, discrete DNA sequences.
 Upon incorporation and evaluation of the G specifi c Im ring into the Im-Hz dimer cap 
(polyamide 1), we were surprised to fi nd that it failed to demonstrate any preference for its designed 
site in addition to displaying a signifi cantly decreased affi nity. The shortcomings of the Im-Hz 
dimer prompted a search for a ring system that was capable of specifying for G > C within the X-Hz 
context. The oxazole (No) cap (Figure C.1) was considered because of its structural resemblance to 
Im (both rings present a nitrogen atom capable of hydrogen bonding to the minor groove). When 
the No-Hz dimer was incorporated into polyamide 2, it was found to be specifi c for its designed 
sequence of 5’-TGTACA-3’ with a 25-fold preference for G > C and an affi nity of K
a
 = 6.8  109 M-1 
at its match site (Figure C.3). The No-Hz dimer presents the same functionality to the minor groove 
as the Im-Hz dimer but with an enhanced ability to target a 5’-GT-3’ site, which could be due to 
a combination oxazole lone-pair basicity and differential solvation/desolvation effects between 
oxazole and imidazole.
 The Ct-Hz dimer cap represents our fi rst effort to target a short sequence of DNA using 
sequence-inspired recognition elements. Studies have shown that Hz exhibits specifi city for T > 
A at the N-1 positions relative to the polyamide N-terminus and that Ct polyamides exhibited 
specifi city for T > A at the cap position with excellent polyamide affi nities. We hoped that a hybrid 
dimer would impart specifi city for the TT sequence while maintaining a biologically relevant 
affi nity. Polyamide 3 bound its designed match site 5’-TTTACA-3’ with an affi nity of K
a
 = 2.4 x 
Table C.1 Affi nities of X/Py ring pairs proximal to a hydroxybenzimidazole bicycle K
a
 (M -1).a,b 
296
109 M-1 and a specifi city of 10-fold for T•A over A•T. This result is attributed to the fact that both 
the sulfur and hydroxyl groups prefer to lie over the less-bulky thymine base in a T•A base pair 
and that the –OH of the Hz ring is able to form an energetically favorable hydrogen bond with the 
O(2) carbonyl of thymine.10 Combined, these attributes make this dimer the preferred solution for 
targeting consecutive thymine residues.
 As a fi rst step in the design of programmable oligomers devoid of directly linked pyrrole- or 
imidazole-carboxamides, we incorporated the new No-Hz dimer into a hairpin structure, oligomer 9, 
consisting only of 6-5 fused ring systems (Figure C.2). The oligomer was designed to target the site 
5’-GTAC-3’ and is a third generation molecule from our previously reported hairpin polyamides, 
Figure C.4 a) Postulated hydrogen-bonding model and structure of oligomer 9. b) Ball and stick 
representation of 9 and the 6-base-pair binding site with variable region (W = A or T) shown. c) 
Quantitative DNase I footprint titration experiment on the 5’-32P-labeled PCR product shown with 
an illustration and complete sequence of the 285 bp EcoRI/PνuII restriction fragment from plasmid 
pDEH10. Binding affi nities are shown next to their respective binding sites and the match site is 
designated.sites.
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which were shown to code for the four Watson-Crick base pairs in a sequence specifi c manner.16 To 
evaluate the impact of removing four carboxamide linkages and moving to a system consisting of 
only 6-5 fused recognition elements, binding properties were evaluated using quantitative DNase I 
footprinting titrations. Oligomer 9 was found to bind its match site with an impressive affi nity of K
a
 
= 2.3 x 1010 M-1 while discriminating against its mismatch sites of 5’-GAAC-3’ and 5’-GATC-3’ with 
specifi cities (K
a
  match/K
a
 mismatch) of ~7- and ~23-fold, respectively (Figure C.4). The four 6-5 
fused rings of oligomer 9 present an “inside edge” with complimentary shape to the minor groove 
fl oor as the carboxamide linkages of traditional Py-Im-Hp polyamides. The complementary bumps 
and holes fi t together between the oligomer and the DNA surface, which is the key to specifi city. 
The dimer recognition elements in oligomer 9 are linked by a single carbon-carbon bond, resulting 
in fewer degrees of rotational freedom, which may result in a reduced entropic penalty for minor-
groove binding. Undoubtedly, much of the favorable energetics for complexation with DNA for all 
these molecules is a result of differential solvation. The oligomer’s large hydrophobic surface may 
result in increased favorable van der Waals interactions with the walls of the minor groove.
C.5 Conclusion
 Hairpin polyamides containing the No-Hz and Ct-Hz dimer caps at the polyamide 
N-terminus are able to target 5’-GT-3’ and 5’-TT-3’ sequences with good affi nity and specifi city 
and represent new recognition elements for the minor groove of DNA. The No-Hz and Ct-Hz dimer 
caps represent attempts to broaden heterocycle designs beyond single base pair interactions. In 
addition, the development of the No-Hz cap has allowed for the design of a DNA binding molecule, 
which in a formal sense is no longer a polyamide, hence the term programmable oligomer. We are 
encouraged by the fact that this oligomer demonstrates excellent affi nity for DNA while exhibiting 
good levels of specifi city. We hope to apply these new heterocycles to the targeting of biologically 
relevant sequences in the context of integrating artifi cial transcription factors with living biological 
systems.
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C.7 Supplemental Information
C.7.1 General
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N,N-dimethylformamide (DMF), N,N-diisopropylethylamine (DIEA), thiophenol (PhSH), 
3-dimethylamino-1-propylamine (Dp), Triethylamine (TEA), and thiourea were purchased from 
Aldrich. Boc-β-alanine-(4-carbonylaminomethyl)benzyl-ester-copoly(styrenedivinylbenzene) 
resin (Boc-β-Pam-resin), dicyclohexylcarbodiimide (DCC), hydroxybenzotriazole (HOBt), 
2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafl uorophosphate (HBTU), 
4-dimethylaminopyridine (DMAP), and Boc-β-alanine were purchased from NOVA Biochem. 
Trifl uoroacetic acid (TFA) was purchased from Halocarbon. All other solvents were reagent grade 
from EMD Chemicals. Oligonucleotide inserts were synthesized by the Biopolymer Synthesis 
Center at the California Institute of Technology. Precoated silica gel plates 60 F
254
 for TLC and 
silica gel 60 (40 μm) for fl ash chromatography were from Merck. Glycogen (20 mg/mL), dNTPs 
(PCR nucleotide mix), and all enzymes, unless otherwise stated, were purchased from Boehringer-
Mannheim. pUC19 was purchased from New England Biolabs, and deoxyadenosine [γ-32P]
triphosphate was provided by ICN.  Calf thymus DNA (sonicated, deproteinized) and DNaseI (7500 
units/mL, FPLC pure) were from Amersham Pharmacia. AmpliTaq DNA polymerase was from 
Perkin-Elmer and used with the provided buffers. Tris.HCl, DTT, RNase-free water, and 0.5 M 
EDTA were from United States Biochemical. Calcium chloride, potassium chloride, and magnesium 
chloride were purchased from Fluka. Tris-borate-EDTA was from GIBCO, and bromophenol blue 
was from Acros. All reagents were used without further purifi cation.  NMR spectra were recorded 
on a Varian spectrometer at 300 MHz in DMSO-d
6
 or CDCl
3
, with chemical shifts reported in parts 
per million relative to residual solvent. UV spectra were measured on a Hewlett-Packard model 
8452A diode-array spectrophotometer. High-resolution FAB and EI mass spectra were recorded at 
the Mass Spectroscopy Laboratory at the California Institute of Technology. Matrix-assisted laser 
desorption/ionization time-of-fl ight mass spectrometry (MALDI-TOF-MS) was conducted at the 
Mass Spectroscopy Laboratory at the California Institute of Technology.
C.7.2 Heterocycle Synthesis
The synthesis of compounds 4 (Boc-Py-OBt), 5 (Boc-Im-OH), 10 (Boc-Py-Bi-OH), 11 (Boc-Im-
HzOMe-OH), 19 (Ct-OH), 10, 22 (Im-HzOMe-OH), and 16 (aryl diamine) have previously been 
reported.8,10a
C.7.2.1 Methyl 5-methyl-1,3-oxazole-4-carboxylate (No-OMe) (14)
Compound 14 was prepared following an exact preparation reported by Suzuki et al.18 and purifi ed 
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by normal phase column chromatography. According to the Suzuki procedure a mixture of methyl-
alpha-isocyanoacetate (3.0 g, 30.2 mmol) and DBU (4.5 g, 30.2 mmol) in dry THF (40 mL) at 
10oC, was treated with acetic anhydride (3.06 g, 30 mmol) in dry THF (10 mL) dropwise.  The 
reaction was allowed to warm to room temperature and stirred for 10 h.  The solvent was removed 
by rotoevaporation and water (100 mL) was added.  The mixture was extracted with EtOAc (2 x 
100 mL). The organic layers were combined, dried over sodium sulfate, fi ltered, and concentrated 
in vacuo to provided 14 as a crude amber oil.  The oil was subjected to column chromatography 
using (3:2 Hex/EtOAc) to provide 14 (2.73 g, 64% Yield) as a crystalline white solid.  TLC (3:2 
Hex/EtOAc) R
f  
0.5; 1H NMR (DMSO-d
6
) 8.32 (s, 1H), 3.77 (s, 3H), 2.55 (s, 3H); 13C (DMSO-d
6
) 
161.9, 156.1, 150.3, 126.2, 51.5, 11.5; HR-MS (EI): calculated for C
6
H
7
NO
3
: 141.0426; found: 
141.0427.
C.7.2.2 5-Methyl-1,3-oxazole-4-carboxylic acid (No-OH) (15)
A mixture of 14 (1 g, 7.08 mmol), 1N NaOH (10 mL) and MeOH (5 mL) was stirred at 40oC 
for 4 h.  The MeOH was removed by rotoevaporation and the pH adjusted to pH = 2 with 1N 
HCl.  The precipitate was extracted with EtOAc (3 x 10 mL), the organics dried over sodium 
sulfate and removed by rotoevaporation to provide 15 (738 mg, 82% Yield) as a fi brous white 
solid.  TLC (3:2 EtOAc/Hex +10% AcOH) R
f  
0.4; 1H NMR (DMSO-d
6
) 8.27 (s, 1H), 2.45 (s, 3H); 
13C (DMSO-d
6
) 163.0, 155.6, 150.1, 145.6, 11.6; HR-MS (EI): calculated for C
5
H
5
NO
3
: 127.0269; 
found: 127.0268.
C.7.2.3 Methyl 7-methoxy-2-(5-methyl(1,3-oxazole-4-yl))benzimidazole-6-carboxylate 
(NoHz(OMe)OMe) (17)
To a solution of 15 (0.3 g, 2.36 mmol) in DMF (4 mL) was added DIEA (915 mg, 1.23 mL, 7.08 
mmol) and HBTU (895 mg, 2.36 mmol). The mixture was stirred at room temperature for 1 h, 
followed by the addition of the aryl diamine 16 (463 mg, 2.36 mmol).  The reaction was then heated 
to 35oC and stirred for an additional 24 h. The reaction was allowed to cool to room temperature and 
then poured into a separatory funnel containing water (200 mL). The water was then extracted with 
Scheme C.2 Synthesis of 15.
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EtOAc (2 x 100 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated 
in vacuo to provide a crude solid, which was dissolved in glacial acetic acid (5 mL) and heated to 
90oC.  The reaction was stirred for 12 h, followed by removal of the solvent by rotoevaporation. 
The resultant residue was subjected to column chromatography (4:1 EtOAc/Hex) to provide 17 as 
a thin fi lm.  Addition of hexanes to the fi lm, followed by rotoevaporation and drying under high 
vacuum provided 17 as a white solid (379 mg, 56% Yield).  TLC (4:1 EtOAc/Hex) R
f  
0.75; 1H 
NMR (DMSO-d
6
) 8.49 (s, 1H), 7.51 (d, 1H, J = 8.7 Hz), 7.16 (d, 1H, J = 8.7 Hz), 4.34 (s, 3H), 3.77 
(s, 3H) 2.78 (s, 3H); 13C (DMSO-d
6
) 166.7, 151.0, 149.3, 145.5, 139.0, 135.3, 125.6, 124.8, 114.2, 
105.3, 60.8, 51.6, 11.3; HR-MS (EI): calculated for C
14
H
13
N
3
O
4
: 287.0906; found: 287.0914.
C.7.2.4 7-methoxy-2-(5-methyl(1,3-oxazole-4-yl))benzimidazole-6-carboxylic acid (NoHz(OMe)
OH) (7)
A mixture of 17 (200 mg, 0.69 mmol), DMSO (0.8 mL), and 1N NaOH (4 mL) was stirred at 23 
oC for 3 h. The solution was diluted with 8 mL of H
2
O and the pH was adjusted to pH = 2 with 1N 
HCl (4.4 mL).  The precipitate was fi ltered and washed with diethyl ether.  The crude material was 
purifi ed by silica gel chromatography (1:1 EtOAc/Hexanes + 2% AcOH to 3:1 EtOAc/Hexanes + 
2% AcOH) to provide 7 (156 mg, 82% Yield) as a white solid after drying under high vacuum.  TLC 
(3:1 EtOAc/Hex +2% AcOH) R
f  
0.55; 1H NMR (DMSO-d
6
) 13.12 (s, 1H), 12.37 (s, 1H), 8.51 (s, 
1H), 7.52 (d, 1H, J = 8.5 Hz), 7.15 (d, 1H, J = 8.5 Hz), 4.34 (s, 3H), 2.78 (s, 3H); 13C (DMSO-d
6
) 
167.8, 151.1, 150.9, 149.3, 145.5, 139.0, 135.5, 125.8, 125.2, 115.2, 105.4, 60.9, 11.4; HR-MS 
Scheme C.3 Synthesis of 7.
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(FAB): calculated for C
13
H
12
N
3
O
4
: 274.0828; found: 274.0833 [M+H]+.
C.7.2.5 Ct-Hz(OMe)OMe (19)
To a solution of 18 (294 mg, 1.80 mmol) in DMF (5 mL) was added DIEA (0.348 mL, 1.98 mmol) 
and HBTU (650 mg, 1.72 mmol).  The mixture was stirred at room temperature for 1 h, followed 
by the addition of the aryl diamine 16 (300 mg, 1.80 mmol).  The reaction was then heated to 
35oC and stirred for an additional 24 h.  The reaction was allowed to cool to room temperature and 
then poured into a Falcon tube containing cold water (40 mL) resulting in a cloudy precipitate. 
The Falcon tube was centrifuged at 14000 rpm for 10 min, the mother liquor decanted, and the 
precipitate dried under high vacuum.  After drying, the crude solid was dissolved in glacial acetic 
acid (5 mL) and heated to 90 oC.  The reaction was stirred for 12 h, followed by removal of the 
solvent by rotoevaporation.  The resultant residue was subjected to column chromatography (3:2 
EtOAc/Hex) to provide 19 as an off-white solid (647 mg, 57% Yield). TLC (3:2 EtOAc/Hex) R
f
 
0.5; 1H NMR (DMSO-d
6
) 12.85 (s, 1H), 7.89 (d, 1H, J = 5.3 Hz), 7.56 (d, 1H, J = 8.5 Hz), 7.27 (d, 
1H, J = 8.2), 7.26 (d, 1H, J = 5.3), 4.30 (s, 3H), 3.80 (s, 3H); 13C (DMSO-d
6
) 166.6, 151.2, 144.0, 
139.8, 134.8, 129.7, 129.4, 126.3, 125.6, 123.2, 114.8, 106.1, 61.2, 51.8; HR-MS (EI): calculated 
for C
14
H
11
N
2
O
3
SCl: 322.0179; found: 322.0171.
Scheme C.4 Synthesis of 8.
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C.7.2.6 Ct-Hz(OMe)OH (8)
A mixture of 19 ( 1.8 g, 5.58 mmol), 1N NaOH (36 mL) and MeOH (27 mL) was stirred at 45oC 
for 24 h.  The MeOH was removed by rotoevaporation and the pH adjusted to pH = 5.5 with 1N 
HCl, resulting in a precipitate.  The mixture was spun down in a centrafuge (5 min at 14,000 
rpm).  The tube was decanted leaving a white solid that was dried under high vacuum to provide 
8 (2.6 g, Quant. Yield) as a light yellow solid. TLC (3:2 EtOAc/Hex + 10% AcOH) R
f 
 0.5; 1H 
NMR (DMSO-d
6
) 13.00 (s, 1H), 7.89 (d, 1H, J = 5.3 Hz), 7.57 (d, 1H, J = 8.5 Hz), 7.30 (d, 1H, J 
= 8.5), 7.25 (d, 1H, J = 5.3 Hz), 4.28 (s, 3H); 13C (DMSO-d
6
) 167.7, 151.1, 143.9, 139.7, 134.9, 
129.6, 129.3, 126.4, 125.7, 123.2, 115.9, 106.1, 61.2; HR-MS (EI): calculated for C
13
H
9
N
2
O
3
SCl: 
308.0022; found: 308.0033.
Scheme C.5 Synthesis of 1.
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C.7.3 Polyamide Synthesis
Polyamides were synthesized from Boc-β-alanine-Pam resin (50 mg, 0.59 mmol/g) and purifi ed 
by preparatory HPLC according to published manual solid phase protocols.4 The synthesis of batch 
resin BR1 (H
2
N-Py-Py-γ-Im-Py-Py-Py-β-Pam) has previously been reported.8
C.7.3.1 Im-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (1)
22 (Im-HzOMe-OH) (25 mg, 88.5 μmol) was incorporated by activation with HBTU (32 mg, 84 
μmol), DIEA (23 mg, 31 μl, 177 μmol) and DMF (250 μl).  The mixture was allowed to stand for 
Scheme C.6 Compound 2.
Scheme C.7 Compound 3.
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15 min at room temperature and then added to the reaction vessel containing base resin BR1 H
2
N-
Py-Py-γ-Im-Py-Py-Py-β-Pam.  Coupling was allowed to proceed for 12 h at room temperature.  The 
resin-bound polyamide was then washed with DCM and treated as described in the deprotection 
protocol below to provide Im-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (1) (0.9 mg, 2.4 % recovery) as a 
fi ne white powder under lyophilization of the appropriate fractions.  MALDI-TOF-MS: calculated 
for C
59
H
70
N
21
O
10
: 1232.56; found 1232.55 [M+H]+.
C.7.3.2 No-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (2)
7 (No-HzOMe-OH) was incorporated as described  above for Im-Hz-OH (polyamide 1) to provide 
No-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (2) (1.5 mg, 4.1 % recovery) as a fi ne white powder under 
lyophilization of the appropriate fractions. MALDI-TOF-MS: calculated for C
59
H
69
N
20
O
11
: 1233.55; 
found 1233.54 [M+H]+.
C.7.3.3 Ct-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (3)
8 (Ct-HzOMe-OH) was incorporated as described  above for Im-Hz-OH (polyamide 1) to provide 
Ct-Hz-Py-Py-γ-Im-Py-Py-Py-β-Dp (3) (1.1 mg, 2.9 % recovery) as a fi ne white powder under 
lyophilization of the appropriate fractions. MALDI-TOF-MS: calculated for C
59
H
67
ClN
19
O
10
S: 
1269.47; found 1269.47 [M+H]+.
C.7.4 Deprotection of the O-Methyl-Protected Polyamides
O-Methyl protected polyamides were cleaved from resin, purifi ed, deprotected and subject to further 
purifi cation using the following general procedure. Upon completion of solid phase synthesis, 
3-dimethylamino-1-propylamine (Dp) (500 μL) was added to the synthesis vessel containing the 
resin (50 mg). The mixture was allowed to stand for 2 h at 85oC with occasional agitation.  The 
resin was then fi ltered and the solution diluted to 8 mL using 0.1% TFA. The sample was purifi ed 
by reversed phase HPLC and lyophilized to provide polyamides containing the O-methyl protected 
hydroxybenzimidazole unit (-HzOMe-) as a dry solid. The polyamides were then dissolved in DMF 
(200 μl) and added to a suspension of sodium hydride (40 mg, 60% oil dispersion) and thiophenol 
(200 μl) in DMF (400 μl) that was pre-heated for 5 min at 85oC. The mixture was heated for 2 h at 
85oC. The mixture was then cooled to 0 oC and 20% TFA (7.0 mL) was added. The aqueous layer 
was washed three times with diethyl ether (8 mL) and then diluted to a total volume of 9.5 mL 
using 0.1% TFA.  The mixture was then purifi ed by reverse-phase HPLC to give the deprotected 
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Hz-containing polyamides 1, 2, and 3.
C.7.5 Oligomer 9 Synthesis
Oligomer 9 was prepared using Kaiser oxime resin (0.65 meqiv/gram) from Nova Biochem. Oxime 
resin (0.1 grams), was added to a solid phase synthesis vessel. The resin was then washed with 
DCM (15 mL) followed by DMF (15 mL). In a separate vessel was added Boc-PyBi-OH (10) (60 
mg, 0.168 mmol), HBTU (61 mg, 0.159 mmol), DIEA (43 mg, 60 μL, 0.336 mmol), and DMF (400 
μL). The mixture was vortexed and allowed to activate for 20 minutes at room temperature. The 
Scheme C.8 Synthesis of 9-13.
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activated mixture was then added to the resin. The reaction vessel was shaken at room temperature 
overnight. The reaction vessel was then drained and the resin washed with DMF (15 mL), followed 
by DCM (15 mL). The resin was then washed with a solution of 25% TFA in DCM (20 mL), followed 
by shaking with 25% TFA in DCM at room temperature for 25 min to deprotect the Boc-protected 
alkyl amine, followed by shaking at room temperature for 25 min to deprotect the Boc-protected 
amine of pyrrole. In a separate vessel, a mixture of Boc-ImHz-OH (11) was activated using HBTU, 
DIEA, and DMF as described above. The reaction vessel containing the resin was then drained and 
washed with DCM (15 mL) and 10% DIEA in DMF. The activated Boc-ImHz-OBt dimer was then 
added to the vessel containing (Resin-BiPy-NH
2
). The mixture was shaken at room temperature for 
2.5 h. The reaction vessel was then drained and washed with DMF (15 mL) and DCM (15 mL). 
A solution of 50% TFA in DCM was then washed over the resin (20 mL), followed by shaking 
at room temperature for 25 minutes. In a separate vessel, a mixture of α-Fmoc-γ-Boc-(R)-2,4-
diaminobutyric acid, ((R)-Fmoc-α-Boc-γ-Daba, and (12) was activated using HBTU, DIEA, and 
DMF as described above. The reaction vessel containing the resin was then drained and washed 
with DCM (15 mL) and 10% DIEA in DMF. The activated (R)-Fmoc-α-Boc-γ-Daba-OBt monomer 
was then added to the vessel containing (Resin-BiPy-HzIm-NH
2
). The mixture was shaken for 2 
h at room temperature. The reaction vessel was then drained and the resin washed with DMF (15 
mL), followed by DCM (15 mL). The resin was then washed with a solution of 25% TFA in DCM 
(20 mL), followed by shaking with 25% TFA in DCM at room temperature for 25 min to deprotect 
the Boc-protected alkyl amine. In a separate vessel, a mixture of Boc-PyBi-OH (10) was activated 
using HBTU, DIEA and DMF as described above. The reaction vessel containing the resin was 
then drained and washed with DCM (15 mL) and 10% DIEA in DMF. The activated Boc-PyBi-OBt 
dimer was then added to the vessel containing (Resin-BiPy-HzIm-γDaba-NH
2
).  The mixture was 
shaken at room temperature for 2.5 h. The reaction vessel was then drained and the resin washed 
with DMF (15 mL), followed by DCM (15 mL).  The resin was then washed with a solution of 
25% TFA in DCM  (20 mL), followed by shaking with 25% TFA in DCM at room temperature 
for 25 min to deprotect the Boc-protected alkyl amine, followed by shaking at room temperature 
with  25% TFA in DCM for 25 min to deprotect the Boc-protected amine of pyrrole. In a separate 
vessel, a mixture of NoHzOMe-OH (13) was activated using HBTU, DIEA and DMF as described 
above for (10). The reaction vessel containing the resin was then drained and washed with DCM 
(15 mL) and 10% DIEA in DMF. The activated NoHzOMe-OBt dimer was then added to the vessel 
containing (Resin-BiPy-HzIm-γDaba-BiPyNH
2
). The mixture was shaken at room temperature for 
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2.5 h. The reaction vessel was then drained and washed with DMF (15 mL) and DCM (15 mL) to 
provide (Resin-BiPy-HzIm-γDaba-BiPy-HzNo).
C.7.6 O-Methyl Deprotection
To the synthesis vessel containing (Resin-BiPy-HzIm-γDaba-BiPy-HzNo) was added DCM (800 
μL) and BCl
3
 (400 μL), (2M in heptanes). The mixture was shaken at room temperature for 2.5 h. 
The vessel was then drained and washed with DCM (15 mL). Deprotection was determined to be 
complete by analytical HPLC
C.7.7 Cleavage From Resin
Following O-Methyl deprotection, DCM (200 μL) and MeNH
2
 (1 mL) (2M in THF) was added to 
the synthesis vessel. The mixture was then shaken at 35oC for 12 h. The fi ltrate was collected from 
the synthesis vessel and the organics removed in vacuo. The remaining residue was dissolved in 
0.1% TFA and purifi ed using preparatory reverse phase HPLC. Lyophilization of the appropriate 
fractions provided oligomer 9 as a fi ne powder solid. MALDI-TOF-MS: calcd for C
55
H
49
N
19
O
8
: 
1103.40; found 1103.41 [M+H]+.
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Appendix D: Peptoid Cell Uptake Studies
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Abstract
 Peptoids 5-FAM (1) and 6-FAM (2), previously reported by the Kodadek group, were 
synthesized and their cell uptake properties evaluated in HeLa cells using confocal laser scanning 
microscopy. A dual imaging laser system was used to image the peptoids and a DNA-binding 
nuclear stain simultaneously. The results demonstrate that the peptoids 5-FAM (1) and 6-FAM (2) 
are not cell permeable in HeLa cells.
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D.1 Summary
 Peptoids are a class of N-alkylated poly-glycine oligomers that have recently been exploited 
for the rapid synthesis of protein-targeted combinatorial libraries in an effort to discover new bio-
active compounds with superior cell permeability and protease sensitivity as compared to traditional 
peptide scaffolds.1-3 Recently, the Kodadek group has demonstrated that these compounds are 
often cell permeable and can be utilized as molecular recognition domains.4 A peptoid was shown 
to be effective as a transcriptional activation domain for GST-KIX in a HeLa cell reporter gene 
assay.5 The peptoid domain which bound a GST-KIX fusion protein with a K
d
 of 11.6 μM was 
discovered from a library of 50,000 members screened against the murine CREB core KIX domain. 
A carboxyfl uoresceinated version of this peptoid (mixture of 1 and 2, Figure D.1) was used for KIX 
binding studies in comparison to a scrambled peptoid sequence, which was shown not to bind the 
GST-KIX domain. In an effort to evaluate the potential use of this peptoid activation domain for 
use with different polyamide DNA binding scaffolds, the exact peptoid-fl uorophore conjugates (1 
and 2, Figure D.1) from the Kodadek study were synthesized independently (not as a mixture) as 
shown in Figure D.2. The cell uptake properties of these peptoid-FAM conjugates were assessed 
using confocal laser scanning microscopy and dual imaging studies with DNA binding dyes were 
performed to provide unambiguous location of the cell nuclei. These studies were performed in 
HeLa cells and show that the peptoid was completely excluded from the cell interior as shown in 
Figures D.3 and D.4.
Figure D.1 Compound 1, 5-FAM, and 2, 6-FAM.
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Figure D.2 Synthesis of compound 1 and 2. For details, see Section D.2 Experimental.
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Figure D.3 HeLa cell uptake studies for compound 1 (5-FAM) using 2μM concentration. Dual 
image with Hoechst 33342. (2-Photon Laser l = 810 nm, 5% Power, BP480 - 520 nm fi lter.).
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D.2 Experimental
D.2.1 Materials
D.2.1.1 Resin
 Knorr Amide MBHA resin, Nova Biochem, 01-64-0459, A33927
 Resin loading = 0.78 mmol/g
 Amount = 200 mg
D.2.1.2 Stock solution preparation 
Stock solution A
Figure D.4 HeLa cell uptake studies for compound 2 (6-FAM) using 2μM concentration. Dual 
image with Hoechst 33342. (2-Photon Laser l = 810 nm, 5% Power, BP480 - 520 nm fi lter.)
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 2 mL of piperidine in 8 mL of DMF.
Stock solution B
 3.7 g of bromoacetic acid (3) in 14 mL of DMF.
Stock solution C
 7 mL of N,N’-diisopropylcarbodiamide in 7 mL of DMF.
D.2.1.3 Amine solution preparation
Solution M1
 300 μL of allylamine (4) in 1.7 mL DMF.
Solution M2
 510 μL of (R)-(+)-α-methylbenzylamine (5) in 1.49 mL DMF.
Solution M3
 1.5 g (1.53 mL) of N-Boc-1,4-butane diamine (6) in 2.47 mL DMF.
Solution M4
 1.5 g (1.53 mL) of N-Boc-1,4-butane diamine (6) in 2.47 mL DMF.
Solution M5
 500 μL of piperonylamine (7) in 1.5 mL DMF.
D.2.2 General bromoacetic acid addition procedure
Resin was treated with 2 mL of stock solution B followed by 2 mL of stock solution C. Next, the 
synthesis vessel was capped and microwaved for 15 sec on the low power setting followed by 
shaking and another 15 sec in the microwave. Next, the resin synthesis vessel was drained and 
washed with DMF (4 x 5 mL) followed by a fi nal wash with 10 mL of anhydrous DMF.
D.2.3 General amine addition procedure
Resin was treated with the appropriate amine solution and agitated for 15 sec followed by 15 sec 
in the microwave on the low power setting. The reaction mixture was agitated for another 15 sec 
and microwaved again for 15 sec on the lower power setting followed by draining of the vessel and 
washed with DMF (4 x 5mL). Finally, a wash with 10 mL of anhydrous DMF was performed.
D.2.4 Peptoid synthesis procedure (Synthesis of Resin PR-1)
A solid phase synthesis vessel was charged with 200 mg of Knorr Amide MBHA resin and swelled 
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in DMF for 20 min with agitation. The resin was then washed 4 times with DMF, treated with 20% 
piperidine in DMF for 20 min (2 mL x 20 min each), washed with DMF (8 x 5 mL), and washed 
with 10 mL of anhydrous DMF. 
 1. General bromoacetic acid addition procedure.
 2. General amine addition procedure using solution M1.
 3. General bromoacetic acid addition procedure.
 4. General amine addition procedure using solution M2.
 5. General bromoacetic acid addition procedure.
 6. General amine addition procedure using solution M3.
 7. General bromoacetic acid addition procedure.
 8. General amine addition procedure using solution M4.
 9. General bromoacetic acid addition procedure.
 10. General amine addition procedure using solution M5.
After step 10, the resin washed with DMF (5 x 5 mL), dichloromethane (10 x 5 mL), and then dried 
under high vacuum. This resin was called PR-1. Next, a very small aliquot of resin was cleaved 
using 95% TFA/H
2
O for 1 h at room temperature. The solution was diluted with water, fi ltered, and 
checked by HPLC and ESI-MS. HPLC showed a single peak for product and the ESI-MS results 
are listed below.
 Expected mass of product = 722.41 
 Found [M+H]+ = 723.3, [M+Na]+ = 745.4
D.2.5 Procedure for fi rst mini-PEG coupling (Synthesis of Resin PR-2)
The resin, PR-1, from the peptoid synthesis procedure above was swelled in DMF for 30 min and 
drained. A separate vial was charged with 180 mg of Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-
AEEA, 8, CAS 166108-71-0, Peptides International), 244 mg of PyBOP, 92 μL of DIEA, and 1 mL 
of DMF. This reaction mixture was stirred at 23 C for 15 min and then added to the swelled resin 
PR-1. The reaction mixture was then put in a shaker at 37 C for 8 h. The resin washed with DMF 
(5 x 5 mL), dichloromethane (10 x 5 mL), and then dried under high vacuum to give resin PR-2 
(Yield = 351 mg of dry resin). Next, a very small aliquot of resin was cleaved using 95% TFA/H
2
O 
for 1 h at room temperature. The solution was diluted with water, fi ltered, and checked by HPLC 
and ESI-MS. HPLC showed a single peak for product and the ESI-MS results are listed below.
 Expected mass of product = 1089.55 
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 Found [M+H]+ = 1090.4, [M+Na]+ = 1112.5
D.2.6 Preparation of peptoid 5-FAM (1)
The resin PR-2 (20 mg) from the peptoid synthesis procedure above was swelled in DMF for 20 
min and drained. Next, the Fmoc protecting group was removed by addition of 20% piperidine 
in DMF (2 x 4 mL for 10 min each). The resin was then washed with DMF (10 x 2 mL) then 
5 mL of anhydrous DMF. Next, the deprotected resin was treated with a solution of 2 mg of 
5-carboxyfl uorescein succinimidyl ester (5-FAM-SE, Molecular Probes, C2210) in 300 μL of 
DMF. The reaction fl ask was covered with foil and agitated at 23 C for 1 h followed by 37 C for 
1 hr. Next, the resin was drained, washed with DMF (10 x 1 mL), dichloromethane (10 x 1 mL), 
and dried under high vacuum. Next, the FAM labeled peptoid was cleaved from resin using 95% 
TFA/2.5% H
2
O/2.5% triisopropylsilane for 1 h. The crude product was purifi ed by preparative 
reverse phase HPLC eluting from 10% acetonitrile/90% (0.1% TFA-H
2
O) to 50% acetonitrile/50% 
(0.1% TFA-H
2
O) over 70 min. The pure product eluted at minute 47 to give 5-FAM (1.74 μmol). 
Extinction coeffi cient for 5-FAM is 75000 at pH = 9.0, λ
max
 = 498 nm.
1 (5-FAM): ESI-MS calculated for [M+H]+: 1226.5, observed [M+H]+: 1226.4
D.2.7 Preparation of peptoid 6-FAM (2)
Peptoid 6-FAM (2) was synthesized using the exact same procedure as for making 5-FAM except 
6-carboxyfl uorescein succinimidyl ester (6-FAM-SE, Molecular Probes, C-6164) was used. 
Purifi cation was performed in the same manner and the elution time for the pure product was the 
same to give 6-FAM (1.13 μmol). Extinction coeffi cient for 6-FAM is 75000 at pH = 9.0, λ
max
 = 
498 nm.
2 (6-FAM): ESI-MS calculated for [M+H]+: 1226.2, observed [M+H]+: 1226.2 
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Appendix E: Cell Uptake Studies of 4G Targeting Polyamides
The research in this appendix is an extension of results from a combination of Chapter 7 and 8. 
Julie A. Poposki (Caltech) is thanked for HeLa cell culture work and assistance with cell uptake 
experiments.
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Abstract
 A benzimidazole-containing polyamide targeted to the sequence 5’-WGGGGW-3’ was 
discovered to have fl uorescent properties in aqueous solution in the presence and absence of DNA. 
This set of properties allowed for the unique opportunity to interrogate polyamide cell uptake in 
the absence of fl uorophore conjugation, which alters the molecular architecture of a compound and 
often infl uences cell permeability. A 23-member library of the core benzimidazole polyamide with 
variations at the tail and turn was synthesized and uptake properties were evaluated in HeLa cells 
using 2-photon confocal laser scanning microscopy. Investigations of cellular localization using 
organelle specifi c dyes were also conducted along with the elucidation of an effl ux mechanism for 
certain polyamides in the library.
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E.1 Introduction
 The core benzimidazole containing polyamide 2 from Chapter 61 (Figure E.1) was discovered 
to possess a unique set of photophysical properties where the emission maximum was found to be 
475 nm and the excitation maximum was λ = 330 nm. Excitation in the range of 380–390 nm was 
used to minimize photobleaching while still producing a detectible amount of emission at 500 nm. 
This inherent fl uorescent property allowed for the unique opportunity to study cellular localization 
of this polyamide architecture without attachment of a fl uorophore, which can often infl uence the 
cellular uptake process.2-4 A library of polyamides (Figure E.2) containing the fl uorescent core was 
synthesized, where the functionality at the turn and tail was modifi ed in an effort to alter the overall 
uptake properties. HeLa cells were used for all studies and the polyamides were imaged using two-
photon confocal laser scanning microscopy. After assessing the cellular uptake properties of the 
library of polyamide tail and turn modifi cations a study was conducted to determine the location of 
the polyamides in cells (mitochondria, 
nuclei, vessicals, lysozomes, etc.). 
Additionally, a polyamide that 
was found to remain extracellular 
was investigated to discriminate 
between cellular impermeability 
versus effl ux using the the racemic 
effl ux pump inhibitor (±)-Verapamil 
(2-(3,4-dimethoxyphenyl)-5-[2-
( 3 , 4 - d i m e t h o x y p h e n y l ) e t h y l -
methyl-amino]-2-(1-methylethyl)
pentanenitrile, CAS 52-53-9). The 
effect of ethanol fi xing on the cellular 
uptake of polyamides as a function 
of time was also investigated and the 
ability of common transfection reagents 
to infl uence polyamide uptake was 
studied. 
E.2 Results and Discussion
Figure E.1 Fluorescent polyamide 2 from Chapter 7 
of this thesis. (bottom) Overlaid emission and excitation 
spectra of polyamide 2.
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 A focused library of 23 
compounds was synthesized 
containing tail and turn 
modifi cations on a common 
polyamide core (Figure E.2). The 
polyamide was synthesized on 
Kaiser Oxime resin by standard 
solid-phase synthesis methods as 
shown in Scheme E.1 to provide 
a base resin loaded with the 
desired polyamide core used for 
tail and turn diversifi cation. With 
the core in hand, diversifi cation 
commenced with deprotection 
and cleavage from resin to afford 
triamine derivatives 3, 9, 20, 22, 
and 23 (Scheme E.2). Deprotection 
and resin cleavage with a small set 
of amine nucleophiles produced 
compounds 1, 2, 4-8, 10, 11, 13-
16, and 19. Acylation prior to 
deprotection followed by cleavage 
from resin with amine nucleophiles 
produced compounds 12, 17, and 
18. Deprotection and cleavage 
from resin with lithium hydroxide 
produce compound 21.
 The cell permeability 
of this small focused library of 
compounds was evaluated in HeLa cells using 2-photon laser-scanning confocal microscopy and the 
results are shown in Figures E.3–E.8. The results are grouped according to their cellular localization 
profi le with Figures E.3–E.6 showing compounds that appear to be cell permeable but non-nuclear, 
Figure E.2 Tail and turn modifi cations used for the contruc-
tion of a 23 compound benzimidazole-containing polyamide 
library.
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Scheme E.1. Synthesis of R4. Standard solid-phase synthesis methods from Chapter 71 were 
used.
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producing punctate cytoplastmic staining pattern. The compounds shown in Figure E.7 appear to 
be primarily extracellular and aggregated or precipitated with the fi rst two compounds coating the 
exterior cell membranes. Figure E.8 shows compounds that are primarily extracellular although in 
a few cases there is a small amount of non-nuclear cellular localization observed. 
 In an effort to determine the location of the compounds inside the cells in Figures E.3–E.6 
(punctate cytoplasmic staining) two organelle specifi c dyes were utilized. MitoTracker Red (CM-
H2XRos) was used to asses the possibility of mitochondrial localization and LysoTracker Red 
(DND-99, a lysosome and trans-golgi stain) to asses localization in acidic lysosomes within the cell. 
Previous reports by Lown and coworkers demonstrated that a distamycin-fl uorophore conjugate 
Scheme E.2. Synthesis of compound library. Reaction conditions: (i) NMP, Triamine, 80 ºC 
(Heat Block), 15-20 min; (ii) Conjugation to triamine, TFA, DCM; (iii) TFA, DMC; (iv) NMP, 
Nucleophile, 80 ºC (Heat Block), 15-20 min; (v) Ac
2
O, NMP. 
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primarily localizes in the mitochondria of human ovarian adenocarcinoma cells.5 The mechanism 
of mitochondrial staining by MitoTracker relies upon passive diffusion of the pro-fl uorescent dye 
into the cell where it is oxidized and sequestered in the mitochondria (Figure E.9). Once in the 
mitochondria, nucleophilic attack resulting in thiol conjugation by proteins and peptides serves to 
retain the dye. Polyamide treated HeLa cells were dosed with MitoTracker prior to dual imaging 
using confocal laser scanning microscopy. The results show that the mitochondria appear as a diffuse 
cytoplasmic stain (Figure E.10, upper left live cell panel, magenta). The upper right panel shows 
the polyamide imaged with an orthogonal wavelength to Mitotracker and the bottom right panel 
shows that the two do not colocalize. It appears that the polyamide is not localized in mitochondria. 
Interestingly, ethanol fi xing (fi xed cell panel, bottom right, Figure E.10) of the cells leads to rapid 
nuclear traffi cking of the polyamide however the diffuse mitochondria staining appears unchanged. 
It appears that unlike the Distamycin conjugates studied by Lown this class of polyamides does not 
localize in the mitochondria. However, this is not a surprising result given the dramatic differences 
in molecular structure and cell type. 
 Next, LysoTracker was used to determine if the polyamides were localized in acidic 
lysosomes of the cells. Figure E.11 shows the results of this study and it appears that the fl uorescence 
Figure E.3 Fluorescent polyamide cell uptake studies for compounds 1-4. 2-Photon Laser Imag-
ing Setup: Coherent Chameleon 2-photon Laser, (λ = 810 nm, 5% power), HFT KP 680 dichroic, 
BP 480-520 nm HeLa cells treated with 2mM 1-4 and imaged using 2-photon laser microscopy: 
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Figure E.5 Fluorescent polyamide cell uptake studies 9-11. 2-Photon laser imaging setup and 
polyamide dosing concentration as described in Figure E.2. 
Figure E.4 Fluorescent polyamide cell uptake studies 5-8. 2-Photon laser imaging setup and poly-
amide dosing concentration as described in Figure E.2.
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signal of the internalized polyamides colocalizes with the fl uorescence signal of LysoTracker, 
indicating that the polyamides are likely sequestered in acidic vessicles within the cells. This result 
is consistent with previous studies showing that in all cases 8-ring polyamides with 4 imidazoles 
show poor nuclear uptake profi les.3 Weakly basic amines have also been shown to selectively 
accumulate within low pH cellular compartments such as lysosomes.6 It should also be noted that 
the N,N-dimethylaminopropylamine tail commonly used to terminate polyamides and other classes 
of minor groove binders is very similar to the functionality present in LysoTracker responsible for 
targeting it to the lysosomes and acidic vessicles of cells. Additionally, high imidazole content has 
been correlated with low cell uptake and the four contiguous imidazoles in the polyamide core 
may be basic enough to target the polyamides to the lysosomes without the infl uence of any other 
functionality, however benzimidazole involvement can not be ruled out.3,4
 The uptake properties of polyamide 23 in Figure E.8 were investigated in an effort to 
determine their mechanism of exclusion from the cells. Polyamide 23 (Figure E.8) dosed HeLa cells 
were treated with (±)-Verapamil and imaged using 2-photon laser confocal microscopy. The results 
in Figure E.12 show that treatment of polyamide dosed cells with (±)-Verapamil causes uptake 
Figure E.6 Fluorescent polyamide cell uptake studies 12-15. 2-Photon laser imaging setup and 
polyamide dosing concentration as described in Figure E.2. 
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of the polyamide however the polyamide appears to be localized in acidic vessicles (potentially 
lysosomes) as in Figures E.3–E.6. Figure E.12 also shows that treatment of the cells with ethanol 
allows the polyamide to readily traffi c to the nucleus with signifi cant nuclear localization after 
2 h and complete localization after 4 h. Next the effect of a commonly used transfection reagent 
(Lipofectamine 2000) on polyamide nuclear localization was investigated (Figure E.13). The results 
show that the transfection reagent has little to no affect on the nuclear localization of this class of 
polyamide, however increased extracellular aggregation was observed.
Figure E.7 Fluorescent polyamide cell uptake studies 16-19. 2-Photon laser imaging setup and 
polyamide dosing concentration as described in Figure E.2. 
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Figure E.8 Fluorescent polyamide cell uptake studies 20–23. 2-Photon laser imaging setup and 
polyamide dosing concentration as described in Figure E.2.
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Figure E.10 Results of HeLa cell uptake study using MitoTracker and compound 4. Dual Laser 
Imaging Setup: Coherent Chameleon 2-photon Laser, (λ = 810 nm, 5% power), HFT KP 680 di-
chroic, BP 480-520 nm MitoTracker, HeNe Laser (λ = 543 nm, 10% power), HFT KP 680 dichroic, 
BP 565-615 nm 
Figure E.9 Mechanism of mitochondrial staining using MitoTracker.
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Figure E.11 Results of HeLa cell uptake study using Lysotracker and compound 4. Dual Laser 
Imaging Setup: Coherent Chameleon 2-photon Laser, (λ = 810 nm, 5% power), HFT KP 680 di-
chroic, BP 480-520 nm LysoTracker, HeNe Laser (λ = 543 nm, 10% power), HFT KP 680 dichroic, 
BP 565-615 nm 
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Figure E.12 Cell uptake with (±)-verapamil. Compound 23 concentration = 2μM in all experi-
ments and (±)-verapamil concentration = 100μM. HeLa cells used in all experiments. 2-Photon 
Laser Imaging Setup: Coherent Chameleon 2-photon Laser, (λ = 810 nm, 5% power), HFT KP 680 
dichroic, BP 480-520 nm  
334
E.3 Conclusion
 The results presented in these studies of a focused 23-member library of tail and turn 
modifi ed polyamides demonstrate that the uptake properties of benzimidazole-containing 
polyamides, targeted to the sequence 5’-WGGGGW-3’, can be divided into 2 broad categories. 
The fi rst category includes compounds that are intracellular but non-nuclear, displaying a punctate 
cytoplasmic staining. The second category of compounds remain extracellular and have overall poor 
cellular uptake properties. Localization studies of non-nuclear intracellular polyamides indicated 
lysosomal sequestering as determined by LysoTracker Red DND-99 colocalization studies. This 
is in stark contrast to observations by Lown and coworkers who found that fl uorescently-labeled 
dystamycin derivatives localized primarly to the mitochondria of human ovarian adenocarcinoma 
Figure E.13 Cell uptake study with Lipofectamine 2000 and compound 23 (concentration = 2μM 
in all experiments). Lipofectamine 2000 (Lipo2000) concentration = 1μL/150μL media. HeLa cells 
used in all experiments. 2-Photon Laser Imaging Setup: Coherent Chameleon 2-photon Laser, (λ = 
810 nm, 5% power), HFT KP 680 dichroic, BP 480-520 nm 
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cells (SKOV-3).5 In addition, the mechanism of poor uptake for compound 23 was investigated 
using the effl ux pump inhibitor (±)-verapamil7 and results from this study indicate that inhibition 
of effl ux pumps causes rapid cellular uptake, however lysosomal sequestration is observed as 
indicated by colocalization studies with LysoTracker. As documented previously, ethanol fi xing of 
cells causes rapid nuclear uptake due to increased membrane permeability.2-4 It has been reported 
that weakly basic amines selectively accumulate in cellular compartments with low internal pH and 
can be used to investigate the biosynthesis and pathogenesis of lysosomes.6 In addition to the use 
of weakly basic amines on the tail and turns of polyamides, high imidazole content has also been 
shown to be a negative determinant of nuclear localization.3,4 Currently, the cell uptake of high 
imidazole-containing polyamide sequences1 remains an unsolved problem.
E.4 Experimental
Synthesis of polyamides 1–23 was performed according to general solid phase synthesis protocols 
outlined in Chapter 7 and MALDI-TOF-MS data for all compounds is presented in Section E.6. 
The setup for 2-photon confocal laser scanning microscopy is reported in fi gure captions in this 
appendix.
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E.6 Spectra and Supplemental Information
1: MALDI-TOF-MS calculated for [M]: 1155.51, observed [M+H]+: 1156.13
2: MALDI-TOF-MS calculated for [M]: 1348.63, observed [M+H]+: 1348.54
3: MALDI-TOF-MS calculated for [M]: 1240.57, observed [M+H]+: 1241.63
4: MALDI-TOF-MS calculated for [M]: 1181.53, observed [M+H]+: 1182.50
5: MALDI-TOF-MS calculated for [M]: 1112.47, observed [M+H]+: 1113.76
6: MALDI-TOF-MS calculated for [M]: 1084.44, observed [M+H]+: 1085.58
7: MALDI-TOF-MS calculated for [M]: 1114.45, observed [M+H]+: 1115.53
8: MALDI-TOF-MS calculated for [M]: 1128.47, observed [M+H]+: 1129.78
9: MALDI-TOF-MS calculated for [M]: 1362.57, observed [M+H]+: 1363.71
10: MALDI-TOF-MS calculated for [M]: 1183.51, observed [M+H]+: 1184.55
11: MALDI-TOF-MS calculated for [M]: 1197.52, observed [M+H]+: 1198.74
12: MALDI-TOF-MS calculated for [M]: 1197.52, observed [M+H]+: 1198.45
13: MALDI-TOF-MS calculated for [M]: 1141.50, observed [M+H]+: 1142.37
14: MALDI-TOF-MS calculated for [M]: 1153.50, observed [M+H]+: 1154.61
15: MALDI-TOF-MS calculated for [M]: 1178.49, observed [M+H]+: 1179.76
16: MALDI-TOF-MS calculated for [M]: 1201.52, observed [M+H]+: 1202.90
17: MALDI-TOF-MS calculated for [M]: 1223.54, observed [M+H]+: 1224.59
18: MALDI-TOF-MS calculated for [M]: 1240.57, observed [M+H]+: 1241.60
19: MALDI-TOF-MS calculated for [M]: 1198.55, observed [M+H]+: 1199.50
20: MALDI-TOF-MS calculated for [M]: 1587.59, observed [M-FITC]+: 1199.90; 
      ESI-MS calculated for [M]: 1587.6, observed [M+H]+: 1588.1
21: MALDI-TOF-MS calculated for [M]: 1071.41, observed [M+H]+: 1072.51
22: MALDI-TOF-MS calculated for [M]: 1312.58, observed [M+H]+: 1313.53
23: MALDI-TOF-MS calculated for [M]: 1346.57, observed [M+H]+: 1347.78
